data_1xhj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xhj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.7 p . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.818 0.342 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 20.3 mtt -50.23 -53.75 25.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.624 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -39.92 -51.88 2.45 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.964 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.53 -51.16 69.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.717 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -61.29 -60.02 4.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.642 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.603 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.1 m -54.47 -54.22 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.72 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.603 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.28 -43.92 64.68 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.177 0.513 . . . . 0.0 109.743 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -61.6 -61.8 2.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.458 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.51 -40.22 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.337 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.8 mt -54.72 -64.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.841 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -30.59 32.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.717 0.294 . . . . 0.0 111.051 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -68.06 -51.41 46.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.602 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.2 -22.52 55.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.569 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 9.8 mtp180 -36.84 -60.58 0.76 Allowed Pre-proline 0 N--CA 1.469 0.494 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.9 Cg_endo -45.9 -39.26 19.13 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.809 2.339 . . . . 0.0 112.406 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -75.15 -43.7 51.03 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.403 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.3 mt -59.48 -48.73 80.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.285 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.1 tp -53.08 -43.67 66.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.8 mmm-85 -58.04 -48.04 81.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.037 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.75 -57.5 2.06 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -90.73 -76.41 1.32 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.462 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.5 -136.83 3.66 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -130.77 131.15 44.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.48 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.1 t -95.33 156.19 16.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 85.2 m -149.93 114.07 5.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.375 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 tp -69.6 126.77 30.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.258 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.98 -39.07 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.955 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -157.82 133.78 9.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.023 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 7.7 p -104.05 117.98 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.971 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -120.32 -179.18 3.88 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.964 0.411 . . . . 0.0 110.76 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -13.93 62.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.33 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.43 -32.69 0.03 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.7 59.98 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.019 0.437 . . . . 0.0 110.602 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 41' ' ' LYS . 1.2 t -69.51 163.75 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.153 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.493 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -151.19 121.08 7.09 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.378 -179.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.72 -179.66 5.32 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.205 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -144.08 117.91 9.33 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.022 0.439 . . . . 0.0 111.103 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tp -92.12 148.01 22.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.087 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.435 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 16.1 p80 -164.27 120.08 1.55 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 0.0 110.711 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.11 -25.53 6.7 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.753 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.74 118.34 5.27 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.932 2.421 . . . . 0.0 112.391 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -91.04 -24.15 20.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.235 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -84.43 -41.99 16.09 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.89 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -56.85 -35.6 69.05 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.463 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.7 mt -59.19 -47.51 90.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.143 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 m -63.98 -50.4 68.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.191 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.68 -45.69 88.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.409 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -46.1 -58.72 3.38 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.558 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.1 68.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.443 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.34 -56.62 14.56 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -53.62 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -43.93 -56.2 4.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.71 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -54.79 -47.81 73.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.643 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.06 84.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.73 -56.07 26.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.373 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -54.61 -43.26 72.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.02 -45.8 80.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -81.84 -2.15 50.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.132 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.5 t -152.47 70.11 7.4 Favored Pre-proline 0 C--N 1.332 -0.179 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.01 125.36 9.79 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.893 2.396 . . . . 0.0 111.986 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.72 -13.38 1.75 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 m -65.17 165.75 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.105 0.479 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.19 -34.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.575 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -163.6 156.44 18.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.103 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -152.39 124.91 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.382 . . . . 0.0 110.706 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -99.64 98.96 9.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.619 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -103.93 94.89 5.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.802 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.5 m -87.62 121.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.35 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.254 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.639 0.257 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 46.6 mtt -49.86 -45.13 50.14 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.79 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -41.64 -35.3 0.73 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.55 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.39 -61.84 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.21 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.55 -54.41 47.31 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.63 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 15.3 m -52.34 -60.3 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.635 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.63 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.23 -41.73 60.52 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -65.21 -55.55 17.87 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.797 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.56 -51.75 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.033 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 20' ' ' ARG . 49.2 mt -52.68 -49.42 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.712 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -50.49 -47.23 57.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.907 0.384 . . . . 0.0 110.179 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -69.7 -42.21 74.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.37 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tp -74.92 -22.85 58.36 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' CB ' ' CD ' ' A' ' 21' ' ' PRO . 14.4 mtt180 -43.14 -63.25 1.03 Allowed Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.619 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 20' ' ' ARG . 2.4 Cg_endo -44.78 -28.36 2.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.975 2.45 . . . . 0.0 112.509 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -77.42 -51.46 10.76 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.865 0.364 . . . . 0.0 110.321 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 27' ' ' GLY . 11.3 mt -57.62 -41.87 82.17 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.76 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tt -54.5 -54.07 45.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.552 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -56.42 -34.68 67.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.366 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -101.34 -58.96 1.78 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -101.08 -75.72 1.16 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -178.11 -147.6 6.99 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -106.99 133.68 51.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 110.389 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 55.0 m -97.86 150.88 20.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.102 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.9 m -148.71 111.97 4.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 110.531 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.67 129.89 40.86 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.054 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.56 -39.46 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.395 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -163.09 143.53 9.24 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.498 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.9 t -108.78 103.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.904 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.46 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 18.1 tt0 -104.89 176.89 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.981 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.46 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.5 m-20 -55.45 -9.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 36' ' ' GLU . . . 176.88 -24.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.404 HD11 ' H ' ' A' ' 39' ' ' ILE . 4.2 mp -83.23 62.08 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.247 0.546 . . . . 0.0 110.225 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -74.73 117.54 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.635 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -84.39 150.14 25.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 tp -144.63 160.24 41.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.18 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -144.4 109.16 4.94 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.856 0.36 . . . . 0.0 111.095 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.91 143.42 26.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.303 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 10.5 p80 -162.21 112.7 1.56 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.145 0.497 . . . . 0.0 110.603 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.62 -84.41 1.78 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 120.657 0.265 . . . . 0.0 110.357 179.826 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.777 0.322 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.07 134.14 19.08 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 112.452 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t -93.54 -25.9 17.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.424 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 p -83.98 -44.72 13.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.547 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -50.88 -32.19 19.73 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.823 0.344 . . . . 0.0 110.397 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.8 mt -57.54 -42.84 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.178 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -64.73 -53.45 47.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.346 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 tp -57.06 -46.9 82.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.303 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -48.97 -52.61 23.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.03 -23.12 66.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.632 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.68 -59.73 4.29 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.31 -49.14 84.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.242 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -45.49 -60.74 2.01 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.428 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -53.17 -45.9 68.68 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.623 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.56 -57.89 10.7 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.676 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.47 -49.39 74.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.105 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -51.11 -40.35 58.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.362 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.4 -55.63 29.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.761 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.87 -120.39 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.409 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 10.9 t 36.53 53.24 2.37 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.579 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 70' ' ' VAL . 2.7 Cg_endo -42.46 99.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.074 2.516 . . . . 0.0 112.003 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 130.84 -9.11 5.77 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.94 141.5 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.029 0.442 . . . . 0.0 110.499 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.72 -50.5 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.507 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -164.86 109.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.998 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.08 179.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.622 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -148.67 86.63 1.53 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.159 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -101.75 90.39 4.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.304 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 m -89.55 176.05 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.456 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.236 179.894 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.5 p . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.853 0.358 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' PHE . 21.1 mtp -51.68 -53.42 39.19 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.321 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 8' ' ' MET . 28.4 t80 -36.25 -48.07 0.61 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.638 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.0 -52.17 66.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.485 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -68.95 0.25 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.811 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.606 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.3 m -46.55 -52.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.986 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.606 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.27 -49.31 61.46 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -63.48 -53.96 43.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.163 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.84 -54.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.247 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.2 mt -51.9 -56.04 7.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.739 0.304 . . . . 0.0 110.612 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -50.58 -33.21 21.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -66.15 -56.66 10.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.287 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mt -75.27 -24.46 57.56 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.542 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.501 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 4.3 ttp180 -35.7 -59.84 0.7 Allowed Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.734 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.0 Cg_endo -44.62 -36.54 10.32 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.877 2.385 . . . . 0.0 112.254 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -76.87 -45.09 29.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.459 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 27' ' ' GLY . 11.1 mp -60.84 -47.33 86.85 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.554 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -54.27 45.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 111.199 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -56.62 -39.42 73.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.574 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -98.88 -57.25 2.22 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -98.32 -77.19 1.32 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.219 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -176.22 -158.83 20.71 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -108.69 139.99 42.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.711 0.291 . . . . 0.0 110.668 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 31' ' ' THR . 4.4 t -108.45 156.56 19.32 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 5.9 m -149.89 119.36 6.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.761 0.315 . . . . 0.0 110.772 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -69.48 112.81 6.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.761 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.3 t -78.98 -45.31 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.988 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -166.73 142.93 4.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.946 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.68 127.44 67.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.97 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 38' ' ' GLY . 17.3 tt0 -152.75 99.17 2.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.282 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 52.69 -85.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.721 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -129.1 -12.09 2.68 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.422 HD11 ' H ' ' A' ' 39' ' ' ILE . 4.0 mp -83.83 60.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.08 0.467 . . . . 0.0 110.023 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.99 111.49 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.689 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -88.11 129.01 35.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.494 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.68 144.62 37.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.98 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -99.97 165.03 11.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.189 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 tp -150.1 100.96 2.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.758 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -78.97 97.38 6.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.289 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.93 69.44 0.78 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.188 0 C-N-CA 122.054 0.142 . . . . 0.0 111.229 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.455 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.13 0.048 . . . . 0.0 111.13 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 51' ' ' CYS . 3.2 Cg_exo -45.02 124.28 5.78 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.7 2.266 . . . . 0.0 112.238 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -82.13 -20.37 38.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.862 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 94.3 p -85.29 -30.43 23.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.391 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -45.62 -33.66 2.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 110.19 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.7 mt -58.72 -43.77 88.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.496 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.6 m -63.25 -50.82 68.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.381 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.44 -46.98 88.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.649 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -45.58 -61.8 1.55 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.74 -24.79 64.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.53 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.58 -59.36 7.27 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -51.2 72.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.189 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -43.72 -53.66 5.68 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.419 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -53.7 -56.79 14.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.676 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.9 -51.35 66.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.417 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.38 -56.03 27.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.327 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -50.72 -40.88 55.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.639 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -63.08 -57.03 12.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.868 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -84.02 -118.93 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.241 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.423 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 9.0 t 35.91 53.89 2.23 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.642 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 70' ' ' VAL . 3.0 Cg_endo -42.15 109.38 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 123.253 2.635 . . . . 0.0 112.34 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.21 -8.32 12.38 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.01 147.71 12.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 121.053 0.454 . . . . 0.0 111.021 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.01 -32.62 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.896 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.01 107.33 0.62 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.88 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -88.38 171.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -142.78 117.28 9.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.898 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -112.87 88.71 2.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.615 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.9 m -92.31 153.64 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.82 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.031 179.632 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.416 ' H ' ' HG1' ' A' ' 7' ' ' THR . 1.1 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.764 0.316 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 13.1 mmt -46.99 -54.46 10.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.21 -40.77 1.67 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.996 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.32 -60.04 4.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.874 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -57.06 14.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.886 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.615 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 13.2 m -51.57 -59.21 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.38 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.615 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.47 -41.28 63.2 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.986 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -63.29 -58.84 5.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.048 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.8 t -58.98 -52.7 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.041 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.5 mt -55.58 -51.63 56.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.921 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -51.35 -40.5 59.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.009 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.7 mtt-85 -66.17 -45.88 79.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.7 mt -74.69 -24.56 58.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.159 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.436 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 18.3 mtt-85 -36.9 -62.07 0.59 Allowed Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.6 Cg_endo -45.53 -48.34 12.03 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.639 2.226 . . . . 0.0 112.277 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -76.52 -45.12 32.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.654 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.9 tp -58.55 -53.48 57.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.032 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -47.25 -45.21 23.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -55.39 -62.03 1.95 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.353 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -102.95 -52.67 3.0 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -82.17 5.46 71.92 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-O 119.992 -0.338 . . . . 0.0 113.901 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 66.75 -159.38 48.87 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -122.71 145.42 48.41 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.901 0.382 . . . . 0.0 111.38 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.9 m -116.9 170.21 8.79 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.92 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 96.6 m -151.33 123.68 8.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.436 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.5 tp -74.02 109.8 7.81 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.08 -31.35 6.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.616 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -165.01 139.62 5.09 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.484 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.57 137.96 36.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.797 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -154.2 85.34 1.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.705 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 56.52 -86.12 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.94 -15.49 2.86 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -86.99 62.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 0.0 109.96 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.33 121.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.888 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -84.98 151.79 23.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.415 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mt -140.91 171.28 14.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 110.997 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -146.5 121.72 10.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.554 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.11 162.44 20.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.843 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -155.87 78.55 0.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.025 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.13 50.95 0.62 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 121.018 0.437 . . . . 0.0 110.606 -179.786 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 29.5 p . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.68 0.276 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 51' ' ' CYS . 2.8 Cg_endo -46.21 112.85 0.5 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.9 2.4 . . . . 0.0 111.967 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.7 t -89.33 -21.15 23.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.564 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.1 p -80.35 -41.28 25.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.994 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -57.71 -42.79 84.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.929 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -59.44 -45.83 93.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.536 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.3 m -64.52 -44.96 89.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.484 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -55.99 27.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.398 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -46.19 -55.48 7.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.55 -27.34 66.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.23 -52.24 37.79 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -53.13 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -43.72 -59.05 2.38 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.16 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.75 -50.64 65.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.936 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.32 -45.08 88.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.573 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 70' ' ' VAL . 27.9 mt -58.53 -53.85 53.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -54.55 -41.14 69.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.786 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.74 -48.49 74.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -81.77 -7.94 59.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.538 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 66' ' ' LEU . 97.7 t -153.76 71.26 6.61 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 120.966 0.412 . . . . 0.0 110.088 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.91 125.68 8.22 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.993 2.462 . . . . 0.0 111.742 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.59 -0.3 1.91 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.551 -0.619 . . . . 0.0 111.551 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.4 m -62.79 153.62 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.157 0.504 . . . . 0.0 110.484 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.14 -63.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.428 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -164.76 107.33 0.86 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.406 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 11.3 p -84.12 166.73 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.922 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 14.0 mt-10 -143.59 128.33 18.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.029 0.443 . . . . 0.0 110.591 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 87.94 2.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.655 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.6 m -85.23 168.81 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.949 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.884 -179.715 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.779 0.323 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 42.2 mtt -47.36 -51.58 19.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.853 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -40.59 -44.64 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -57.42 -55.66 31.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -65.7 0.59 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.656 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.617 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.3 m -49.14 -52.97 9.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.617 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.92 -46.87 64.81 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -65.16 -54.41 30.18 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.952 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.53 -49.21 81.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.996 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.2 mt -53.61 -61.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -54.35 -35.73 63.07 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.656 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.4 tpt85 -65.76 -50.9 63.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.668 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tp -78.14 -22.1 49.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.798 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.583 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 43.7 ttm180 -36.86 -55.01 1.66 Allowed Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.8 Cg_endo -41.6 -37.42 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.839 2.36 . . . . 0.0 112.477 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -77.59 -48.7 16.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.0 110.133 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.2 mt -60.08 -43.48 95.44 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.946 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.6 tp -56.13 -56.41 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.991 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -58.11 -32.82 68.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -100.64 -57.78 2.04 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.148 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -96.47 -75.49 1.26 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 170.53 -148.71 11.75 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -105.5 132.33 51.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.876 0.37 . . . . 0.0 110.318 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.0 t -119.26 153.97 34.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.317 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.5 m -149.87 124.02 9.46 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.897 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -74.65 122.03 22.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.926 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.02 -29.04 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.732 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -163.58 128.11 2.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.813 0.339 . . . . 0.0 110.583 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 p -92.93 122.2 44.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.038 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' H ' HG23 ' A' ' 40' ' ' VAL . 38.8 mt-10 -140.65 165.42 27.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.315 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -47.6 -55.18 9.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.58 -22.2 0.62 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.47 HD11 ' H ' ' A' ' 39' ' ' ILE . 2.1 mp -87.77 59.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.906 0.384 . . . . 0.0 110.35 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.453 HG23 ' H ' ' A' ' 36' ' ' GLU . 2.1 t -83.74 123.04 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.112 0.482 . . . . 0.0 111.349 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -87.91 143.41 27.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.75 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mt -136.14 162.55 32.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.867 0.365 . . . . 0.0 110.688 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -147.58 116.44 6.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.953 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.97 171.31 13.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -158.3 84.27 0.85 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.836 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.51 -3.65 64.59 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.839 0.352 . . . . 0.0 110.814 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.55 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 19.4 p . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 51' ' ' CYS . 2.5 Cg_endo -46.32 105.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 123.175 2.583 . . . . 0.0 112.207 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -97.28 -28.43 14.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.188 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -89.64 -32.65 16.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.984 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.6 m -59.94 -30.11 68.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.58 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.76 -57.56 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.7 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.3 m -62.77 -45.68 91.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.555 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -58.16 -57.51 12.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.332 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -46.26 -56.86 5.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -27.24 67.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.493 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.71 -48.09 51.81 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -53.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -43.84 -59.92 2.04 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.727 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -38.01 71.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.29 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.18 -50.0 75.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.561 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.67 -50.13 73.02 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.503 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -54.75 -52.95 60.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.07 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.9 -25.2 67.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.571 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -84.11 -10.47 57.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.83 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.448 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 7.8 p -156.14 55.67 1.13 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 120.92 0.391 . . . . 0.0 110.965 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.72 124.66 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 123.058 2.506 . . . . 0.0 111.925 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.78 16.61 3.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.9 m -65.13 155.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.326 0.584 . . . . 0.0 111.225 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mm -102.73 -60.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.268 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -165.7 104.19 0.7 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.597 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.9 p -87.88 161.39 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -145.42 124.07 12.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.0 110.857 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.57 88.13 2.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.746 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 m -86.35 173.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.895 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.698 -179.678 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.461 0.092 0 CA-C-O 120.808 0.337 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -48.95 60.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.082 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -40.15 -41.92 1.36 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.736 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.83 -58.02 9.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.162 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.53 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -61.02 -60.54 3.62 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.52 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.642 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 10.0 m -46.0 -61.33 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.791 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.642 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.28 -42.53 63.79 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.175 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.43 -61.87 1.95 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.133 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 16' ' ' ILE . 11.8 m -61.59 -44.83 99.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.665 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' ARG . 52.4 mt -55.41 -52.62 44.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.333 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.23 -37.32 67.02 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.812 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -67.07 -52.48 41.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.588 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.65 -20.78 58.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.106 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' ILE . 28.2 ttm-85 -33.63 -59.16 0.5 Allowed Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.807 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.0 Cg_exo -42.42 -35.13 3.52 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.606 2.204 . . . . 0.0 111.953 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -77.73 -50.68 11.9 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.225 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 28' ' ' GLY . 4.4 mm? -58.56 -45.55 88.75 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.87 -43.23 69.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.918 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -56.44 -62.02 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.322 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -101.77 -54.84 2.64 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -71.53 5.23 11.26 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.583 -0.341 . . . . 0.0 112.465 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 60.65 -162.9 19.93 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.49 142.81 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.865 0.364 . . . . 0.0 110.799 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.5 p -128.65 156.18 43.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.887 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.2 m -149.79 120.21 7.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.974 0.416 . . . . 0.0 111.227 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.87 119.89 21.98 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.366 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.91 -31.04 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.53 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -164.86 142.98 6.46 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.644 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -109.73 142.84 21.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.873 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 38' ' ' GLY . 24.0 tt0 -162.34 99.06 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.027 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 49.37 -86.76 0.01 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.099 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -129.09 -13.42 2.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.43 ' CD1' ' N ' ' A' ' 39' ' ' ILE . 3.7 mp -86.99 63.22 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.157 0.503 . . . . 0.0 110.276 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.68 125.91 38.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.845 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -87.57 148.7 24.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.594 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 mt -143.87 167.88 21.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.915 0.388 . . . . 0.0 110.915 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.4 HE21 ' CG2' ' A' ' 79' ' ' VAL . 9.8 mp0 -142.01 120.81 12.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.923 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -85.67 168.42 14.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.075 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -161.29 74.98 0.49 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.958 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.18 31.23 0.18 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.213 0 CA-C-O 120.552 0.215 . . . . 0.0 110.892 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.789 0.328 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.8 116.98 4.92 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.853 2.369 . . . . 0.0 112.113 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.1 p -82.56 -19.46 38.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.336 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -77.24 -42.31 37.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.626 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.7 m -52.61 -42.74 64.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.361 . . . . 0.0 110.246 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mm -60.01 -45.57 95.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.041 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.7 m -64.85 -46.01 83.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.511 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.0 tp -57.6 -51.35 69.85 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.052 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -50.74 -49.91 56.83 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.138 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.66 -29.32 69.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.578 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.07 -58.06 8.65 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 pt -61.71 -44.27 98.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -45.29 -65.12 0.58 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.614 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -54.97 -47.38 74.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.963 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.77 82.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.715 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 70' ' ' VAL . 9.3 mt -56.0 -45.31 79.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.63 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.534 ' CD2' HG21 ' A' ' 73' ' ' VAL . 27.9 m170 -54.35 -55.88 24.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.428 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -68.57 -29.07 67.54 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -85.71 -11.49 53.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.022 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' LEU . 1.9 t -151.97 57.13 2.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.15 142.32 4.13 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 123.369 2.713 . . . . 0.0 112.38 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 136.93 -31.96 2.49 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.534 HG21 ' CD2' ' A' ' 67' ' ' HIS . 5.2 m -65.6 145.18 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.007 0.432 . . . . 0.0 110.409 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.28 -28.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.282 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -165.02 171.11 14.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.719 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.31 158.62 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.442 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -142.65 116.72 9.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.393 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.3 86.61 2.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.812 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.4 ' CG2' HE21 ' A' ' 43' ' ' GLN . 12.9 m -89.59 178.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.043 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.09 179.575 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.482 ' N ' ' SD ' ' A' ' 8' ' ' MET . 1.2 mpp? -51.74 -46.21 63.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.634 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -41.0 -36.44 0.67 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.36 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -60.76 -62.56 1.77 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -52.85 63.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.123 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.617 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 19.2 m -51.22 -60.34 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.989 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.617 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.24 -37.9 56.54 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.102 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.82 -60.48 3.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.609 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 m -55.68 -43.64 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.76 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 12' ' ' VAL . 14.9 mm -53.58 -48.79 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.034 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -53.47 -45.9 69.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.642 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -68.49 -37.58 80.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.338 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.63 -32.72 64.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.56 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' CB ' ' CD ' ' A' ' 21' ' ' PRO . 14.3 mtt180 -42.64 -63.21 0.99 Allowed Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 20' ' ' ARG . 2.9 Cg_endo -46.15 -36.76 17.12 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.821 2.347 . . . . 0.0 112.986 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -75.46 -60.31 2.36 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.542 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 26.9 mt -58.52 -45.05 89.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.936 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.2 tp -51.39 -41.52 60.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.104 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.6 mtt85 -58.92 -54.28 48.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.407 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -100.91 -59.35 1.71 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -80.33 -77.73 0.95 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.911 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 170.71 -142.79 7.34 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -109.27 165.25 11.77 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 111.159 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 31' ' ' THR . 38.4 t -126.93 158.02 37.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.833 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.448 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 64.0 m -150.29 122.27 8.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.884 0.373 . . . . 0.0 111.204 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.14 128.22 35.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.864 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.1 t -97.58 -39.79 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.199 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -155.48 118.54 4.33 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.677 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.9 p -81.85 142.14 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.741 ' CG ' ' H ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -158.93 -158.49 0.69 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.843 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.545 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -88.94 -46.27 9.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.406 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 36' ' ' GLU . . . -157.0 27.2 0.51 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.916 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.741 ' H ' ' CG ' ' A' ' 36' ' ' GLU . 1.1 mp -145.34 59.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.435 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -78.96 128.01 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.254 -178.176 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -91.06 145.16 24.92 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.443 HD23 ' SG ' ' A' ' 30' ' ' CYS . 2.9 mt -139.66 174.13 10.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.293 0.568 . . . . 0.0 111.47 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -146.31 126.72 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.021 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.613 ' H ' ' HB2' ' A' ' 80' ' ' PHE . 5.2 mt -86.88 -179.24 6.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.915 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.457 ' HA ' ' CE2' ' A' ' 80' ' ' PHE . 1.4 m-70 -162.82 63.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.03 -89.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.865 0.364 . . . . 0.0 110.42 -179.839 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.406 ' C ' ' H ' ' A' ' 53' ' ' SER . 4.5 p . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' A' ' 54' ' ' SER . 3.3 Cg_exo -73.2 28.33 0.3 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.673 2.248 . . . . 0.0 113.154 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 51' ' ' CYS . 1.3 p -63.01 -9.93 12.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 52' ' ' PRO . 8.4 m -90.73 -31.89 16.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.334 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.46 -42.79 54.85 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.17 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.1 mm -56.02 -50.86 67.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.875 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 m -65.41 -54.91 21.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.05 -53.12 61.7 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.712 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -48.99 -47.24 44.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.4 69.69 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.188 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.63 -45.17 95.23 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -60.67 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -43.72 -51.61 7.07 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.832 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -53.56 -50.86 64.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.696 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.62 -48.84 79.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.767 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 8.7 mp -58.62 -54.57 45.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.089 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -53.06 -44.07 67.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.349 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -64.61 -45.33 87.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.198 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.64 -9.58 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.102 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 66' ' ' LEU . 47.7 t -153.39 72.46 6.85 Favored Pre-proline 0 N--CA 1.463 0.184 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.79 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.96 37.32 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 123.153 2.569 . . . . 0.0 112.163 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -102.68 -21.14 10.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.7 m -64.07 160.72 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.11 -41.66 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.786 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -164.54 157.03 16.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.993 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -149.94 156.18 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -143.8 78.17 1.58 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.111 0.481 . . . . 0.0 110.583 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -102.33 96.39 6.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.36 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 2.9 m -111.18 161.58 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.613 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 6.5 t80 . . . . . 0 C--O 1.233 0.211 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.605 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.8 0.333 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 44.3 mtm -51.13 -45.04 61.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.81 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -42.79 -34.16 0.88 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.437 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.62 -63.69 1.21 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.036 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -58.04 -58.87 6.51 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.029 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.618 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 10.4 m -48.27 -60.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.528 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.618 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -50.07 -42.7 50.5 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.632 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.81 -51.68 63.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.77 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.56 -61.64 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.312 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 12' ' ' VAL . 20.4 mm -48.54 -46.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.706 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -53.06 -43.26 66.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.347 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -66.55 -47.07 74.02 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.203 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.93 -33.53 63.98 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.44 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -34.84 -63.35 0.36 Allowed Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.2 Cg_exo -42.88 -39.04 7.34 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 123.119 2.546 . . . . 0.0 113.219 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -77.51 -50.34 12.82 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.516 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 27' ' ' GLY . 8.0 mp -55.93 -37.55 69.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.25 -60.94 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.475 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -54.57 -34.01 61.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.666 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.64 -57.63 2.07 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.263 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -100.41 -76.04 1.2 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.782 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 179.63 -150.75 9.52 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -111.05 137.11 49.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.815 0.34 . . . . 0.0 110.726 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.6 t -111.78 148.57 33.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.937 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.7 m -150.57 124.81 9.44 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.371 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.75 129.23 38.58 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.696 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.65 -35.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.763 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -160.27 134.16 7.15 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.318 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.69 123.62 54.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.915 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.6 tp10 -148.9 80.32 1.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.764 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 t0 54.79 -81.29 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.122 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -124.87 -22.36 1.99 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.02 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.65 65.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.193 0.52 . . . . 0.0 110.296 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.3 t -87.32 120.23 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.225 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -90.03 139.97 30.09 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.33 148.27 29.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 0.0 111.21 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -96.49 166.28 11.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.882 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.5 tp -148.56 94.76 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.237 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -75.9 77.68 2.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.025 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.66 -88.19 0.19 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.74 0.305 . . . . 0.0 110.681 -179.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.4 t . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.803 0.335 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -70.3 106.2 1.71 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.587 2.191 . . . . 0.0 112.311 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.8 t -81.18 -11.06 59.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.394 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.6 t -86.66 -49.9 7.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.115 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -47.45 -35.16 8.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.998 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 90.0 mt -58.18 -46.68 88.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.1 m -64.48 -46.22 83.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.127 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.3 tp -57.5 -57.62 11.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.807 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -46.36 -54.87 8.2 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.21 68.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.613 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.97 -45.0 90.55 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.82 -62.23 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.519 0.2 . . . . 0.0 110.918 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -43.84 -51.94 7.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.9 0.381 . . . . 0.0 110.517 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.2 ttm-85 -55.4 -39.85 70.69 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.202 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -57.16 -42.92 81.99 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.342 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.44 -53.31 59.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -59.14 -59.88 4.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.387 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.69 -10.26 34.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.229 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 mt-10 -157.15 99.12 1.78 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.849 0.357 . . . . 0.0 110.376 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 69' ' ' GLU . 62.1 t 77.05 72.77 0.19 Allowed Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.175 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.84 -149.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 123.03 2.487 . . . . 0.0 111.35 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.19 -20.72 44.36 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -64.54 151.02 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.023 0.439 . . . . 0.0 110.684 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.56 -30.55 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.411 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -159.91 154.31 23.8 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.463 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.15 119.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -96.53 124.72 40.61 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.468 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.48 83.2 1.97 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.103 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 m -94.03 157.22 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 111.694 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--O 1.232 0.162 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.192 179.552 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.894 0.378 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 8' ' ' MET . 5.3 mpp? -49.08 -51.96 28.55 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.784 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -41.57 -39.36 1.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.066 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -59.36 -62.06 2.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -57.93 10.66 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.051 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.624 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 8.5 m -51.03 -59.84 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.442 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.624 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.28 -42.03 63.38 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.13 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.4 -57.22 12.07 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.945 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.13 -48.86 86.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.203 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.6 mt -54.39 -53.37 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.593 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -50.87 -47.13 60.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.62 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -65.78 -38.31 88.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.054 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tp -76.85 -26.37 54.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.994 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 6.2 mtt180 -40.14 -60.92 1.27 Allowed Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.8 Cg_endo -43.83 -36.01 7.46 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.078 2.518 . . . . 0.0 113.184 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -75.53 -46.07 34.34 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' GLY . 4.6 mp -58.42 -38.5 77.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.669 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 tt -54.5 -58.79 6.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.119 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -56.74 -34.65 67.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.567 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -100.4 -58.65 1.86 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.469 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -97.86 -76.2 1.27 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.76 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 178.15 -141.48 5.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -114.65 125.44 53.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.676 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 31' ' ' THR . 7.8 t -84.48 158.03 21.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.472 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.524 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 18.5 m -146.99 114.9 6.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.818 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tp -73.6 125.17 27.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.126 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.76 -47.59 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.814 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -165.37 143.51 6.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.95 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 p -107.23 122.33 61.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.572 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.4 tp10 -141.0 88.48 2.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.734 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.7 t0 55.02 -79.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -131.0 -17.35 1.48 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.88 60.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.051 0.453 . . . . 0.0 109.979 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.62 115.96 16.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.763 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -88.98 140.5 29.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.146 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' A' ' 42' ' ' LEU . 2.2 pt? -159.79 -178.76 7.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.294 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.88 170.72 15.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.165 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tt -150.51 138.64 20.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.595 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -162.34 130.79 4.1 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.91 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.21 -26.51 5.96 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.208 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.671 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.793 0.33 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.53 121.42 7.42 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.709 2.272 . . . . 0.0 112.089 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t -86.94 -28.93 22.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.046 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.9 t -68.32 -41.95 80.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.621 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 m -65.97 -47.35 74.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.679 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.31 -48.86 85.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.685 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -64.5 -45.44 87.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.246 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.4 tp -57.94 -56.99 14.85 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.545 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.558 ' HZ1' ' CB ' ' A' ' 78' ' ' GLN . 13.1 tppt? -47.37 -54.29 11.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 110.156 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 64' ' ' ARG . . . -59.07 -21.24 58.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.31 -44.93 26.5 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.8 OUTLIER -65.63 -61.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -43.89 -47.42 8.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.524 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.411 ' CG ' ' O ' ' A' ' 60' ' ' ALA . 14.4 mmt180 -54.38 -47.3 72.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.63 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.39 -54.74 43.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.521 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.523 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 7.3 mp -55.48 -64.1 0.96 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.203 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -42.55 -50.87 5.28 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.951 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.98 -14.57 62.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.755 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 66' ' ' LEU . 32.0 mt-10 -155.76 98.44 1.92 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 66' ' ' LEU . 2.0 m -135.06 66.15 66.87 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.627 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 70' ' ' VAL . 3.2 Cg_exo -79.4 29.43 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.884 2.389 . . . . 0.0 111.301 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 70' ' ' VAL . . . -173.45 -48.97 0.05 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.406 HG11 ' CB ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -69.16 145.91 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.096 0.474 . . . . 0.0 110.659 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.02 -49.84 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.802 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -166.27 108.8 0.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.037 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -83.4 174.81 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -145.94 87.47 1.76 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.765 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.558 ' CB ' ' HZ1' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -97.96 94.88 7.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.843 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.0 m -87.0 168.39 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.959 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.336 179.686 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.854 0.359 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 19.1 mmt -49.78 -59.8 3.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.292 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -44.23 -36.64 2.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.239 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -61.07 2.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -57.67 -55.77 30.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.978 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.664 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 18.6 m -51.66 -63.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.171 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.664 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -47.29 -38.99 13.62 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 120.086 -0.645 . . . . 0.0 109.565 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.9 -63.99 1.01 Allowed 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.073 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 16' ' ' ILE . 4.8 m -62.32 -45.26 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.483 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 12' ' ' VAL . 23.4 mm -53.87 -62.17 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.801 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -53.78 -31.37 48.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -66.97 -50.64 61.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.402 ' C ' ' CD ' ' A' ' 21' ' ' PRO . 11.0 mp -79.03 -21.49 46.83 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.536 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 12.9 ttm180 -37.3 -43.28 1.18 Allowed Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 20' ' ' ARG . 3.4 Cg_exo -77.5 -28.31 5.59 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.292 1.995 . . . . 0.0 112.506 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -77.08 -46.9 22.04 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.633 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 27' ' ' GLY . 12.4 mt -55.78 -37.8 69.06 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' GLY . 1.3 tt -57.45 -56.06 26.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -54.07 -35.19 61.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.988 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -100.99 -60.94 1.43 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -102.03 -76.31 1.17 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.816 -0.513 . . . . 0.0 111.816 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 24' ' ' LEU . . . -173.0 -138.31 2.57 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -130.94 123.7 29.45 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.421 -0.458 . . . . 0.0 110.602 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.418 ' C ' ' HG1' ' A' ' 31' ' ' THR . 24.1 p -94.93 159.53 14.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.54 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' A' ' 30' ' ' CYS . 3.7 m -150.75 124.75 9.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.136 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 tp -77.25 123.08 25.96 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.847 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.11 -34.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.066 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -167.98 139.49 2.91 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.885 0.374 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.8 p -104.04 126.8 58.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.761 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -149.64 77.76 1.34 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.662 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.9 t70 55.38 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.021 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.73 -21.6 5.34 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 39' ' ' ILE . 3.2 mp -84.05 63.79 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.374 0.607 . . . . 0.0 109.883 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.18 118.97 33.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.125 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -85.26 139.66 31.45 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -139.72 169.6 17.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 0.0 111.176 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -145.41 112.86 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.108 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 tp -91.02 105.53 17.89 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.343 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -78.35 86.25 4.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.503 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.96 91.63 1.75 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.823 0.344 . . . . 0.0 111.022 -179.807 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 51' ' ' CYS . 21.7 t . . . . . 0 C--O 1.233 0.216 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 51' ' ' CYS . 3.0 Cg_exo -76.96 114.95 3.92 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.993 2.462 . . . . 0.0 111.895 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.3 p -83.36 -17.81 41.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.029 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -78.6 -49.58 13.0 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.948 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.9 m -41.67 -39.88 1.79 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.899 0.38 . . . . 0.0 110.179 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.2 mt -61.24 -53.35 50.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.591 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 94.2 m -62.88 -36.11 82.23 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.718 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 tp -57.17 -57.23 13.5 Favored 'General case' 0 CA--C 1.523 -0.063 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.524 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -48.35 -54.81 12.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.176 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.14 -21.57 61.76 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.036 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.56 -44.23 41.32 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -60.62 -58.86 5.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -45.07 -52.96 8.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.93 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -53.45 -41.27 65.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.481 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -58.34 -47.43 83.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.172 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.4 mt -59.36 -59.62 5.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.024 0.44 . . . . 0.0 110.496 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -53.59 -56.88 13.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.508 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -68.76 -12.02 60.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.637 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -152.78 98.99 2.4 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.456 ' CB ' ' O ' ' A' ' 69' ' ' GLU . 11.2 t 86.28 78.52 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.533 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.9 -151.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.451 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.22 -21.78 22.76 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.78 142.24 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.065 0.459 . . . . 0.0 110.3 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.75 -39.02 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.326 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -164.74 108.97 0.92 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.084 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.487 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 8.8 p -84.16 176.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.379 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.487 ' H ' ' CG2' ' A' ' 76' ' ' VAL . 15.7 mt-10 -147.33 85.65 1.6 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.995 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.85 91.04 3.98 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.181 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.2 m -93.63 174.77 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.121 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.773 -179.851 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -75.05 -81.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.814 2.343 . . . . 0.0 111.801 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -172.99 158.66 3.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.147 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -81.36 37.64 0.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -53.68 175.41 0.14 Allowed Pre-proline 0 N--CA 1.456 -0.133 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 5' ' ' ASN . 3.7 Cg_exo -39.83 91.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.821 1.681 . . . . 0.0 110.469 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 5' ' ' ASN . 75.7 p -66.76 -175.27 0.39 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.95 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 20.3 mtt -50.23 -53.75 25.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.624 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -39.92 -51.88 2.45 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.964 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.53 -51.16 69.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.717 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -61.29 -60.02 4.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.642 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.603 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.1 m -54.47 -54.22 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.72 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.603 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.28 -43.92 64.68 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.177 0.513 . . . . 0.0 109.743 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -61.6 -61.8 2.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.458 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.51 -40.22 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.337 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.8 mt -54.72 -64.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.841 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -30.59 32.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.717 0.294 . . . . 0.0 111.051 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -68.06 -51.41 46.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.602 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.2 -22.52 55.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.569 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 9.8 mtp180 -36.84 -60.58 0.76 Allowed Pre-proline 0 N--CA 1.469 0.494 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.9 Cg_endo -45.9 -39.26 19.13 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.809 2.339 . . . . 0.0 112.406 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -75.15 -43.7 51.03 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.403 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.3 mt -59.48 -48.73 80.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.285 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.1 tp -53.08 -43.67 66.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.8 mmm-85 -58.04 -48.04 81.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.037 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.75 -57.5 2.06 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -90.73 -76.41 1.32 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.462 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.5 -136.83 3.66 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -130.77 131.15 44.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.48 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.1 t -95.33 156.19 16.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 85.2 m -149.93 114.07 5.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.375 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 tp -69.6 126.77 30.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.258 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.98 -39.07 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.955 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -157.82 133.78 9.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.023 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 7.7 p -104.05 117.98 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.971 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -120.32 -179.18 3.88 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.964 0.411 . . . . 0.0 110.76 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -13.93 62.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.33 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.43 -32.69 0.03 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.7 59.98 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.019 0.437 . . . . 0.0 110.602 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 41' ' ' LYS . 1.2 t -69.51 163.75 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.153 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.493 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -151.19 121.08 7.09 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.378 -179.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.72 -179.66 5.32 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.205 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -144.08 117.91 9.33 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.022 0.439 . . . . 0.0 111.103 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tp -92.12 148.01 22.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.087 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.435 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 16.1 p80 -164.27 120.08 1.55 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 0.0 110.711 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.11 -25.53 6.7 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -173.75 -103.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.8 t -175.84 98.82 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.619 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.427 ' H ' ' CB ' ' A' ' 82' ' ' GLU . . . -119.06 -148.4 8.33 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.466 ' HG1' ' N ' ' A' ' 51' ' ' CYS . 52.2 p -140.25 -44.4 0.42 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.737 0.304 . . . . 0.0 110.415 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.466 ' N ' ' HG1' ' A' ' 50' ' ' THR . 97.1 m -135.99 79.57 44.41 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.065 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HG3' ' H ' ' A' ' 83' ' ' HIS . 3.3 Cg_exo -74.74 118.34 5.27 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.932 2.421 . . . . 0.0 112.391 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -91.04 -24.15 20.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.235 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -84.43 -41.99 16.09 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.89 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -56.85 -35.6 69.05 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.463 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.7 mt -59.19 -47.51 90.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.143 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 m -63.98 -50.4 68.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.191 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.68 -45.69 88.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.409 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -46.1 -58.72 3.38 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.558 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.1 68.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.443 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.34 -56.62 14.56 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -53.62 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -43.93 -56.2 4.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.71 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -54.79 -47.81 73.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.643 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.06 84.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.73 -56.07 26.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.373 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -54.61 -43.26 72.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.02 -45.8 80.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -81.84 -2.15 50.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.132 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.5 t -152.47 70.11 7.4 Favored Pre-proline 0 C--N 1.332 -0.179 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.01 125.36 9.79 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.893 2.396 . . . . 0.0 111.986 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.72 -13.38 1.75 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 m -65.17 165.75 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.105 0.479 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.19 -34.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.575 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -163.6 156.44 18.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.103 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -152.39 124.91 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.382 . . . . 0.0 110.706 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -99.64 98.96 9.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.619 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -103.93 94.89 5.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.802 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.5 m -87.62 121.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.35 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -94.79 139.93 30.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.254 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 tp -95.95 44.66 1.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.695 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.427 ' CB ' ' H ' ' A' ' 49' ' ' GLY . 2.6 mp0 64.05 154.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.327 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.464 ' H ' ' HG3' ' A' ' 52' ' ' PRO . 12.5 t-160 -178.85 76.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.587 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -59.51 179.21 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.907 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -134.35 156.66 48.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.715 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -57.02 11.65 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.408 ' CG ' ' N ' ' A' ' 88' ' ' HIS . 28.3 t-80 -164.66 162.59 21.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.364 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.408 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 8.0 t60 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.459 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.581 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 2.8 ttm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 1' ' ' MET . 3.4 Cg_exo -73.36 -176.17 2.35 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.444 2.096 . . . . 0.0 112.23 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -58.02 170.06 0.7 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.009 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' H ' HG22 ' A' ' 3' ' ' THR . 2.4 pt-20 -136.56 29.26 2.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.37 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -103.12 -49.26 0.16 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.872 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.8 Cg_endo -76.84 40.87 0.84 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.756 2.304 . . . . 0.0 111.413 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -161.11 0.06 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.496 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 46.6 mtt -49.86 -45.13 50.14 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.79 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -41.64 -35.3 0.73 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.55 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.39 -61.84 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.21 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.55 -54.41 47.31 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.63 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 15.3 m -52.34 -60.3 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.635 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.63 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.23 -41.73 60.52 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -65.21 -55.55 17.87 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.797 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.56 -51.75 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.033 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 20' ' ' ARG . 49.2 mt -52.68 -49.42 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.712 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -50.49 -47.23 57.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.907 0.384 . . . . 0.0 110.179 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -69.7 -42.21 74.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.37 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tp -74.92 -22.85 58.36 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' CB ' ' CD ' ' A' ' 21' ' ' PRO . 14.4 mtt180 -43.14 -63.25 1.03 Allowed Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.619 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 20' ' ' ARG . 2.4 Cg_endo -44.78 -28.36 2.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.975 2.45 . . . . 0.0 112.509 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -77.42 -51.46 10.76 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.865 0.364 . . . . 0.0 110.321 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 27' ' ' GLY . 11.3 mt -57.62 -41.87 82.17 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.76 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tt -54.5 -54.07 45.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.552 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -56.42 -34.68 67.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.366 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -101.34 -58.96 1.78 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -101.08 -75.72 1.16 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -178.11 -147.6 6.99 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -106.99 133.68 51.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 110.389 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 55.0 m -97.86 150.88 20.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.102 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.9 m -148.71 111.97 4.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 110.531 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.67 129.89 40.86 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.054 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.56 -39.46 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.395 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -163.09 143.53 9.24 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.498 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.9 t -108.78 103.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.904 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.46 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 18.1 tt0 -104.89 176.89 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.981 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.46 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.5 m-20 -55.45 -9.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 36' ' ' GLU . . . 176.88 -24.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.404 HD11 ' H ' ' A' ' 39' ' ' ILE . 4.2 mp -83.23 62.08 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.247 0.546 . . . . 0.0 110.225 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -74.73 117.54 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.635 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -84.39 150.14 25.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 tp -144.63 160.24 41.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.18 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -144.4 109.16 4.94 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.856 0.36 . . . . 0.0 111.095 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.91 143.42 26.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.303 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 10.5 p80 -162.21 112.7 1.56 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.145 0.497 . . . . 0.0 110.603 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.62 -84.41 1.78 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.57 -90.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.657 0.265 . . . . 0.0 110.357 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.5 p -143.63 7.33 1.48 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.37 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.48 28.16 22.9 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER -72.18 61.94 0.47 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.087 0.47 . . . . 0.0 110.419 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.405 ' C ' ' O ' ' A' ' 50' ' ' THR . 7.6 p 32.64 76.82 0.37 Allowed Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.562 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.07 134.14 19.08 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 112.452 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t -93.54 -25.9 17.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.424 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 p -83.98 -44.72 13.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.547 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -50.88 -32.19 19.73 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.823 0.344 . . . . 0.0 110.397 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.8 mt -57.54 -42.84 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.178 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -64.73 -53.45 47.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.346 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 tp -57.06 -46.9 82.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.303 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -48.97 -52.61 23.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.03 -23.12 66.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.632 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.68 -59.73 4.29 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.31 -49.14 84.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.242 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -45.49 -60.74 2.01 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.428 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -53.17 -45.9 68.68 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.623 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.56 -57.89 10.7 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.676 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.47 -49.39 74.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.105 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -51.11 -40.35 58.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.362 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.4 -55.63 29.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.761 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.87 -120.39 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.409 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 10.9 t 36.53 53.24 2.37 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.579 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 70' ' ' VAL . 2.7 Cg_endo -42.46 99.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.074 2.516 . . . . 0.0 112.003 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 130.84 -9.11 5.77 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.94 141.5 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.029 0.442 . . . . 0.0 110.499 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.72 -50.5 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.507 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -164.86 109.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.998 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.08 179.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.622 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -148.67 86.63 1.53 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.159 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -101.75 90.39 4.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.304 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 m -89.55 176.05 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.456 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -109.97 108.63 18.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.236 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 tp -89.73 91.88 8.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.488 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -71.77 0.09 9.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.394 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -92.29 94.05 8.96 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.992 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.472 ' CG ' ' N ' ' A' ' 85' ' ' HIS . 37.2 t-80 -59.18 -104.65 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.356 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.472 ' N ' ' CG ' ' A' ' 84' ' ' HIS . 15.9 t-80 58.13 164.89 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 111.065 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -131.31 153.96 49.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.266 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -87.21 -48.93 7.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.372 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.036 179.743 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -74.66 134.04 17.91 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.775 2.317 . . . . 0.0 111.511 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.8 m -77.72 164.77 24.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.132 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -93.17 32.35 1.32 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.932 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.463 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.5 OUTLIER -100.66 -51.37 0.18 Allowed Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HD3' ' CB ' ' A' ' 5' ' ' ASN . 2.5 Cg_endo -81.35 98.22 1.01 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.682 2.255 . . . . 0.0 110.116 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.5 p -71.2 176.8 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.358 . . . . 0.0 110.973 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' PHE . 21.1 mtp -51.68 -53.42 39.19 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.321 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 8' ' ' MET . 28.4 t80 -36.25 -48.07 0.61 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.638 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.0 -52.17 66.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.485 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -68.95 0.25 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.811 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.606 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.3 m -46.55 -52.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.986 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.606 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.27 -49.31 61.46 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -63.48 -53.96 43.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.163 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.84 -54.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.247 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.2 mt -51.9 -56.04 7.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.739 0.304 . . . . 0.0 110.612 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -50.58 -33.21 21.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -66.15 -56.66 10.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.287 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mt -75.27 -24.46 57.56 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.542 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 4.3 ttp180 -35.7 -59.84 0.7 Allowed Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.734 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.0 Cg_endo -44.62 -36.54 10.32 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.877 2.385 . . . . 0.0 112.254 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -76.87 -45.09 29.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.459 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 27' ' ' GLY . 11.1 mp -60.84 -47.33 86.85 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.554 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -54.27 45.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 111.199 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -56.62 -39.42 73.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.574 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -98.88 -57.25 2.22 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -98.32 -77.19 1.32 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.219 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -176.22 -158.83 20.71 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -108.69 139.99 42.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.711 0.291 . . . . 0.0 110.668 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 31' ' ' THR . 4.4 t -108.45 156.56 19.32 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 5.9 m -149.89 119.36 6.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.761 0.315 . . . . 0.0 110.772 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -69.48 112.81 6.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.761 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.3 t -78.98 -45.31 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.988 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -166.73 142.93 4.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.946 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.68 127.44 67.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.97 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 38' ' ' GLY . 17.3 tt0 -152.75 99.17 2.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.282 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 52.69 -85.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.721 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -129.1 -12.09 2.68 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.422 HD11 ' H ' ' A' ' 39' ' ' ILE . 4.0 mp -83.83 60.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.08 0.467 . . . . 0.0 110.023 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.99 111.49 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.689 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -88.11 129.01 35.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.494 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.68 144.62 37.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.98 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -99.97 165.03 11.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.189 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 tp -150.1 100.96 2.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.758 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -78.97 97.38 6.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.289 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.93 69.44 0.78 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.466 ' O ' ' SG ' ' A' ' 48' ' ' CYS . . . 70.25 -46.35 0.61 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.054 0.142 . . . . 0.0 111.229 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 47' ' ' ALA . 2.1 m -166.18 31.5 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.72 0.295 . . . . 0.0 110.817 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.16 179.84 28.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.2 t -41.46 114.98 0.57 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.566 0.222 . . . . 0.0 110.891 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.455 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -178.28 -63.92 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.13 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 51' ' ' CYS . 3.2 Cg_exo -45.02 124.28 5.78 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.7 2.266 . . . . 0.0 112.238 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -82.13 -20.37 38.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.862 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 94.3 p -85.29 -30.43 23.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.391 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -45.62 -33.66 2.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 110.19 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.7 mt -58.72 -43.77 88.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.496 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.6 m -63.25 -50.82 68.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.381 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.44 -46.98 88.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.649 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -45.58 -61.8 1.55 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.74 -24.79 64.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.53 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.58 -59.36 7.27 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -51.2 72.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.189 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -43.72 -53.66 5.68 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.419 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -53.7 -56.79 14.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.676 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.9 -51.35 66.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.417 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.38 -56.03 27.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.327 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -50.72 -40.88 55.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.639 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -63.08 -57.03 12.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.868 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -84.02 -118.93 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.241 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.423 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 9.0 t 35.91 53.89 2.23 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.642 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 70' ' ' VAL . 3.0 Cg_endo -42.15 109.38 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 123.253 2.635 . . . . 0.0 112.34 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.21 -8.32 12.38 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.01 147.71 12.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 121.053 0.454 . . . . 0.0 111.021 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.01 -32.62 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.896 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.01 107.33 0.62 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.88 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -88.38 171.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -142.78 117.28 9.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.898 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -112.87 88.71 2.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.615 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.9 m -92.31 153.64 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.82 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -95.99 -179.57 4.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.031 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 tp -71.48 75.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 110.085 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -53.67 161.08 1.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.585 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -73.56 -58.28 3.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.651 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 61.99 139.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.57 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -164.14 136.15 4.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.523 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -114.0 84.05 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.937 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.605 ' H ' ' HD1' ' A' ' 87' ' ' HIS . 8.0 p-80 -66.72 -163.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.467 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t60 . . . . . 0 C--O 1.223 -0.34 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.068 179.49 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -74.53 -83.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.689 2.26 . . . . 0.0 111.882 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.83 147.35 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.623 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -48.29 -42.46 30.94 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.601 ' HB2' ' CD ' ' A' ' 6' ' ' PRO . 7.5 p30 43.7 -165.87 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.486 0 O-C-N 123.534 0.521 . . . . 0.0 110.006 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.601 ' CD ' ' HB2' ' A' ' 5' ' ' ASN . 3.9 Cg_exo -68.97 84.69 0.52 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 N-CA-C 108.874 -1.241 . . . . 0.0 108.874 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.416 ' H ' ' HG1' ' A' ' 7' ' ' THR . 1.1 m -63.01 168.08 4.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.767 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 13.1 mmt -46.99 -54.46 10.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.21 -40.77 1.67 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.996 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.32 -60.04 4.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.874 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -57.06 14.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.886 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.615 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 13.2 m -51.57 -59.21 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.38 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.615 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.47 -41.28 63.2 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.986 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -63.29 -58.84 5.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.048 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.8 t -58.98 -52.7 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.041 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.5 mt -55.58 -51.63 56.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.921 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -51.35 -40.5 59.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.009 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.7 mtt-85 -66.17 -45.88 79.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.7 mt -74.69 -24.56 58.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.159 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.436 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 18.3 mtt-85 -36.9 -62.07 0.59 Allowed Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.6 Cg_endo -45.53 -48.34 12.03 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.639 2.226 . . . . 0.0 112.277 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -76.52 -45.12 32.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.654 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.9 tp -58.55 -53.48 57.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.032 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -47.25 -45.21 23.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -55.39 -62.03 1.95 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.353 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -102.95 -52.67 3.0 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -82.17 5.46 71.92 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-O 119.992 -0.338 . . . . 0.0 113.901 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 66.75 -159.38 48.87 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -122.71 145.42 48.41 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.901 0.382 . . . . 0.0 111.38 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.9 m -116.9 170.21 8.79 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.92 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 96.6 m -151.33 123.68 8.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.436 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.5 tp -74.02 109.8 7.81 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.08 -31.35 6.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.616 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -165.01 139.62 5.09 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.484 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.57 137.96 36.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.797 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -154.2 85.34 1.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.705 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 56.52 -86.12 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.94 -15.49 2.86 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -86.99 62.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 0.0 109.96 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.33 121.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.888 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -84.98 151.79 23.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.415 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mt -140.91 171.28 14.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 110.997 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -146.5 121.72 10.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.554 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.11 162.44 20.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.843 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -155.87 78.55 0.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.025 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.13 50.95 0.62 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 67.84 98.94 0.05 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.018 0.437 . . . . 0.0 110.606 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.4 m -52.48 -35.32 52.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.809 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 57.82 -119.85 18.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.4 t -152.76 -36.77 0.11 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.787 0.327 . . . . 0.0 110.398 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 29.5 p -151.95 48.88 0.5 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.847 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 51' ' ' CYS . 2.8 Cg_endo -46.21 112.85 0.5 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.9 2.4 . . . . 0.0 111.967 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.7 t -89.33 -21.15 23.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.564 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.1 p -80.35 -41.28 25.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.994 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -57.71 -42.79 84.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.929 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -59.44 -45.83 93.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.536 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.3 m -64.52 -44.96 89.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.484 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -55.99 27.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.398 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -46.19 -55.48 7.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.55 -27.34 66.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.23 -52.24 37.79 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -53.13 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -43.72 -59.05 2.38 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.16 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.75 -50.64 65.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.936 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.32 -45.08 88.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.573 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 70' ' ' VAL . 27.9 mt -58.53 -53.85 53.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -54.55 -41.14 69.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.786 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.74 -48.49 74.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -81.77 -7.94 59.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.538 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 66' ' ' LEU . 97.7 t -153.76 71.26 6.61 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 120.966 0.412 . . . . 0.0 110.088 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.91 125.68 8.22 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.993 2.462 . . . . 0.0 111.742 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.59 -0.3 1.91 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.551 -0.619 . . . . 0.0 111.551 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.4 m -62.79 153.62 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.157 0.504 . . . . 0.0 110.484 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.14 -63.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.428 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -164.76 107.33 0.86 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.406 ' CG2' ' N ' ' A' ' 77' ' ' GLU . 11.3 p -84.12 166.73 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.922 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 14.0 mt-10 -143.59 128.33 18.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.029 0.443 . . . . 0.0 110.591 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 87.94 2.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.655 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.6 m -85.23 168.81 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.949 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -93.35 -179.32 5.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.884 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.1 tp -88.04 -9.57 52.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.915 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -96.32 -10.6 27.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.099 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -103.36 77.07 1.48 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.174 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -58.45 156.89 9.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.041 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -122.19 -24.96 4.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.99 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 52.4 -92.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.472 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 51.34 -118.59 1.29 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.872 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.524 ' N ' ' HD1' ' A' ' 88' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.785 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -45.74 148.95 2.21 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.346 2.697 . . . . 0.0 112.452 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.429 ' CG2' ' H ' ' A' ' 4' ' ' GLU . 8.2 m 60.88 175.22 0.1 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.165 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' H ' ' CG2' ' A' ' 3' ' ' THR . 2.0 tp10 -121.69 19.92 11.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.848 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.501 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -107.04 -45.8 0.12 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.264 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.8 Cg_endo -77.58 47.23 2.23 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 122.661 2.241 . . . . 0.0 110.865 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.9 p -69.35 179.51 1.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.992 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 42.2 mtt -47.36 -51.58 19.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.853 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -40.59 -44.64 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -57.42 -55.66 31.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -65.7 0.59 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.656 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.617 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.3 m -49.14 -52.97 9.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.617 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.92 -46.87 64.81 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -65.16 -54.41 30.18 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.952 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -57.53 -49.21 81.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.996 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.2 mt -53.61 -61.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -54.35 -35.73 63.07 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.656 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.4 tpt85 -65.76 -50.9 63.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.668 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tp -78.14 -22.1 49.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.798 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.583 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 43.7 ttm180 -36.86 -55.01 1.66 Allowed Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.8 Cg_endo -41.6 -37.42 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.839 2.36 . . . . 0.0 112.477 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -77.59 -48.7 16.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.0 110.133 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.2 mt -60.08 -43.48 95.44 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.946 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.6 tp -56.13 -56.41 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.991 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -58.11 -32.82 68.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -100.64 -57.78 2.04 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.148 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -96.47 -75.49 1.26 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 170.53 -148.71 11.75 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -105.5 132.33 51.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.876 0.37 . . . . 0.0 110.318 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.0 t -119.26 153.97 34.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.317 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.5 m -149.87 124.02 9.46 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.897 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -74.65 122.03 22.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.926 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.02 -29.04 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.732 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -163.58 128.11 2.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.813 0.339 . . . . 0.0 110.583 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 p -92.93 122.2 44.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.038 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' H ' HG23 ' A' ' 40' ' ' VAL . 38.8 mt-10 -140.65 165.42 27.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.315 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -47.6 -55.18 9.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.58 -22.2 0.62 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.47 HD11 ' H ' ' A' ' 39' ' ' ILE . 2.1 mp -87.77 59.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.906 0.384 . . . . 0.0 110.35 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.453 HG23 ' H ' ' A' ' 36' ' ' GLU . 2.1 t -83.74 123.04 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.112 0.482 . . . . 0.0 111.349 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -87.91 143.41 27.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.75 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mt -136.14 162.55 32.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.867 0.365 . . . . 0.0 110.688 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -147.58 116.44 6.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.953 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.97 171.31 13.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -158.3 84.27 0.85 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.836 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.51 -3.65 64.59 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 53.93 23.87 4.23 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.839 0.352 . . . . 0.0 110.814 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 50' ' ' THR . 7.5 t -139.58 39.23 2.04 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.74 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.71 74.1 0.11 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 48' ' ' CYS . 20.4 p -137.69 -54.88 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.969 0.414 . . . . 0.0 110.164 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.55 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 19.4 p -156.46 47.38 0.29 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.358 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 51' ' ' CYS . 2.5 Cg_endo -46.32 105.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 123.175 2.583 . . . . 0.0 112.207 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -97.28 -28.43 14.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.188 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -89.64 -32.65 16.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.984 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.6 m -59.94 -30.11 68.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.58 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.76 -57.56 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.7 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.3 m -62.77 -45.68 91.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.555 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -58.16 -57.51 12.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.332 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -46.26 -56.86 5.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -27.24 67.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.493 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.71 -48.09 51.81 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -53.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -43.84 -59.92 2.04 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.727 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -38.01 71.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.29 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.18 -50.0 75.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.561 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.67 -50.13 73.02 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.503 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -54.75 -52.95 60.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.07 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.9 -25.2 67.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.571 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -84.11 -10.47 57.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.83 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.448 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 7.8 p -156.14 55.67 1.13 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 120.92 0.391 . . . . 0.0 110.965 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.72 124.66 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 123.058 2.506 . . . . 0.0 111.925 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.78 16.61 3.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.9 m -65.13 155.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.326 0.584 . . . . 0.0 111.225 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mm -102.73 -60.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.268 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -165.7 104.19 0.7 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.597 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.9 p -87.88 161.39 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -145.42 124.07 12.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.0 110.857 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.57 88.13 2.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.746 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 m -86.35 173.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.895 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -95.54 -179.5 4.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.698 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.548 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -65.85 1.0 1.5 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.644 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' N ' HD11 ' A' ' 81' ' ' LEU . 36.8 mm-40 -63.5 139.06 58.73 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.87 14.72 2.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.806 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -139.32 80.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.192 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.644 ' CG ' ' H ' ' A' ' 86' ' ' HIS . 12.1 t-160 -89.46 -140.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.969 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.644 ' H ' ' CG ' ' A' ' 85' ' ' HIS . 27.7 t-80 48.85 -130.79 1.81 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.57 ' H ' ' CG ' ' A' ' 86' ' ' HIS . 0.4 OUTLIER -153.83 -66.79 0.14 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.969 0.414 . . . . 0.0 109.906 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.3 t60 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.095 179.783 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.28 -170.6 0.83 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.849 2.366 . . . . 0.0 111.87 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.418 ' HG1' ' H ' ' A' ' 4' ' ' GLU . 71.2 p -67.62 -108.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.172 0.511 . . . . 0.0 110.548 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.418 ' H ' ' HG1' ' A' ' 3' ' ' THR . 1.8 tp10 63.31 6.37 2.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.286 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.497 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -63.5 -47.81 82.54 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.6 Cg_endo -79.41 94.79 1.05 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.728 2.285 . . . . 0.0 110.885 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 p -73.79 -175.7 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.745 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -48.95 60.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.082 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -40.15 -41.92 1.36 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.736 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.83 -58.02 9.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.162 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.53 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -61.02 -60.54 3.62 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.52 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.642 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 10.0 m -46.0 -61.33 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.791 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.642 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.28 -42.53 63.79 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.175 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.43 -61.87 1.95 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.133 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 16' ' ' ILE . 11.8 m -61.59 -44.83 99.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.665 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' ARG . 52.4 mt -55.41 -52.62 44.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.333 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.23 -37.32 67.02 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.812 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -67.07 -52.48 41.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.588 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.65 -20.78 58.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.106 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' ILE . 28.2 ttm-85 -33.63 -59.16 0.5 Allowed Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.807 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.0 Cg_exo -42.42 -35.13 3.52 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.606 2.204 . . . . 0.0 111.953 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -77.73 -50.68 11.9 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.225 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 28' ' ' GLY . 4.4 mm? -58.56 -45.55 88.75 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.87 -43.23 69.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.918 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -56.44 -62.02 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.322 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -101.77 -54.84 2.64 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -71.53 5.23 11.26 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.583 -0.341 . . . . 0.0 112.465 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 60.65 -162.9 19.93 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.49 142.81 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.865 0.364 . . . . 0.0 110.799 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.5 p -128.65 156.18 43.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.887 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.2 m -149.79 120.21 7.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.974 0.416 . . . . 0.0 111.227 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.87 119.89 21.98 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.366 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.91 -31.04 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.53 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -164.86 142.98 6.46 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.644 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -109.73 142.84 21.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.873 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 38' ' ' GLY . 24.0 tt0 -162.34 99.06 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.027 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 49.37 -86.76 0.01 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.099 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -129.09 -13.42 2.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.43 ' CD1' ' N ' ' A' ' 39' ' ' ILE . 3.7 mp -86.99 63.22 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.157 0.503 . . . . 0.0 110.276 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.68 125.91 38.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.845 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -87.57 148.7 24.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.594 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 mt -143.87 167.88 21.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.915 0.388 . . . . 0.0 110.915 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.4 HE21 ' CG2' ' A' ' 79' ' ' VAL . 9.8 mp0 -142.01 120.81 12.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.923 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -85.67 168.42 14.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.075 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -161.29 74.98 0.49 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.958 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.18 31.23 0.18 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.08 2.27 18.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.552 0.215 . . . . 0.0 110.892 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.2 t -69.25 73.64 0.32 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.973 0.416 . . . . 0.0 110.57 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.73 36.49 0.16 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.5 p 44.29 70.43 0.33 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.926 0.393 . . . . 0.0 110.92 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.1 m 56.35 81.39 0.26 Allowed Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.641 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.8 116.98 4.92 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.853 2.369 . . . . 0.0 112.113 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.1 p -82.56 -19.46 38.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.336 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -77.24 -42.31 37.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.626 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.7 m -52.61 -42.74 64.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.361 . . . . 0.0 110.246 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mm -60.01 -45.57 95.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.041 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.7 m -64.85 -46.01 83.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.511 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.0 tp -57.6 -51.35 69.85 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.052 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -50.74 -49.91 56.83 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.138 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.66 -29.32 69.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.578 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.07 -58.06 8.65 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 pt -61.71 -44.27 98.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -45.29 -65.12 0.58 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.614 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -54.97 -47.38 74.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.963 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.77 82.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.715 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 70' ' ' VAL . 9.3 mt -56.0 -45.31 79.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.63 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.534 ' CD2' HG21 ' A' ' 73' ' ' VAL . 27.9 m170 -54.35 -55.88 24.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.428 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -68.57 -29.07 67.54 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -85.71 -11.49 53.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.022 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' LEU . 1.9 t -151.97 57.13 2.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.15 142.32 4.13 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 123.369 2.713 . . . . 0.0 112.38 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 136.93 -31.96 2.49 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.534 HG21 ' CD2' ' A' ' 67' ' ' HIS . 5.2 m -65.6 145.18 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.007 0.432 . . . . 0.0 110.409 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.28 -28.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.282 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -165.02 171.11 14.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.719 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.31 158.62 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.442 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -142.65 116.72 9.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.393 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.3 86.61 2.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.812 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.4 ' CG2' HE21 ' A' ' 43' ' ' GLN . 12.9 m -89.59 178.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.043 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -110.28 144.74 38.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.09 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tp -70.05 75.79 0.49 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.887 0.375 . . . . 0.0 110.645 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 49.1 63.62 2.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -94.94 70.01 3.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -154.42 -57.27 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.963 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -92.34 -156.3 0.46 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.855 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -142.1 -166.07 2.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.384 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.418 ' HD1' ' N ' ' A' ' 87' ' ' HIS . 2.1 m80 -87.15 -7.14 58.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.429 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 . . . . . 0 C--O 1.222 -0.381 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.771 179.88 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.0 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -75.49 -88.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.75 2.3 . . . . 0.0 111.567 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.8 m -161.59 -36.41 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.436 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.85 15.4 7.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.34 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -57.63 -50.32 88.81 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.172 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.9 Cg_endo -77.08 91.19 1.19 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.653 2.235 . . . . 0.0 110.815 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 p -75.19 -170.84 1.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.854 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.482 ' N ' ' SD ' ' A' ' 8' ' ' MET . 1.2 mpp? -51.74 -46.21 63.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.634 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -41.0 -36.44 0.67 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.36 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -60.76 -62.56 1.77 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -52.85 63.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.123 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.617 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 19.2 m -51.22 -60.34 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.989 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.617 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.24 -37.9 56.54 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.102 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.82 -60.48 3.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.609 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 m -55.68 -43.64 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.76 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 12' ' ' VAL . 14.9 mm -53.58 -48.79 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.034 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -53.47 -45.9 69.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.642 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -68.49 -37.58 80.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.338 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.63 -32.72 64.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.56 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' CB ' ' CD ' ' A' ' 21' ' ' PRO . 14.3 mtt180 -42.64 -63.21 0.99 Allowed Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 20' ' ' ARG . 2.9 Cg_endo -46.15 -36.76 17.12 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.821 2.347 . . . . 0.0 112.986 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -75.46 -60.31 2.36 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.542 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 26.9 mt -58.52 -45.05 89.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.936 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.2 tp -51.39 -41.52 60.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.104 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.6 mtt85 -58.92 -54.28 48.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.407 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -100.91 -59.35 1.71 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -80.33 -77.73 0.95 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.911 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 170.71 -142.79 7.34 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -109.27 165.25 11.77 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 111.159 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 31' ' ' THR . 38.4 t -126.93 158.02 37.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.833 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.448 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 64.0 m -150.29 122.27 8.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.884 0.373 . . . . 0.0 111.204 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.14 128.22 35.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.864 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.1 t -97.58 -39.79 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.199 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -155.48 118.54 4.33 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.677 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.9 p -81.85 142.14 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.741 ' CG ' ' H ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -158.93 -158.49 0.69 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.843 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.545 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -88.94 -46.27 9.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.406 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 36' ' ' GLU . . . -157.0 27.2 0.51 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.916 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.741 ' H ' ' CG ' ' A' ' 36' ' ' GLU . 1.1 mp -145.34 59.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.435 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -78.96 128.01 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.254 -178.176 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -91.06 145.16 24.92 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.443 HD23 ' SG ' ' A' ' 30' ' ' CYS . 2.9 mt -139.66 174.13 10.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.293 0.568 . . . . 0.0 111.47 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -146.31 126.72 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.021 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.613 ' H ' ' HB2' ' A' ' 80' ' ' PHE . 5.2 mt -86.88 -179.24 6.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.915 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.457 ' HA ' ' CE2' ' A' ' 80' ' ' PHE . 1.4 m-70 -162.82 63.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 82' ' ' GLU . . . -54.03 -89.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.78 39.33 0.27 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.865 0.364 . . . . 0.0 110.42 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 67.4 m 57.18 62.59 2.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.688 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.34 -175.88 10.4 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.3 p -115.97 -38.54 3.63 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.764 0.316 . . . . 0.0 110.618 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.406 ' C ' ' H ' ' A' ' 53' ' ' SER . 4.5 p -128.49 89.44 49.56 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.163 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' A' ' 54' ' ' SER . 3.3 Cg_exo -73.2 28.33 0.3 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.673 2.248 . . . . 0.0 113.154 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 51' ' ' CYS . 1.3 p -63.01 -9.93 12.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 52' ' ' PRO . 8.4 m -90.73 -31.89 16.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.334 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.46 -42.79 54.85 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.17 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.1 mm -56.02 -50.86 67.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.875 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 m -65.41 -54.91 21.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 84' ' ' HIS . 1.2 tt -57.05 -53.12 61.7 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.712 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -48.99 -47.24 44.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.4 69.69 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.188 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.63 -45.17 95.23 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -60.67 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -43.72 -51.61 7.07 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.832 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -53.56 -50.86 64.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.696 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.62 -48.84 79.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.767 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 8.7 mp -58.62 -54.57 45.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.089 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -53.06 -44.07 67.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.349 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -64.61 -45.33 87.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.198 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.64 -9.58 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.102 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 66' ' ' LEU . 47.7 t -153.39 72.46 6.85 Favored Pre-proline 0 N--CA 1.463 0.184 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.79 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.96 37.32 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 123.153 2.569 . . . . 0.0 112.163 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -102.68 -21.14 10.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.7 m -64.07 160.72 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.11 -41.66 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.786 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -164.54 157.03 16.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.993 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -149.94 156.18 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -143.8 78.17 1.58 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.111 0.481 . . . . 0.0 110.583 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -102.33 96.39 6.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.36 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 2.9 m -111.18 161.58 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.613 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 6.5 t80 179.79 -179.4 0.45 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.605 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' N ' ' CG ' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -114.18 52.43 0.83 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.728 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -142.47 -147.97 0.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.286 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 2.6 m-70 -136.69 -47.78 0.62 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.616 ' CG ' ' H ' ' A' ' 85' ' ' HIS . 2.9 t-80 89.66 -158.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.531 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.616 ' H ' ' CG ' ' A' ' 84' ' ' HIS . 6.0 t60 -121.22 -96.02 0.48 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.791 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.556 ' N ' ' CG ' ' A' ' 85' ' ' HIS . 16.2 m-70 -168.04 -170.52 1.34 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.829 0.347 . . . . 0.0 110.459 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 87' ' ' HIS . 82.1 t60 -84.97 13.98 5.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.545 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.833 -179.87 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.8 mtt . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.35 169.86 21.54 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.849 2.366 . . . . 0.0 111.405 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -90.91 150.81 21.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.661 0.267 . . . . 0.0 110.47 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' N ' ' CD ' ' A' ' 4' ' ' GLU . 17.7 mp0 -99.82 5.57 45.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.525 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -69.0 -46.04 30.66 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.186 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.5 Cg_endo -78.51 87.95 1.49 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.507 2.138 . . . . 0.0 110.726 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -74.64 165.52 25.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 44.3 mtm -51.13 -45.04 61.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.81 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -42.79 -34.16 0.88 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.437 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.62 -63.69 1.21 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.036 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -58.04 -58.87 6.51 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.029 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.618 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 10.4 m -48.27 -60.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.528 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.618 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -50.07 -42.7 50.5 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.632 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.81 -51.68 63.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.77 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.56 -61.64 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.312 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 12' ' ' VAL . 20.4 mm -48.54 -46.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.706 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -53.06 -43.26 66.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.347 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -66.55 -47.07 74.02 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.203 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.93 -33.53 63.98 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.44 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -34.84 -63.35 0.36 Allowed Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.2 Cg_exo -42.88 -39.04 7.34 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 123.119 2.546 . . . . 0.0 113.219 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -77.51 -50.34 12.82 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.516 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 27' ' ' GLY . 8.0 mp -55.93 -37.55 69.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.25 -60.94 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.475 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -54.57 -34.01 61.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.666 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.64 -57.63 2.07 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.263 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -100.41 -76.04 1.2 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.782 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 179.63 -150.75 9.52 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -111.05 137.11 49.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.815 0.34 . . . . 0.0 110.726 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.6 t -111.78 148.57 33.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.937 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.7 m -150.57 124.81 9.44 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.371 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.75 129.23 38.58 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.696 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.65 -35.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.763 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -160.27 134.16 7.15 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.318 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.69 123.62 54.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.915 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.6 tp10 -148.9 80.32 1.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.764 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 t0 54.79 -81.29 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.122 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -124.87 -22.36 1.99 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.02 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.65 65.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.193 0.52 . . . . 0.0 110.296 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.3 t -87.32 120.23 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.225 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -90.03 139.97 30.09 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.33 148.27 29.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 0.0 111.21 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -96.49 166.28 11.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.882 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.5 tp -148.56 94.76 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.237 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -75.9 77.68 2.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.025 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.66 -88.19 0.19 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.23 12.93 4.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.74 0.305 . . . . 0.0 110.681 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.4 t -55.49 -13.26 1.42 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.634 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.37 165.7 12.58 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.6 t -58.92 134.66 57.13 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.4 t 48.97 72.88 1.12 Allowed Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.441 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -70.3 106.2 1.71 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.587 2.191 . . . . 0.0 112.311 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.8 t -81.18 -11.06 59.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.394 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.6 t -86.66 -49.9 7.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.115 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -47.45 -35.16 8.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.998 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 90.0 mt -58.18 -46.68 88.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.1 m -64.48 -46.22 83.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.127 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.3 tp -57.5 -57.62 11.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.807 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -46.36 -54.87 8.2 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.21 68.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.613 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.97 -45.0 90.55 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.82 -62.23 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.519 0.2 . . . . 0.0 110.918 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -43.84 -51.94 7.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.9 0.381 . . . . 0.0 110.517 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.2 ttm-85 -55.4 -39.85 70.69 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.202 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -57.16 -42.92 81.99 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.342 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.44 -53.31 59.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -59.14 -59.88 4.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.387 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.69 -10.26 34.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.229 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 mt-10 -157.15 99.12 1.78 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.849 0.357 . . . . 0.0 110.376 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 69' ' ' GLU . 62.1 t 77.05 72.77 0.19 Allowed Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.175 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.84 -149.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 123.03 2.487 . . . . 0.0 111.35 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.19 -20.72 44.36 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -64.54 151.02 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.023 0.439 . . . . 0.0 110.684 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.56 -30.55 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.411 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -159.91 154.31 23.8 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.463 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.15 119.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -96.53 124.72 40.61 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.468 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.48 83.2 1.97 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.103 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 m -94.03 157.22 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 111.694 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -99.55 177.35 5.19 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.192 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.4 tp -94.59 81.01 3.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.99 0.424 . . . . 0.0 109.877 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -39.02 -88.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.231 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.603 ' HD1' ' N ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -51.35 94.64 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.462 ' ND1' ' O ' ' A' ' 85' ' ' HIS . 57.0 t-80 -62.73 130.21 43.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.228 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.462 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -84.74 -170.18 2.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.277 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.423 ' O ' ' CG ' ' A' ' 86' ' ' HIS . 20.3 t-160 -119.78 59.24 0.87 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.074 0.464 . . . . 0.0 110.246 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.6 m80 43.8 25.28 0.09 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.007 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.408 ' OXT' ' CG ' ' A' ' 88' ' ' HIS . 9.8 t60 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.49 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 1' ' ' MET . 2.7 Cg_endo -45.5 136.68 11.87 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.881 2.388 . . . . 0.0 112.015 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.94 162.63 3.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.896 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -152.82 36.98 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.164 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.499 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -105.4 -46.62 0.13 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.332 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.8 Cg_endo -77.88 54.94 5.06 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.779 2.319 . . . . 0.0 111.15 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -70.21 178.25 2.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.849 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 8' ' ' MET . 5.3 mpp? -49.08 -51.96 28.55 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.784 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -41.57 -39.36 1.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.066 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -59.36 -62.06 2.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -57.93 10.66 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.051 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.624 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 8.5 m -51.03 -59.84 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.442 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.624 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.28 -42.03 63.38 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.13 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.4 -57.22 12.07 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.945 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.13 -48.86 86.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.203 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.6 mt -54.39 -53.37 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.593 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -50.87 -47.13 60.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.62 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -65.78 -38.31 88.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.054 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tp -76.85 -26.37 54.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.994 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 6.2 mtt180 -40.14 -60.92 1.27 Allowed Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.8 Cg_endo -43.83 -36.01 7.46 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.078 2.518 . . . . 0.0 113.184 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -75.53 -46.07 34.34 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' GLY . 4.6 mp -58.42 -38.5 77.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.669 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 tt -54.5 -58.79 6.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.119 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -56.74 -34.65 67.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.567 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -100.4 -58.65 1.86 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.469 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -97.86 -76.2 1.27 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.76 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 178.15 -141.48 5.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -114.65 125.44 53.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.676 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 31' ' ' THR . 7.8 t -84.48 158.03 21.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.472 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.524 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 18.5 m -146.99 114.9 6.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.818 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tp -73.6 125.17 27.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.126 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.76 -47.59 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.814 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -165.37 143.51 6.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.95 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 p -107.23 122.33 61.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.572 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.4 tp10 -141.0 88.48 2.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.734 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.7 t0 55.02 -79.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -131.0 -17.35 1.48 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.88 60.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.051 0.453 . . . . 0.0 109.979 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -74.62 115.96 16.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.763 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -88.98 140.5 29.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.146 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' A' ' 42' ' ' LEU . 2.2 pt? -159.79 -178.76 7.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.294 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.88 170.72 15.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.165 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tt -150.51 138.64 20.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.595 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -162.34 130.79 4.1 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.91 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.21 -26.51 5.96 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 172.25 -79.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.2 p -173.13 -50.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.974 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 43.46 -134.88 5.22 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.81 -42.39 0.06 Allowed 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.0 m -154.18 77.04 5.62 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.554 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.53 121.42 7.42 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.709 2.272 . . . . 0.0 112.089 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t -86.94 -28.93 22.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.046 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.9 t -68.32 -41.95 80.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.621 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 m -65.97 -47.35 74.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.679 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.31 -48.86 85.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.685 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -64.5 -45.44 87.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.246 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.4 tp -57.94 -56.99 14.85 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.545 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.558 ' HZ1' ' CB ' ' A' ' 78' ' ' GLN . 13.1 tppt? -47.37 -54.29 11.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 110.156 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 64' ' ' ARG . . . -59.07 -21.24 58.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.31 -44.93 26.5 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.8 OUTLIER -65.63 -61.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -43.89 -47.42 8.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.524 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.411 ' CG ' ' O ' ' A' ' 60' ' ' ALA . 14.4 mmt180 -54.38 -47.3 72.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.63 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.39 -54.74 43.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.521 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.523 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 7.3 mp -55.48 -64.1 0.96 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.203 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -42.55 -50.87 5.28 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.951 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.98 -14.57 62.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.755 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 66' ' ' LEU . 32.0 mt-10 -155.76 98.44 1.92 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 66' ' ' LEU . 2.0 m -135.06 66.15 66.87 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.627 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 70' ' ' VAL . 3.2 Cg_exo -79.4 29.43 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.884 2.389 . . . . 0.0 111.301 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 70' ' ' VAL . . . -173.45 -48.97 0.05 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.406 HG11 ' CB ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -69.16 145.91 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.096 0.474 . . . . 0.0 110.659 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.02 -49.84 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.802 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -166.27 108.8 0.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.037 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -83.4 174.81 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -145.94 87.47 1.76 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.765 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.558 ' CB ' ' HZ1' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -97.96 94.88 7.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.843 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.0 m -87.0 168.39 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.959 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -112.52 121.13 43.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.336 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 tp -65.24 82.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.049 0.452 . . . . 0.0 110.513 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -60.23 179.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -176.8 0.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.738 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -72.78 -172.73 1.05 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.701 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -113.26 -88.22 0.55 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.089 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -111.25 63.17 0.61 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.008 0.433 . . . . 0.0 110.562 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.407 ' CD2' ' H ' ' A' ' 88' ' ' HIS . 32.4 t60 -75.64 168.19 20.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.54 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.407 ' H ' ' CD2' ' A' ' 87' ' ' HIS . 35.2 m80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.703 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' H3 ' ' CD ' ' A' ' 2' ' ' PRO . 25.8 mmt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.516 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 2.5 Cg_endo -45.45 148.02 2.37 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.8 2.333 . . . . 0.0 111.938 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.79 130.49 2.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.617 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -92.2 26.45 2.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.379 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -101.39 -47.28 0.2 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.261 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.5 Cg_endo -81.45 77.03 4.11 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.567 2.178 . . . . 0.0 110.702 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -73.68 -174.93 1.89 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.854 0.359 . . . . 0.0 111.006 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 19.1 mmt -49.78 -59.8 3.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.292 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -44.23 -36.64 2.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.239 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -61.07 2.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -57.67 -55.77 30.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.978 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.664 ' CG2' ' H ' ' A' ' 13' ' ' ALA . 18.6 m -51.66 -63.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.171 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.664 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -47.29 -38.99 13.62 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 120.086 -0.645 . . . . 0.0 109.565 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.9 -63.99 1.01 Allowed 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.073 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 16' ' ' ILE . 4.8 m -62.32 -45.26 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.483 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 12' ' ' VAL . 23.4 mm -53.87 -62.17 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.801 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -53.78 -31.37 48.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -66.97 -50.64 61.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.402 ' C ' ' CD ' ' A' ' 21' ' ' PRO . 11.0 mp -79.03 -21.49 46.83 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.536 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 12.9 ttm180 -37.3 -43.28 1.18 Allowed Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 20' ' ' ARG . 3.4 Cg_exo -77.5 -28.31 5.59 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.292 1.995 . . . . 0.0 112.506 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -77.08 -46.9 22.04 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.633 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 27' ' ' GLY . 12.4 mt -55.78 -37.8 69.06 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' GLY . 1.3 tt -57.45 -56.06 26.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -54.07 -35.19 61.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.988 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -100.99 -60.94 1.43 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -102.03 -76.31 1.17 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.816 -0.513 . . . . 0.0 111.816 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 24' ' ' LEU . . . -173.0 -138.31 2.57 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -130.94 123.7 29.45 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.421 -0.458 . . . . 0.0 110.602 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.418 ' C ' ' HG1' ' A' ' 31' ' ' THR . 24.1 p -94.93 159.53 14.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.54 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' A' ' 30' ' ' CYS . 3.7 m -150.75 124.75 9.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.136 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.6 tp -77.25 123.08 25.96 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.847 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.11 -34.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.066 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -167.98 139.49 2.91 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.885 0.374 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.8 p -104.04 126.8 58.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.761 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -149.64 77.76 1.34 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.662 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.9 t70 55.38 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.021 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.73 -21.6 5.34 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 39' ' ' ILE . 3.2 mp -84.05 63.79 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.374 0.607 . . . . 0.0 109.883 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.18 118.97 33.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.125 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -85.26 139.66 31.45 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -139.72 169.6 17.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 0.0 111.176 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -145.41 112.86 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.108 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 tp -91.02 105.53 17.89 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.343 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -78.35 86.25 4.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.503 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 48' ' ' CYS . . . -86.96 91.63 1.75 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.52 1.03 0.88 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.823 0.344 . . . . 0.0 111.022 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.471 ' H ' ' C ' ' A' ' 46' ' ' GLY . 36.9 t -96.32 58.94 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.883 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.44 111.84 4.47 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.457 ' CG2' ' H ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER 175.48 -100.98 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 51' ' ' CYS . 21.7 t -149.23 65.62 8.09 Favored Pre-proline 0 C--O 1.233 0.216 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 51' ' ' CYS . 3.0 Cg_exo -76.96 114.95 3.92 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.993 2.462 . . . . 0.0 111.895 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.3 p -83.36 -17.81 41.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.029 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -78.6 -49.58 13.0 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.948 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.9 m -41.67 -39.88 1.79 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.899 0.38 . . . . 0.0 110.179 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.2 mt -61.24 -53.35 50.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.591 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 94.2 m -62.88 -36.11 82.23 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.718 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 tp -57.17 -57.23 13.5 Favored 'General case' 0 CA--C 1.523 -0.063 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.524 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -48.35 -54.81 12.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.176 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.14 -21.57 61.76 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.036 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.56 -44.23 41.32 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -60.62 -58.86 5.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -45.07 -52.96 8.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.93 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -53.45 -41.27 65.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.481 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -58.34 -47.43 83.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.172 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.4 mt -59.36 -59.62 5.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.024 0.44 . . . . 0.0 110.496 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -53.59 -56.88 13.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.508 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -68.76 -12.02 60.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.637 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -152.78 98.99 2.4 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.456 ' CB ' ' O ' ' A' ' 69' ' ' GLU . 11.2 t 86.28 78.52 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.533 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.9 -151.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.451 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.22 -21.78 22.76 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.78 142.24 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.065 0.459 . . . . 0.0 110.3 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.75 -39.02 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.326 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -164.74 108.97 0.92 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.084 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.487 ' CG2' ' H ' ' A' ' 77' ' ' GLU . 8.8 p -84.16 176.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.379 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.487 ' H ' ' CG2' ' A' ' 76' ' ' VAL . 15.7 mt-10 -147.33 85.65 1.6 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.995 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.85 91.04 3.98 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.181 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.2 m -93.63 174.77 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.121 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -97.94 164.86 12.19 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.8 tp -76.26 -72.42 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.297 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -177.02 144.77 0.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.52 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.529 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 1.0 OUTLIER -86.79 -68.39 0.75 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -154.72 97.34 1.96 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.248 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -157.35 88.15 1.0 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.218 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -91.01 -47.97 7.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.848 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -124.73 164.94 18.86 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.482 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.7 p80 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.593 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.7 p . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.818 0.342 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.623 ' O ' HG13 ' A' ' 12' ' ' VAL . 20.3 mtt -50.23 -53.75 25.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.624 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -39.92 -51.88 2.45 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.964 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.53 -51.16 69.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.717 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.487 ' O ' HG22 ' A' ' 15' ' ' VAL . 12.9 mt-30 -61.29 -60.02 4.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.642 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 8' ' ' MET . 1.1 m -54.47 -54.22 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.72 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.603 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.28 -43.92 64.68 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.177 0.513 . . . . 0.0 109.743 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -61.6 -61.8 2.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.458 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 11' ' ' GLN . 34.1 m -60.51 -40.22 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.337 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 12' ' ' VAL . 26.8 mt -54.72 -64.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.841 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -30.59 32.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.717 0.294 . . . . 0.0 111.051 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -68.06 -51.41 46.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.602 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.2 -22.52 55.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.569 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 9.8 mtp180 -36.84 -60.58 0.76 Allowed Pre-proline 0 N--CA 1.469 0.494 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.9 Cg_endo -45.9 -39.26 19.13 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.809 2.339 . . . . 0.0 112.406 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -75.15 -43.7 51.03 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.403 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.3 mt -59.48 -48.73 80.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.285 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.1 tp -53.08 -43.67 66.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.8 mmm-85 -58.04 -48.04 81.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.037 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.75 -57.5 2.06 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -90.73 -76.41 1.32 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.462 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.5 -136.83 3.66 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.406 ' HB2' ' CE1' ' A' ' 45' ' ' HIS . 4.1 m-20 -130.77 131.15 44.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.48 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.1 t -95.33 156.19 16.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 85.2 m -149.93 114.07 5.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.375 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 tp -69.6 126.77 30.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.258 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.98 -39.07 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.955 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -157.82 133.78 9.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.023 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 35' ' ' VAL . 7.7 p -104.05 117.98 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.971 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -120.32 -179.18 3.88 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.964 0.411 . . . . 0.0 110.76 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -13.93 62.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.33 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.43 -32.69 0.03 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.801 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.6 mp -84.7 59.98 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.019 0.437 . . . . 0.0 110.602 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 41' ' ' LYS . 1.2 t -69.51 163.75 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.153 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.493 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -151.19 121.08 7.09 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.378 -179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.454 ' N ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -129.72 -179.66 5.32 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.205 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -144.08 117.91 9.33 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.022 0.439 . . . . 0.0 111.103 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tp -92.12 148.01 22.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.087 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.435 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 16.1 p80 -164.27 120.08 1.55 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 0.0 110.711 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.11 -25.53 6.7 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.753 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.74 118.34 5.27 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.932 2.421 . . . . 0.0 112.391 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -91.04 -24.15 20.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.235 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -84.43 -41.99 16.09 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.89 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -56.85 -35.6 69.05 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.463 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.7 mt -59.19 -47.51 90.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.143 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 m -63.98 -50.4 68.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.191 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.68 -45.69 88.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.409 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -46.1 -58.72 3.38 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.558 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.1 68.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.443 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.34 -56.62 14.56 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -53.62 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -43.93 -56.2 4.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.71 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -54.79 -47.81 73.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.643 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.06 84.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.73 -56.07 26.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.373 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -54.61 -43.26 72.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.02 -45.8 80.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -81.84 -2.15 50.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.132 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.5 t -152.47 70.11 7.4 Favored Pre-proline 0 C--N 1.332 -0.179 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.01 125.36 9.79 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.893 2.396 . . . . 0.0 111.986 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.72 -13.38 1.75 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 m -65.17 165.75 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.105 0.479 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.19 -34.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.575 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -163.6 156.44 18.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.103 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -152.39 124.91 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.382 . . . . 0.0 110.706 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -99.64 98.96 9.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.619 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -103.93 94.89 5.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.802 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 79' ' ' VAL . 17.5 m -87.62 121.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.35 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.254 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 8' ' ' MET . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.639 0.257 . . . . 0.0 110.496 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.531 ' H ' HG22 ' A' ' 7' ' ' THR . 46.6 mtt -49.86 -45.13 50.14 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.79 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -41.64 -35.3 0.73 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.55 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.39 -61.84 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.21 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.55 -54.41 47.31 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.754 HG23 ' N ' ' A' ' 13' ' ' ALA . 15.3 m -52.34 -60.3 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.635 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.754 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -51.23 -41.73 60.52 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -65.21 -55.55 17.87 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.797 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.56 -51.75 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.033 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 20' ' ' ARG . 49.2 mt -52.68 -49.42 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.712 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -50.49 -47.23 57.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.907 0.384 . . . . 0.0 110.179 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -69.7 -42.21 74.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.37 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tp -74.92 -22.85 58.36 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' CB ' ' CD ' ' A' ' 21' ' ' PRO . 14.4 mtt180 -43.14 -63.25 1.03 Allowed Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.619 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 20' ' ' ARG . 2.4 Cg_endo -44.78 -28.36 2.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.975 2.45 . . . . 0.0 112.509 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -77.42 -51.46 10.76 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.865 0.364 . . . . 0.0 110.321 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.522 HD13 ' SG ' ' A' ' 30' ' ' CYS . 11.3 mt -57.62 -41.87 82.17 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.76 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.2 tt -54.5 -54.07 45.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.552 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -56.42 -34.68 67.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.366 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -101.34 -58.96 1.78 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -101.08 -75.72 1.16 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -178.11 -147.6 6.99 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -106.99 133.68 51.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 110.389 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 23' ' ' LEU . 55.0 m -97.86 150.88 20.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.102 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.9 m -148.71 111.97 4.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 110.531 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.67 129.89 40.86 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.054 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.56 -39.46 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.395 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -163.09 143.53 9.24 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.498 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 40' ' ' VAL . 69.9 t -108.78 103.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.904 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 18.1 tt0 -104.89 176.89 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.981 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.469 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.5 m-20 -55.45 -9.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.88 -24.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.649 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.2 mp -83.23 62.08 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.247 0.546 . . . . 0.0 110.225 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 35' ' ' VAL . 2.3 t -74.73 117.54 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -84.39 150.14 25.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.409 HD23 ' HG3' ' A' ' 78' ' ' GLN . 38.7 tp -144.63 160.24 41.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.18 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -144.4 109.16 4.94 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.856 0.36 . . . . 0.0 111.095 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.91 143.42 26.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.303 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 10.5 p80 -162.21 112.7 1.56 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.145 0.497 . . . . 0.0 110.603 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.62 -84.41 1.78 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 120.657 0.265 . . . . 0.0 110.357 179.826 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.777 0.322 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.07 134.14 19.08 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 112.452 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t -93.54 -25.9 17.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.424 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 p -83.98 -44.72 13.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.547 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -50.88 -32.19 19.73 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.823 0.344 . . . . 0.0 110.397 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.8 mt -57.54 -42.84 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.178 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -64.73 -53.45 47.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.346 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 tp -57.06 -46.9 82.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.303 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -48.97 -52.61 23.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.03 -23.12 66.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.632 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.68 -59.73 4.29 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.31 -49.14 84.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.242 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -45.49 -60.74 2.01 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.428 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -53.17 -45.9 68.68 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.623 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.56 -57.89 10.7 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.676 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.47 -49.39 74.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.105 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -51.11 -40.35 58.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.362 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.4 -55.63 29.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.761 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.87 -120.39 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.409 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 10.9 t 36.53 53.24 2.37 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.579 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 70' ' ' VAL . 2.7 Cg_endo -42.46 99.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.074 2.516 . . . . 0.0 112.003 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 130.84 -9.11 5.77 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.94 141.5 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.029 0.442 . . . . 0.0 110.499 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.72 -50.5 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.507 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -164.86 109.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.998 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.08 179.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.622 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -148.67 86.63 1.53 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.159 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.409 ' HG3' HD23 ' A' ' 42' ' ' LEU . 4.8 tt0 -101.75 90.39 4.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.304 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 m -89.55 176.05 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.456 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.236 179.894 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.5 p . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.853 0.358 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' PHE . 21.1 mtp -51.68 -53.42 39.19 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.321 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 8' ' ' MET . 28.4 t80 -36.25 -48.07 0.61 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.638 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.0 -52.17 66.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.485 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.43 -68.95 0.25 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.811 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.606 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.3 m -46.55 -52.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.986 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.606 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.27 -49.31 61.46 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -63.48 -53.96 43.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.163 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.84 -54.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.247 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.2 mt -51.9 -56.04 7.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.739 0.304 . . . . 0.0 110.612 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -50.58 -33.21 21.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -66.15 -56.66 10.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.287 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mt -75.27 -24.46 57.56 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.542 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 4.3 ttp180 -35.7 -59.84 0.7 Allowed Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.734 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.0 Cg_endo -44.62 -36.54 10.32 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.877 2.385 . . . . 0.0 112.254 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -76.87 -45.09 29.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.459 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 27' ' ' GLY . 11.1 mp -60.84 -47.33 86.85 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.554 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -54.27 45.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 111.199 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -56.62 -39.42 73.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.574 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -98.88 -57.25 2.22 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -98.32 -77.19 1.32 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.219 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -176.22 -158.83 20.71 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -108.69 139.99 42.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.711 0.291 . . . . 0.0 110.668 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 31' ' ' THR . 4.4 t -108.45 156.56 19.32 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 5.9 m -149.89 119.36 6.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.761 0.315 . . . . 0.0 110.772 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -69.48 112.81 6.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.761 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.3 t -78.98 -45.31 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.988 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -166.73 142.93 4.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.946 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.438 ' HA ' HG22 ' A' ' 40' ' ' VAL . 9.7 p -110.68 127.44 67.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.97 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 38' ' ' GLY . 17.3 tt0 -152.75 99.17 2.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.282 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 52.69 -85.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.721 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -129.1 -12.09 2.68 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.0 mp -83.83 60.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.08 0.467 . . . . 0.0 110.023 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.3 t -81.99 111.49 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.689 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -88.11 129.01 35.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.494 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.68 144.62 37.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.98 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -99.97 165.03 11.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.189 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.438 ' HB3' HE21 ' A' ' 78' ' ' GLN . 4.5 tp -150.1 100.96 2.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.758 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -78.97 97.38 6.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.289 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -70.93 69.44 0.78 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 46' ' ' GLY . . . . . . . . 0 CA--C 1.53 0.188 0 C-N-CA 122.054 0.142 . . . . 0.0 111.229 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.455 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.13 0.048 . . . . 0.0 111.13 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 51' ' ' CYS . 3.2 Cg_exo -45.02 124.28 5.78 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.7 2.266 . . . . 0.0 112.238 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -82.13 -20.37 38.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.862 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 94.3 p -85.29 -30.43 23.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.391 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -45.62 -33.66 2.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 110.19 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.7 mt -58.72 -43.77 88.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.496 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.6 m -63.25 -50.82 68.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.381 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.44 -46.98 88.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.649 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -45.58 -61.8 1.55 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.74 -24.79 64.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.53 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.58 -59.36 7.27 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -51.2 72.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.189 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -43.72 -53.66 5.68 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.419 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -53.7 -56.79 14.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.676 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.9 -51.35 66.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.417 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 70' ' ' VAL . 97.4 mt -59.38 -56.03 27.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.327 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -50.72 -40.88 55.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.639 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -63.08 -57.03 12.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.868 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -84.02 -118.93 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.241 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 66' ' ' LEU . 9.0 t 35.91 53.89 2.23 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.642 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 70' ' ' VAL . 3.0 Cg_endo -42.15 109.38 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 123.253 2.635 . . . . 0.0 112.34 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.21 -8.32 12.38 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.01 147.71 12.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 121.053 0.454 . . . . 0.0 111.021 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.01 -32.62 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.896 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.01 107.33 0.62 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.88 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.583 HG22 ' H ' ' A' ' 77' ' ' GLU . 7.0 p -88.38 171.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.583 ' H ' HG22 ' A' ' 76' ' ' VAL . 3.6 mm-40 -142.78 117.28 9.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.898 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 44' ' ' LEU . 14.3 tm0? -112.87 88.71 2.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.615 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.9 m -92.31 153.64 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.82 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.031 179.632 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 8' ' ' MET . 1.1 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.764 0.316 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.458 ' O ' HG22 ' A' ' 12' ' ' VAL . 13.1 mmt -46.99 -54.46 10.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.21 -40.77 1.67 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.996 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.32 -60.04 4.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.874 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -57.06 14.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.886 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.754 HG23 ' N ' ' A' ' 13' ' ' ALA . 13.2 m -51.57 -59.21 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.38 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.754 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.47 -41.28 63.2 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.986 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -63.29 -58.84 5.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.048 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.8 t -58.98 -52.7 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.041 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.5 mt -55.58 -51.63 56.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.921 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -51.35 -40.5 59.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.009 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.7 mtt-85 -66.17 -45.88 79.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.7 mt -74.69 -24.56 58.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.159 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 18.3 mtt-85 -36.9 -62.07 0.59 Allowed Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.6 Cg_endo -45.53 -48.34 12.03 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.639 2.226 . . . . 0.0 112.277 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -76.52 -45.12 32.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.654 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.9 tp -58.55 -53.48 57.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.032 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 24' ' ' LEU . 4.4 tt -47.25 -45.21 23.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -55.39 -62.03 1.95 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.353 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -102.95 -52.67 3.0 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -82.17 5.46 71.92 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-O 119.992 -0.338 . . . . 0.0 113.901 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 66.75 -159.38 48.87 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -122.71 145.42 48.41 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.901 0.382 . . . . 0.0 111.38 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.9 m -116.9 170.21 8.79 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.92 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 96.6 m -151.33 123.68 8.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.436 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.5 tp -74.02 109.8 7.81 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.08 -31.35 6.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.616 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -165.01 139.62 5.09 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.484 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.621 ' HA ' HG22 ' A' ' 40' ' ' VAL . 7.3 p -107.57 137.96 36.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.797 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -154.2 85.34 1.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.705 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 56.52 -86.12 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.94 -15.49 2.86 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.6 mp -86.99 62.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 0.0 109.96 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.621 HG22 ' HA ' ' A' ' 35' ' ' VAL . 1.4 t -81.33 121.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.888 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -84.98 151.79 23.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.415 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mt -140.91 171.28 14.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 110.997 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -146.5 121.72 10.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.554 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.428 HD13 ' CG2' ' A' ' 55' ' ' THR . 1.2 mt -84.11 162.44 20.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.843 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -155.87 78.55 0.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.025 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -145.13 50.95 0.62 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 46' ' ' GLY . . . . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 121.018 0.437 . . . . 0.0 110.606 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 29.5 p . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.68 0.276 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 51' ' ' CYS . 2.8 Cg_endo -46.21 112.85 0.5 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.9 2.4 . . . . 0.0 111.967 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.7 t -89.33 -21.15 23.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.564 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.1 p -80.35 -41.28 25.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.994 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.428 ' CG2' HD13 ' A' ' 44' ' ' LEU . 3.8 m -57.71 -42.79 84.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.929 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -59.44 -45.83 93.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.536 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.3 m -64.52 -44.96 89.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.484 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -57.56 -55.99 27.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.398 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -46.19 -55.48 7.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.55 -27.34 66.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.23 -52.24 37.79 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -53.13 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -43.72 -59.05 2.38 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.16 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.75 -50.64 65.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.936 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.32 -45.08 88.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.573 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 70' ' ' VAL . 27.9 mt -58.53 -53.85 53.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -54.55 -41.14 69.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.786 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.74 -48.49 74.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -81.77 -7.94 59.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.538 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 70' ' ' VAL . 97.7 t -153.76 71.26 6.61 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 120.966 0.412 . . . . 0.0 110.088 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.91 125.68 8.22 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.993 2.462 . . . . 0.0 111.742 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.59 -0.3 1.91 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.551 -0.619 . . . . 0.0 111.551 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.4 m -62.79 153.62 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.157 0.504 . . . . 0.0 110.484 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.14 -63.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.428 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -164.76 107.33 0.86 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 77' ' ' GLU . 11.3 p -84.12 166.73 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.922 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.564 ' N ' HG22 ' A' ' 76' ' ' VAL . 14.0 mt-10 -143.59 128.33 18.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.029 0.443 . . . . 0.0 110.591 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.413 HE22 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -133.43 87.94 2.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.655 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.6 m -85.23 168.81 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.949 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.884 -179.715 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.779 0.323 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.442 ' O ' HG13 ' A' ' 12' ' ' VAL . 42.2 mtt -47.36 -51.58 19.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.853 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -40.59 -44.64 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -57.42 -55.66 31.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.565 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.9 tt0 -57.8 -65.7 0.59 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.656 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.617 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.3 m -49.14 -52.97 9.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.617 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.92 -46.87 64.81 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -65.16 -54.41 30.18 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.952 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 11' ' ' GLN . 40.8 t -57.53 -49.21 81.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.996 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.2 mt -53.61 -61.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -54.35 -35.73 63.07 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.656 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.4 tpt85 -65.76 -50.9 63.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.668 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tp -78.14 -22.1 49.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.798 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.59 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 43.7 ttm180 -36.86 -55.01 1.66 Allowed Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.8 Cg_endo -41.6 -37.42 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.839 2.36 . . . . 0.0 112.477 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -77.59 -48.7 16.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.0 110.133 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.2 mt -60.08 -43.48 95.44 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.946 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.6 tp -56.13 -56.41 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.991 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -58.11 -32.82 68.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -100.64 -57.78 2.04 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.148 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -96.47 -75.49 1.26 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 170.53 -148.71 11.75 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -105.5 132.33 51.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.876 0.37 . . . . 0.0 110.318 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.594 ' SG ' HD22 ' A' ' 42' ' ' LEU . 33.0 t -119.26 153.97 34.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.317 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.5 m -149.87 124.02 9.46 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.897 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -74.65 122.03 22.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.926 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.02 -29.04 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.732 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -163.58 128.11 2.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.813 0.339 . . . . 0.0 110.583 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 35' ' ' VAL . 11.5 p -92.93 122.2 44.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.038 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.65 165.42 27.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.315 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -47.6 -55.18 9.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.58 -22.2 0.62 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 39' ' ' ILE . 2.1 mp -87.77 59.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.906 0.384 . . . . 0.0 110.35 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.74 123.04 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.112 0.482 . . . . 0.0 111.349 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -87.91 143.41 27.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.75 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.594 HD22 ' SG ' ' A' ' 30' ' ' CYS . 3.7 mt -136.14 162.55 32.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.867 0.365 . . . . 0.0 110.688 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -147.58 116.44 6.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.953 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.97 171.31 13.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -158.3 84.27 0.85 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.836 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.51 -3.65 64.59 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.839 0.352 . . . . 0.0 110.814 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.55 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 19.4 p . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 51' ' ' CYS . 2.5 Cg_endo -46.32 105.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 123.175 2.583 . . . . 0.0 112.207 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -97.28 -28.43 14.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.188 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -89.64 -32.65 16.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.984 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.6 m -59.94 -30.11 68.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.58 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.76 -57.56 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.7 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.3 m -62.77 -45.68 91.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.555 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 58' ' ' LEU . 2.9 mm? -58.16 -57.51 12.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.332 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -46.26 -56.86 5.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -27.24 67.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.493 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.71 -48.09 51.81 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -63.5 -53.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -43.84 -59.92 2.04 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.727 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -38.01 71.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.29 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 62' ' ' ILE . . . -59.18 -50.0 75.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.561 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.644 ' O ' HG12 ' A' ' 70' ' ' VAL . 9.1 mp -56.67 -50.13 73.02 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.503 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -54.75 -52.95 60.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.07 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.9 -25.2 67.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.571 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -84.11 -10.47 57.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.83 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 70' ' ' VAL . 7.8 p -156.14 55.67 1.13 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 120.92 0.391 . . . . 0.0 110.965 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.72 124.66 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 123.058 2.506 . . . . 0.0 111.925 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.78 16.61 3.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.9 m -65.13 155.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.326 0.584 . . . . 0.0 111.225 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mm -102.73 -60.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.268 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -165.7 104.19 0.7 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.597 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 77' ' ' GLU . 7.9 p -87.88 161.39 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.52 ' N ' HG22 ' A' ' 76' ' ' VAL . 32.2 mt-10 -145.42 124.07 12.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.0 110.857 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -127.57 88.13 2.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.746 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 m -86.35 173.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.895 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.698 -179.678 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.461 0.092 0 CA-C-O 120.808 0.337 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -48.95 60.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.082 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -40.15 -41.92 1.36 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.736 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.83 -58.02 9.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.162 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.872 ' O ' HG22 ' A' ' 15' ' ' VAL . 1.5 mp0 -61.02 -60.54 3.62 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.52 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.776 HG23 ' N ' ' A' ' 13' ' ' ALA . 10.0 m -46.0 -61.33 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.791 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.776 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.28 -42.53 63.79 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.175 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.43 -61.87 1.95 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.133 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 11' ' ' GLN . 11.8 m -61.59 -44.83 99.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.665 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' ARG . 52.4 mt -55.41 -52.62 44.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.333 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.23 -37.32 67.02 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.812 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -67.07 -52.48 41.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.588 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 19' ' ' LEU . 10.4 mp -75.65 -20.78 58.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.106 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' ILE . 28.2 ttm-85 -33.63 -59.16 0.5 Allowed Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.807 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.0 Cg_exo -42.42 -35.13 3.52 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.606 2.204 . . . . 0.0 111.953 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -77.73 -50.68 11.9 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.225 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 28' ' ' GLY . 4.4 mm? -58.56 -45.55 88.75 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.87 -43.23 69.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.918 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -56.44 -62.02 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.322 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -101.77 -54.84 2.64 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -71.53 5.23 11.26 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.583 -0.341 . . . . 0.0 112.465 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 60.65 -162.9 19.93 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.49 142.81 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.865 0.364 . . . . 0.0 110.799 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.5 p -128.65 156.18 43.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.887 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.2 m -149.79 120.21 7.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.974 0.416 . . . . 0.0 111.227 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.87 119.89 21.98 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.366 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.91 -31.04 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.53 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -164.86 142.98 6.46 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.644 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 40' ' ' VAL . 10.8 p -109.73 142.84 21.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.873 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 38' ' ' GLY . 24.0 tt0 -162.34 99.06 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.027 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 49.37 -86.76 0.01 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.099 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -129.09 -13.42 2.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.768 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.7 mp -86.99 63.22 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.157 0.503 . . . . 0.0 110.276 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -78.68 125.91 38.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.845 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -87.57 148.7 24.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.594 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' GLU . 3.9 mt -143.87 167.88 21.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.915 0.388 . . . . 0.0 110.915 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.426 HE21 ' CG2' ' A' ' 79' ' ' VAL . 9.8 mp0 -142.01 120.81 12.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.923 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 44' ' ' LEU . 6.9 tp -85.67 168.42 14.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.075 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -161.29 74.98 0.49 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.958 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.18 31.23 0.18 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.213 0 CA-C-O 120.552 0.215 . . . . 0.0 110.892 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.789 0.328 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.8 116.98 4.92 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.853 2.369 . . . . 0.0 112.113 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.1 p -82.56 -19.46 38.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.336 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -77.24 -42.31 37.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.626 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.7 m -52.61 -42.74 64.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.361 . . . . 0.0 110.246 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 56' ' ' ILE . 2.9 mm -60.01 -45.57 95.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.041 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.7 m -64.85 -46.01 83.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.511 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.0 tp -57.6 -51.35 69.85 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.052 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -50.74 -49.91 56.83 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.138 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.66 -29.32 69.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.578 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.07 -58.06 8.65 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 pt -61.71 -44.27 98.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.428 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 24.8 tt0 -45.29 -65.12 0.58 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.614 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -54.97 -47.38 74.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.963 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.77 82.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.715 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 70' ' ' VAL . 9.3 mt -56.0 -45.31 79.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.63 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.483 ' ND1' HG21 ' A' ' 73' ' ' VAL . 1.4 m-70 -54.35 -55.88 24.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.428 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -68.57 -29.07 67.54 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -85.71 -11.49 53.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.022 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' LEU . 1.9 t -151.97 57.13 2.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.15 142.32 4.13 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 123.369 2.713 . . . . 0.0 112.38 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 136.93 -31.96 2.49 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.483 HG21 ' ND1' ' A' ' 67' ' ' HIS . 5.2 m -65.6 145.18 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.007 0.432 . . . . 0.0 110.409 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.28 -28.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.282 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -165.02 171.11 14.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.719 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.31 158.62 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.442 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' LEU . 67.5 mt-10 -142.65 116.72 9.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.393 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -125.3 86.61 2.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.812 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.426 ' CG2' HE21 ' A' ' 43' ' ' GLN . 12.9 m -89.59 178.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.043 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.09 179.575 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.482 ' N ' ' SD ' ' A' ' 8' ' ' MET . 1.2 mpp? -51.74 -46.21 63.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.634 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.415 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 13.0 t80 -41.0 -36.44 0.67 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.36 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -60.76 -62.56 1.77 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -52.85 63.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.123 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.755 HG23 ' N ' ' A' ' 13' ' ' ALA . 19.2 m -51.22 -60.34 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.989 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.755 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.24 -37.9 56.54 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.102 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.82 -60.48 3.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.609 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 m -55.68 -43.64 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.76 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 12' ' ' VAL . 14.9 mm -53.58 -48.79 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.034 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -53.47 -45.9 69.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.642 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -68.49 -37.58 80.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.338 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.63 -32.72 64.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.56 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.435 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 14.3 mtt180 -42.64 -63.21 0.99 Allowed Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.9 Cg_endo -46.15 -36.76 17.12 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.821 2.347 . . . . 0.0 112.986 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -75.46 -60.31 2.36 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.542 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 26.9 mt -58.52 -45.05 89.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.936 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.2 tp -51.39 -41.52 60.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.104 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.6 mtt85 -58.92 -54.28 48.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.407 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -100.91 -59.35 1.71 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -80.33 -77.73 0.95 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.911 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 170.71 -142.79 7.34 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -109.27 165.25 11.77 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 111.159 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.668 ' SG ' HD22 ' A' ' 42' ' ' LEU . 38.4 t -126.93 158.02 37.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.833 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.448 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 64.0 m -150.29 122.27 8.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.884 0.373 . . . . 0.0 111.204 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 33' ' ' VAL . 1.1 tt -69.14 128.22 35.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.864 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 32' ' ' LEU . 49.1 t -97.58 -39.79 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.199 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -155.48 118.54 4.33 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.677 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.9 p -81.85 142.14 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.814 ' CG ' ' H ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -158.93 -158.49 0.69 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.843 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.535 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -88.94 -46.27 9.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.406 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.567 ' H ' HD12 ' A' ' 39' ' ' ILE . . . -157.0 27.2 0.51 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.916 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.814 ' H ' ' CG ' ' A' ' 36' ' ' GLU . 1.1 mp -145.34 59.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.435 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -78.96 128.01 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.254 -178.176 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -91.06 145.16 24.92 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.668 HD22 ' SG ' ' A' ' 30' ' ' CYS . 2.9 mt -139.66 174.13 10.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.293 0.568 . . . . 0.0 111.47 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 1.2 mt-30 -146.31 126.72 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.021 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.689 ' H ' ' HB2' ' A' ' 80' ' ' PHE . 5.2 mt -86.88 -179.24 6.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.915 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.467 ' HA ' ' CE2' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -162.82 63.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.03 -89.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.865 0.364 . . . . 0.0 110.42 -179.839 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 54' ' ' SER . 3.3 Cg_exo -73.2 28.33 0.3 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.673 2.248 . . . . 0.0 113.154 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -63.01 -9.93 12.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.425 ' N ' ' C ' ' A' ' 52' ' ' PRO . 8.4 m -90.73 -31.89 16.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.334 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.46 -42.79 54.85 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.17 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.528 HD13 ' N ' ' A' ' 56' ' ' ILE . 2.1 mm -56.02 -50.86 67.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.875 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 m -65.41 -54.91 21.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.05 -53.12 61.7 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.712 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -48.99 -47.24 44.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.4 69.69 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.188 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.63 -45.17 95.23 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.431 HG13 ' H ' ' A' ' 62' ' ' ILE . 0.9 OUTLIER -64.7 -60.67 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -43.72 -51.61 7.07 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.832 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -53.56 -50.86 64.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.696 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.62 -48.84 79.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.767 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 8.7 mp -58.62 -54.57 45.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.089 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.434 ' NE2' HG21 ' A' ' 73' ' ' VAL . 10.8 m170 -53.06 -44.07 67.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.349 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -64.61 -45.33 87.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.198 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.64 -9.58 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.102 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 66' ' ' LEU . 47.7 t -153.39 72.46 6.85 Favored Pre-proline 0 N--CA 1.463 0.184 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.79 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.96 37.32 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 123.153 2.569 . . . . 0.0 112.163 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -102.68 -21.14 10.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.434 HG21 ' NE2' ' A' ' 67' ' ' HIS . 3.7 m -64.07 160.72 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.11 -41.66 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.786 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HB3' HG23 ' A' ' 39' ' ' ILE . 3.2 mm-40 -164.54 157.03 16.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.993 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -149.94 156.18 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -143.8 78.17 1.58 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.111 0.481 . . . . 0.0 110.583 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.407 ' OE1' HD12 ' A' ' 44' ' ' LEU . 5.4 tm0? -102.33 96.39 6.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.36 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 2.9 m -111.18 161.58 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.689 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 6.5 t80 . . . . . 0 C--O 1.233 0.211 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.605 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.8 0.333 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 44.3 mtm -51.13 -45.04 61.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.81 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -42.79 -34.16 0.88 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.437 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.62 -63.69 1.21 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.036 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.3 tt0 -58.04 -58.87 6.51 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.029 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.766 HG23 ' N ' ' A' ' 13' ' ' ALA . 10.4 m -48.27 -60.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.528 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.766 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -50.07 -42.7 50.5 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.632 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.81 -51.68 63.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.77 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 11' ' ' GLN . 98.7 t -57.56 -61.64 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.312 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 12' ' ' VAL . 20.4 mm -48.54 -46.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.706 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -53.06 -43.26 66.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.347 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -66.55 -47.07 74.02 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.203 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 19' ' ' LEU . 7.4 mp -73.93 -33.53 63.98 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -34.84 -63.35 0.36 Allowed Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.2 Cg_exo -42.88 -39.04 7.34 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 123.119 2.546 . . . . 0.0 113.219 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -77.51 -50.34 12.82 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.516 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 27' ' ' GLY . 8.0 mp -55.93 -37.55 69.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.25 -60.94 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.475 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -54.57 -34.01 61.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.666 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.64 -57.63 2.07 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.263 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -100.41 -76.04 1.2 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.782 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 179.63 -150.75 9.52 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -111.05 137.11 49.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.815 0.34 . . . . 0.0 110.726 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.6 t -111.78 148.57 33.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.937 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.7 m -150.57 124.81 9.44 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.371 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.75 129.23 38.58 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.696 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.65 -35.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.763 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -160.27 134.16 7.15 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.318 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 40' ' ' VAL . 9.9 p -101.69 123.62 54.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.915 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.6 tp10 -148.9 80.32 1.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.764 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 t0 54.79 -81.29 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.122 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -124.87 -22.36 1.99 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.02 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.65 65.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.193 0.52 . . . . 0.0 110.296 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 35' ' ' VAL . 32.3 t -87.32 120.23 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.225 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -90.03 139.97 30.09 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.596 HD21 HG22 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -149.33 148.27 29.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 0.0 111.21 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -96.49 166.28 11.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.882 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 44' ' ' LEU . 23.5 tp -148.56 94.76 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.237 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -75.9 77.68 2.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.025 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.66 -88.19 0.19 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.74 0.305 . . . . 0.0 110.681 -179.7 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.4 t . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.803 0.335 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -70.3 106.2 1.71 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.587 2.191 . . . . 0.0 112.311 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.8 t -81.18 -11.06 59.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.394 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.6 t -86.66 -49.9 7.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.115 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -47.45 -35.16 8.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.998 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 90.0 mt -58.18 -46.68 88.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.1 m -64.48 -46.22 83.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.127 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.3 tp -57.5 -57.62 11.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.807 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -46.36 -54.87 8.2 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.21 68.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.613 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.97 -45.0 90.55 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -64.82 -62.23 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.519 0.2 . . . . 0.0 110.918 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -43.84 -51.94 7.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.9 0.381 . . . . 0.0 110.517 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.2 ttm-85 -55.4 -39.85 70.69 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.202 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -57.16 -42.92 81.99 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.342 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.44 -53.31 59.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -59.14 -59.88 4.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.387 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.69 -10.26 34.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.229 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.494 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 mt-10 -157.15 99.12 1.78 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.849 0.357 . . . . 0.0 110.376 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 69' ' ' GLU . 62.1 t 77.05 72.77 0.19 Allowed Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.175 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.84 -149.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 123.03 2.487 . . . . 0.0 111.35 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.19 -20.72 44.36 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 73' ' ' VAL . 3.3 m -64.54 151.02 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.023 0.439 . . . . 0.0 110.684 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.56 -30.55 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.411 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -159.91 154.31 23.8 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.463 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.596 HG22 HD21 ' A' ' 42' ' ' LEU . 8.2 p -149.15 119.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -96.53 124.72 40.61 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.468 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -118.48 83.2 1.97 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.103 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 79' ' ' VAL . 1.6 m -94.03 157.22 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 111.694 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--O 1.232 0.162 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.192 179.552 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.894 0.378 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 8' ' ' MET . 5.3 mpp? -49.08 -51.96 28.55 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.784 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -41.57 -39.36 1.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.066 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -59.36 -62.06 2.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -60.54 -57.93 10.66 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.051 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.746 HG23 ' N ' ' A' ' 13' ' ' ALA . 8.5 m -51.03 -59.84 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.442 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.746 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.28 -42.03 63.38 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.13 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.4 -57.22 12.07 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.945 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.13 -48.86 86.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.203 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.6 mt -54.39 -53.37 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.593 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -50.87 -47.13 60.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.62 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -65.78 -38.31 88.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.054 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tp -76.85 -26.37 54.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.994 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 6.2 mtt180 -40.14 -60.92 1.27 Allowed Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.8 Cg_endo -43.83 -36.01 7.46 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.078 2.518 . . . . 0.0 113.184 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -75.53 -46.07 34.34 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' GLY . 4.6 mp -58.42 -38.5 77.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.669 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 24' ' ' LEU . 2.0 tt -54.5 -58.79 6.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -56.74 -34.65 67.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.567 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -100.4 -58.65 1.86 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.469 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -97.86 -76.2 1.27 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.76 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 178.15 -141.48 5.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -114.65 125.44 53.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.676 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 31' ' ' THR . 7.8 t -84.48 158.03 21.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.472 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.524 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 18.5 m -146.99 114.9 6.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.818 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tp -73.6 125.17 27.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.126 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.76 -47.59 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.814 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -165.37 143.51 6.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.95 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 35' ' ' VAL . 12.9 p -107.23 122.33 61.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.572 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.4 tp10 -141.0 88.48 2.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.734 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.7 t0 55.02 -79.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -131.0 -17.35 1.48 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.783 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.9 mp -84.88 60.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.051 0.453 . . . . 0.0 109.979 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 35' ' ' VAL . 2.1 t -74.62 115.96 16.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.763 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -88.98 140.5 29.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.146 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 42' ' ' LEU . 2.2 pt? -159.79 -178.76 7.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.294 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.88 170.72 15.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.165 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tt -150.51 138.64 20.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.595 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -162.34 130.79 4.1 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.91 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -106.21 -26.51 5.96 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 46' ' ' GLY . . . . . . . . 0 C--N 1.331 -0.208 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.793 0.33 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.53 121.42 7.42 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.709 2.272 . . . . 0.0 112.089 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t -86.94 -28.93 22.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.046 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.9 t -68.32 -41.95 80.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.621 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 m -65.97 -47.35 74.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.679 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.31 -48.86 85.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.685 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -64.5 -45.44 87.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.246 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.4 tp -57.94 -56.99 14.85 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.545 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -47.37 -54.29 11.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 110.156 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 64' ' ' ARG . . . -59.07 -21.24 58.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.31 -44.93 26.5 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.645 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -65.63 -61.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -43.89 -47.42 8.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.524 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.411 ' CG ' ' O ' ' A' ' 60' ' ' ALA . 14.4 mmt180 -54.38 -47.3 72.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.63 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.39 -54.74 43.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.521 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.088 ' O ' HG13 ' A' ' 70' ' ' VAL . 7.3 mp -55.48 -64.1 0.96 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.203 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -42.55 -50.87 5.28 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.951 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.98 -14.57 62.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.755 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 66' ' ' LEU . 32.0 mt-10 -155.76 98.44 1.92 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.088 HG13 ' O ' ' A' ' 66' ' ' LEU . 2.0 m -135.06 66.15 66.87 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.627 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 70' ' ' VAL . 3.2 Cg_exo -79.4 29.43 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.884 2.389 . . . . 0.0 111.301 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.45 -48.97 0.05 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.946 HG13 HG12 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -69.16 145.91 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.096 0.474 . . . . 0.0 110.659 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.604 HD12 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -122.02 -49.84 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.802 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -166.27 108.8 0.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.037 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -83.4 174.81 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -145.94 87.47 1.76 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.765 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.96 94.88 7.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.843 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 79' ' ' VAL . 17.0 m -87.0 168.39 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.959 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.336 179.686 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.854 0.359 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.447 ' O ' HG22 ' A' ' 12' ' ' VAL . 19.1 mmt -49.78 -59.8 3.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.292 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -44.23 -36.64 2.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.239 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -61.07 2.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -57.67 -55.77 30.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.978 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 13' ' ' ALA . 18.6 m -51.66 -63.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.171 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.777 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -47.29 -38.99 13.62 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 120.086 -0.645 . . . . 0.0 109.565 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.9 -63.99 1.01 Allowed 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.073 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 16' ' ' ILE . 4.8 m -62.32 -45.26 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.483 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 12' ' ' VAL . 23.4 mm -53.87 -62.17 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.801 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -53.78 -31.37 48.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 55.1 ttt180 -66.97 -50.64 61.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 19' ' ' LEU . 11.0 mp -79.03 -21.49 46.83 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.536 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 12.9 ttm180 -37.3 -43.28 1.18 Allowed Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 20' ' ' ARG . 3.4 Cg_exo -77.5 -28.31 5.59 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.292 1.995 . . . . 0.0 112.506 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -77.08 -46.9 22.04 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.633 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 27' ' ' GLY . 12.4 mt -55.78 -37.8 69.06 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 24' ' ' LEU . 1.3 tt -57.45 -56.06 26.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -54.07 -35.19 61.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.988 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -100.99 -60.94 1.43 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -102.03 -76.31 1.17 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.816 -0.513 . . . . 0.0 111.816 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 24' ' ' LEU . . . -173.0 -138.31 2.57 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -130.94 123.7 29.45 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.421 -0.458 . . . . 0.0 110.602 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.1 p -94.93 159.53 14.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.54 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.7 m -150.75 124.75 9.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.136 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 41' ' ' LYS . 25.6 tp -77.25 123.08 25.96 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.847 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.11 -34.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.066 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -167.98 139.49 2.91 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.885 0.374 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 35' ' ' VAL . 14.8 p -104.04 126.8 58.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.761 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -149.64 77.76 1.34 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.662 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.9 t70 55.38 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.021 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.73 -21.6 5.34 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 39' ' ' ILE . 3.2 mp -84.05 63.79 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.374 0.607 . . . . 0.0 109.883 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.18 118.97 33.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.125 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.414 ' O ' HD12 ' A' ' 32' ' ' LEU . 46.9 mttp -85.26 139.66 31.45 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -139.72 169.6 17.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 0.0 111.176 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -145.41 112.86 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.108 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' CD2' HG23 ' A' ' 55' ' ' THR . 9.7 tp -91.02 105.53 17.89 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.343 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -78.35 86.25 4.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.503 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.96 91.63 1.75 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.823 0.344 . . . . 0.0 111.022 -179.807 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 51' ' ' CYS . 21.7 t . . . . . 0 C--O 1.233 0.216 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 51' ' ' CYS . 3.0 Cg_exo -76.96 114.95 3.92 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.993 2.462 . . . . 0.0 111.895 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.3 p -83.36 -17.81 41.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.029 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -78.6 -49.58 13.0 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.948 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.496 HG23 ' CD2' ' A' ' 44' ' ' LEU . 53.9 m -41.67 -39.88 1.79 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.899 0.38 . . . . 0.0 110.179 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.2 mt -61.24 -53.35 50.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.591 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 94.2 m -62.88 -36.11 82.23 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.718 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 tp -57.17 -57.23 13.5 Favored 'General case' 0 CA--C 1.523 -0.063 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.524 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -48.35 -54.81 12.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.176 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.14 -21.57 61.76 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.036 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.56 -44.23 41.32 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 5.9 mt -60.62 -58.86 5.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -45.07 -52.96 8.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.93 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -53.45 -41.27 65.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.481 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 62' ' ' ILE . . . -58.34 -47.43 83.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.172 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.4 mt -59.36 -59.62 5.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.024 0.44 . . . . 0.0 110.496 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -53.59 -56.88 13.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.508 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -68.76 -12.02 60.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.637 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' C ' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -152.78 98.99 2.4 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.514 HG23 ' C ' ' A' ' 69' ' ' GLU . 11.2 t 86.28 78.52 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.533 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.9 -151.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.451 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.22 -21.78 22.76 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.78 142.24 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.065 0.459 . . . . 0.0 110.3 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.75 -39.02 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.326 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -164.74 108.97 0.92 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.084 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 77' ' ' GLU . 8.8 p -84.16 176.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.379 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.725 ' H ' HG22 ' A' ' 76' ' ' VAL . 15.7 mt-10 -147.33 85.65 1.6 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.995 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.85 91.04 3.98 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.181 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.2 m -93.63 174.77 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.121 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.773 -179.851 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.444 ' C ' ' HG1' ' A' ' 3' ' ' THR . 2.9 Cg_endo -75.05 -81.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.814 2.343 . . . . 0.0 111.801 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.444 ' HG1' ' C ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER -172.99 158.66 3.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.147 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -81.36 37.64 0.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -53.68 175.41 0.14 Allowed Pre-proline 0 N--CA 1.456 -0.133 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 5' ' ' ASN . 3.7 Cg_exo -39.83 91.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.821 1.681 . . . . 0.0 110.469 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 5' ' ' ASN . 75.7 p -66.76 -175.27 0.39 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.95 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.623 ' O ' HG13 ' A' ' 12' ' ' VAL . 20.3 mtt -50.23 -53.75 25.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.624 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -39.92 -51.88 2.45 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.964 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.53 -51.16 69.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.717 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.487 ' O ' HG22 ' A' ' 15' ' ' VAL . 12.9 mt-30 -61.29 -60.02 4.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.642 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 8' ' ' MET . 1.1 m -54.47 -54.22 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.72 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.603 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.28 -43.92 64.68 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.177 0.513 . . . . 0.0 109.743 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -61.6 -61.8 2.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.458 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 11' ' ' GLN . 34.1 m -60.51 -40.22 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.337 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 12' ' ' VAL . 26.8 mt -54.72 -64.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.841 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -30.59 32.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.717 0.294 . . . . 0.0 111.051 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -68.06 -51.41 46.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.602 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.2 -22.52 55.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.569 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 9.8 mtp180 -36.84 -60.58 0.76 Allowed Pre-proline 0 N--CA 1.469 0.494 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.9 Cg_endo -45.9 -39.26 19.13 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.809 2.339 . . . . 0.0 112.406 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -75.15 -43.7 51.03 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.403 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.3 mt -59.48 -48.73 80.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.285 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.1 tp -53.08 -43.67 66.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.8 mmm-85 -58.04 -48.04 81.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.037 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.75 -57.5 2.06 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -90.73 -76.41 1.32 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.462 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.5 -136.83 3.66 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.406 ' HB2' ' CE1' ' A' ' 45' ' ' HIS . 4.1 m-20 -130.77 131.15 44.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.48 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.1 t -95.33 156.19 16.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 85.2 m -149.93 114.07 5.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.375 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 tp -69.6 126.77 30.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.258 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.98 -39.07 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.955 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -157.82 133.78 9.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.023 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 35' ' ' VAL . 7.7 p -104.05 117.98 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.971 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -120.32 -179.18 3.88 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.964 0.411 . . . . 0.0 110.76 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -13.93 62.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.33 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.43 -32.69 0.03 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.801 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.6 mp -84.7 59.98 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.019 0.437 . . . . 0.0 110.602 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 41' ' ' LYS . 1.2 t -69.51 163.75 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.153 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.493 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -151.19 121.08 7.09 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.378 -179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -129.72 -179.66 5.32 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.205 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -144.08 117.91 9.33 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.022 0.439 . . . . 0.0 111.103 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tp -92.12 148.01 22.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.087 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.435 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 16.1 p80 -164.27 120.08 1.55 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 0.0 110.711 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.11 -25.53 6.7 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -173.75 -103.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.8 t -175.84 98.82 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.619 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' H ' ' CB ' ' A' ' 82' ' ' GLU . . . -119.06 -148.4 8.33 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.2 p -140.25 -44.4 0.42 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.737 0.304 . . . . 0.0 110.415 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 97.1 m -135.99 79.57 44.41 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.065 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HG3' ' H ' ' A' ' 83' ' ' HIS . 3.3 Cg_exo -74.74 118.34 5.27 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.932 2.421 . . . . 0.0 112.391 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -91.04 -24.15 20.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.235 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -84.43 -41.99 16.09 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.89 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -56.85 -35.6 69.05 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.463 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.7 mt -59.19 -47.51 90.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.143 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 m -63.98 -50.4 68.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.191 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.68 -45.69 88.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.409 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -46.1 -58.72 3.38 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.558 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.1 68.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.443 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.34 -56.62 14.56 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -53.62 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -43.93 -56.2 4.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.71 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -54.79 -47.81 73.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.643 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.06 84.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.73 -56.07 26.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.373 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -54.61 -43.26 72.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.02 -45.8 80.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -81.84 -2.15 50.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.132 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.5 t -152.47 70.11 7.4 Favored Pre-proline 0 C--N 1.332 -0.179 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.01 125.36 9.79 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.893 2.396 . . . . 0.0 111.986 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.72 -13.38 1.75 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 m -65.17 165.75 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.105 0.479 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.19 -34.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.575 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -163.6 156.44 18.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.103 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -152.39 124.91 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.382 . . . . 0.0 110.706 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -99.64 98.96 9.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.619 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -103.93 94.89 5.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.802 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 79' ' ' VAL . 17.5 m -87.62 121.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.35 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -94.79 139.93 30.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.254 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 tp -95.95 44.66 1.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.695 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' CB ' ' H ' ' A' ' 49' ' ' GLY . 2.6 mp0 64.05 154.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.327 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.496 ' H ' ' HG3' ' A' ' 52' ' ' PRO . 3.0 t60 -178.85 76.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.587 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -59.51 179.21 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.907 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -134.35 156.66 48.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.715 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -57.02 11.65 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.408 ' CG ' ' N ' ' A' ' 88' ' ' HIS . 28.3 t-80 -164.66 162.59 21.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.364 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.408 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 8.0 t60 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.459 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.581 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 2.8 ttm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 1' ' ' MET . 3.4 Cg_exo -73.36 -176.17 2.35 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.444 2.096 . . . . 0.0 112.23 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.02 170.06 0.7 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.009 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -136.56 29.26 2.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.37 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.473 ' H ' ' CD ' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -103.12 -49.26 0.16 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.872 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.473 ' CD ' ' H ' ' A' ' 5' ' ' ASN . 2.8 Cg_endo -76.84 40.87 0.84 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.756 2.304 . . . . 0.0 111.413 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 8' ' ' MET . 0.2 OUTLIER -71.72 -161.11 0.06 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.496 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.531 ' H ' HG22 ' A' ' 7' ' ' THR . 46.6 mtt -49.86 -45.13 50.14 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.79 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -41.64 -35.3 0.73 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.55 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.39 -61.84 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.21 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.55 -54.41 47.31 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.754 HG23 ' N ' ' A' ' 13' ' ' ALA . 15.3 m -52.34 -60.3 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.635 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.754 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -51.23 -41.73 60.52 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -65.21 -55.55 17.87 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.797 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.56 -51.75 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.033 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 20' ' ' ARG . 49.2 mt -52.68 -49.42 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.712 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -50.49 -47.23 57.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.907 0.384 . . . . 0.0 110.179 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -69.7 -42.21 74.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.37 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tp -74.92 -22.85 58.36 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' CB ' ' CD ' ' A' ' 21' ' ' PRO . 14.4 mtt180 -43.14 -63.25 1.03 Allowed Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.619 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 20' ' ' ARG . 2.4 Cg_endo -44.78 -28.36 2.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.975 2.45 . . . . 0.0 112.509 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -77.42 -51.46 10.76 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.865 0.364 . . . . 0.0 110.321 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.522 HD13 ' SG ' ' A' ' 30' ' ' CYS . 11.3 mt -57.62 -41.87 82.17 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.76 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 24' ' ' LEU . 1.2 tt -54.5 -54.07 45.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.552 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -56.42 -34.68 67.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.366 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -101.34 -58.96 1.78 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -101.08 -75.72 1.16 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -178.11 -147.6 6.99 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -106.99 133.68 51.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 110.389 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 23' ' ' LEU . 55.0 m -97.86 150.88 20.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.102 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.9 m -148.71 111.97 4.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 110.531 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.67 129.89 40.86 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.054 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.56 -39.46 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.395 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -163.09 143.53 9.24 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.498 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 40' ' ' VAL . 69.9 t -108.78 103.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.904 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 18.1 tt0 -104.89 176.89 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.981 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.469 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.5 m-20 -55.45 -9.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.88 -24.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.649 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.2 mp -83.23 62.08 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.247 0.546 . . . . 0.0 110.225 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 35' ' ' VAL . 2.3 t -74.73 117.54 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -84.39 150.14 25.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.409 HD23 ' HG3' ' A' ' 78' ' ' GLN . 38.7 tp -144.63 160.24 41.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.18 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -144.4 109.16 4.94 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.856 0.36 . . . . 0.0 111.095 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.91 143.42 26.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.303 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 10.5 p80 -162.21 112.7 1.56 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.145 0.497 . . . . 0.0 110.603 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.62 -84.41 1.78 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.57 -90.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.657 0.265 . . . . 0.0 110.357 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.5 p -143.63 7.33 1.48 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.37 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.48 28.16 22.9 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -72.18 61.94 0.47 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.087 0.47 . . . . 0.0 110.419 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.405 ' C ' ' O ' ' A' ' 50' ' ' THR . 7.6 p 32.64 76.82 0.37 Allowed Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.562 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.07 134.14 19.08 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 112.452 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t -93.54 -25.9 17.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.424 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 p -83.98 -44.72 13.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.547 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -50.88 -32.19 19.73 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.823 0.344 . . . . 0.0 110.397 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.8 mt -57.54 -42.84 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.178 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -64.73 -53.45 47.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.346 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 tp -57.06 -46.9 82.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.303 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -48.97 -52.61 23.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.03 -23.12 66.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.632 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.68 -59.73 4.29 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.31 -49.14 84.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.242 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -45.49 -60.74 2.01 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.428 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -53.17 -45.9 68.68 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.623 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.56 -57.89 10.7 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.676 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.47 -49.39 74.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.105 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -51.11 -40.35 58.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.362 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.4 -55.63 29.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.761 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.87 -120.39 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.409 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 10.9 t 36.53 53.24 2.37 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.579 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 70' ' ' VAL . 2.7 Cg_endo -42.46 99.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.074 2.516 . . . . 0.0 112.003 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 130.84 -9.11 5.77 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.94 141.5 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.029 0.442 . . . . 0.0 110.499 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.72 -50.5 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.507 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -164.86 109.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.998 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.08 179.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.622 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -148.67 86.63 1.53 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.159 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.409 ' HG3' HD23 ' A' ' 42' ' ' LEU . 4.8 tt0 -101.75 90.39 4.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.304 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 m -89.55 176.05 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.456 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -109.97 108.63 18.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.236 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 tp -89.73 91.88 8.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.488 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -71.77 0.09 9.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.394 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -92.29 94.05 8.96 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.992 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.472 ' CG ' ' N ' ' A' ' 85' ' ' HIS . 37.2 t-80 -59.18 -104.65 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.356 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.472 ' N ' ' CG ' ' A' ' 84' ' ' HIS . 15.9 t-80 58.13 164.89 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 111.065 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -131.31 153.96 49.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.266 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -87.21 -48.93 7.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.372 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.036 179.743 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -74.66 134.04 17.91 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.775 2.317 . . . . 0.0 111.511 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.542 HG22 ' N ' ' A' ' 4' ' ' GLU . 25.8 m -77.72 164.77 24.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.132 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.542 ' N ' HG22 ' A' ' 3' ' ' THR . 85.2 mt-10 -93.17 32.35 1.32 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.932 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.452 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.5 OUTLIER -100.66 -51.37 0.18 Allowed Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.064 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.452 ' HD3' ' CB ' ' A' ' 5' ' ' ASN . 2.5 Cg_endo -81.35 98.22 1.01 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.682 2.255 . . . . 0.0 110.116 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.5 p -71.2 176.8 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.358 . . . . 0.0 110.973 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' PHE . 21.1 mtp -51.68 -53.42 39.19 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.321 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 8' ' ' MET . 28.4 t80 -36.25 -48.07 0.61 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.638 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.0 -52.17 66.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.485 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.43 -68.95 0.25 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.811 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.606 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.3 m -46.55 -52.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.986 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.606 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.27 -49.31 61.46 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -63.48 -53.96 43.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.163 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.84 -54.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.247 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.2 mt -51.9 -56.04 7.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.739 0.304 . . . . 0.0 110.612 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -50.58 -33.21 21.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -66.15 -56.66 10.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.287 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mt -75.27 -24.46 57.56 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.542 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 4.3 ttp180 -35.7 -59.84 0.7 Allowed Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.734 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.0 Cg_endo -44.62 -36.54 10.32 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.877 2.385 . . . . 0.0 112.254 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -76.87 -45.09 29.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.459 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 27' ' ' GLY . 11.1 mp -60.84 -47.33 86.85 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.554 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -54.27 45.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 111.199 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -56.62 -39.42 73.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.574 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -98.88 -57.25 2.22 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -98.32 -77.19 1.32 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.219 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -176.22 -158.83 20.71 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -108.69 139.99 42.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.711 0.291 . . . . 0.0 110.668 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 31' ' ' THR . 4.4 t -108.45 156.56 19.32 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 5.9 m -149.89 119.36 6.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.761 0.315 . . . . 0.0 110.772 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -69.48 112.81 6.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.761 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.3 t -78.98 -45.31 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.988 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -166.73 142.93 4.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.946 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.438 ' HA ' HG22 ' A' ' 40' ' ' VAL . 9.7 p -110.68 127.44 67.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.97 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 38' ' ' GLY . 17.3 tt0 -152.75 99.17 2.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.282 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 52.69 -85.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.721 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -129.1 -12.09 2.68 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.0 mp -83.83 60.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.08 0.467 . . . . 0.0 110.023 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.3 t -81.99 111.49 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.689 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -88.11 129.01 35.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.494 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.68 144.62 37.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.98 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -99.97 165.03 11.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.189 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.438 ' HB3' HE21 ' A' ' 78' ' ' GLN . 4.5 tp -150.1 100.96 2.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.758 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -78.97 97.38 6.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.289 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -70.93 69.44 0.78 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' O ' ' SG ' ' A' ' 48' ' ' CYS . . . 70.25 -46.35 0.61 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.054 0.142 . . . . 0.0 111.229 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 47' ' ' ALA . 2.1 m -166.18 31.5 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.72 0.295 . . . . 0.0 110.817 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.16 179.84 28.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 50' ' ' THR . 5.2 t -41.46 114.98 0.57 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.566 0.222 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.455 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -178.28 -63.92 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.13 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 51' ' ' CYS . 3.2 Cg_exo -45.02 124.28 5.78 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.7 2.266 . . . . 0.0 112.238 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -82.13 -20.37 38.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.862 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 94.3 p -85.29 -30.43 23.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.391 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -45.62 -33.66 2.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 110.19 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.7 mt -58.72 -43.77 88.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.496 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.6 m -63.25 -50.82 68.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.381 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.44 -46.98 88.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.649 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -45.58 -61.8 1.55 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.74 -24.79 64.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.53 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.58 -59.36 7.27 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -51.2 72.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.189 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -43.72 -53.66 5.68 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.419 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -53.7 -56.79 14.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.676 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.9 -51.35 66.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.417 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 70' ' ' VAL . 97.4 mt -59.38 -56.03 27.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.327 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -50.72 -40.88 55.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.639 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -63.08 -57.03 12.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.868 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -84.02 -118.93 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.241 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 66' ' ' LEU . 9.0 t 35.91 53.89 2.23 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.642 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 70' ' ' VAL . 3.0 Cg_endo -42.15 109.38 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 123.253 2.635 . . . . 0.0 112.34 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.21 -8.32 12.38 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.01 147.71 12.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 121.053 0.454 . . . . 0.0 111.021 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.01 -32.62 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.896 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.01 107.33 0.62 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.88 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.583 HG22 ' H ' ' A' ' 77' ' ' GLU . 7.0 p -88.38 171.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.583 ' H ' HG22 ' A' ' 76' ' ' VAL . 3.6 mm-40 -142.78 117.28 9.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.898 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 44' ' ' LEU . 14.3 tm0? -112.87 88.71 2.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.615 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.9 m -92.31 153.64 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.82 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -95.99 -179.57 4.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.031 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 tp -71.48 75.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 110.085 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -53.67 161.08 1.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.585 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -73.56 -58.28 3.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.651 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 61.99 139.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.57 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -164.14 136.15 4.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.523 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -114.0 84.05 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.937 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -66.72 -163.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.467 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t60 . . . . . 0 C--O 1.223 -0.34 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.068 179.49 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -74.53 -83.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.689 2.26 . . . . 0.0 111.882 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.83 147.35 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.623 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -48.29 -42.46 30.94 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.609 ' HB2' ' CD ' ' A' ' 6' ' ' PRO . 7.5 p30 43.7 -165.87 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.486 0 O-C-N 123.534 0.521 . . . . 0.0 110.006 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.609 ' CD ' ' HB2' ' A' ' 5' ' ' ASN . 3.9 Cg_exo -68.97 84.69 0.52 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 N-CA-C 108.874 -1.241 . . . . 0.0 108.874 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 8' ' ' MET . 1.1 m -63.01 168.08 4.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.767 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.458 ' O ' HG22 ' A' ' 12' ' ' VAL . 13.1 mmt -46.99 -54.46 10.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.21 -40.77 1.67 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.996 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.32 -60.04 4.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.874 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -57.06 14.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.886 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.754 HG23 ' N ' ' A' ' 13' ' ' ALA . 13.2 m -51.57 -59.21 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.38 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.754 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.47 -41.28 63.2 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.986 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -63.29 -58.84 5.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.048 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.8 t -58.98 -52.7 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.041 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.5 mt -55.58 -51.63 56.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.921 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -51.35 -40.5 59.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.009 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.7 mtt-85 -66.17 -45.88 79.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.7 mt -74.69 -24.56 58.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.159 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 18.3 mtt-85 -36.9 -62.07 0.59 Allowed Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.6 Cg_endo -45.53 -48.34 12.03 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.639 2.226 . . . . 0.0 112.277 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -76.52 -45.12 32.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.654 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.9 tp -58.55 -53.48 57.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.032 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 24' ' ' LEU . 4.4 tt -47.25 -45.21 23.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -55.39 -62.03 1.95 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.353 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -102.95 -52.67 3.0 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -82.17 5.46 71.92 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-O 119.992 -0.338 . . . . 0.0 113.901 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 66.75 -159.38 48.87 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -122.71 145.42 48.41 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.901 0.382 . . . . 0.0 111.38 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.9 m -116.9 170.21 8.79 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.92 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 96.6 m -151.33 123.68 8.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.436 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.5 tp -74.02 109.8 7.81 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.08 -31.35 6.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.616 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -165.01 139.62 5.09 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.484 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.621 ' HA ' HG22 ' A' ' 40' ' ' VAL . 7.3 p -107.57 137.96 36.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.797 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -154.2 85.34 1.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.705 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 56.52 -86.12 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.94 -15.49 2.86 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.6 mp -86.99 62.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 0.0 109.96 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.621 HG22 ' HA ' ' A' ' 35' ' ' VAL . 1.4 t -81.33 121.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.888 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -84.98 151.79 23.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.415 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mt -140.91 171.28 14.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 110.997 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -146.5 121.72 10.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.554 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.428 HD13 ' CG2' ' A' ' 55' ' ' THR . 1.2 mt -84.11 162.44 20.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.843 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -155.87 78.55 0.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.025 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -145.13 50.95 0.62 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 46' ' ' GLY . . . 67.84 98.94 0.05 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.018 0.437 . . . . 0.0 110.606 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.4 m -52.48 -35.32 52.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.809 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 57.82 -119.85 18.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.4 t -152.76 -36.77 0.11 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.787 0.327 . . . . 0.0 110.398 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 29.5 p -151.95 48.88 0.5 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.847 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 51' ' ' CYS . 2.8 Cg_endo -46.21 112.85 0.5 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.9 2.4 . . . . 0.0 111.967 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.7 t -89.33 -21.15 23.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.564 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.1 p -80.35 -41.28 25.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.994 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.428 ' CG2' HD13 ' A' ' 44' ' ' LEU . 3.8 m -57.71 -42.79 84.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.929 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -59.44 -45.83 93.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.536 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.3 m -64.52 -44.96 89.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.484 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -57.56 -55.99 27.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.398 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -46.19 -55.48 7.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.55 -27.34 66.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.23 -52.24 37.79 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -53.13 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -43.72 -59.05 2.38 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.16 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.75 -50.64 65.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.936 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.32 -45.08 88.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.573 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 70' ' ' VAL . 27.9 mt -58.53 -53.85 53.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -54.55 -41.14 69.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.786 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.74 -48.49 74.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -81.77 -7.94 59.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.538 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 70' ' ' VAL . 97.7 t -153.76 71.26 6.61 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 120.966 0.412 . . . . 0.0 110.088 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.91 125.68 8.22 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.993 2.462 . . . . 0.0 111.742 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.59 -0.3 1.91 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.551 -0.619 . . . . 0.0 111.551 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.4 m -62.79 153.62 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.157 0.504 . . . . 0.0 110.484 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.14 -63.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.428 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -164.76 107.33 0.86 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 77' ' ' GLU . 11.3 p -84.12 166.73 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.922 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.564 ' N ' HG22 ' A' ' 76' ' ' VAL . 14.0 mt-10 -143.59 128.33 18.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.029 0.443 . . . . 0.0 110.591 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.413 HE22 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -133.43 87.94 2.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.655 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.6 m -85.23 168.81 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.949 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -93.35 -179.32 5.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.884 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.1 tp -88.04 -9.57 52.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.915 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -96.32 -10.6 27.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.099 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -103.36 77.07 1.48 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.174 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -58.45 156.89 9.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.041 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -122.19 -24.96 4.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.99 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 52.4 -92.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.472 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 51.34 -118.59 1.29 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.872 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.785 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -45.74 148.95 2.21 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.346 2.697 . . . . 0.0 112.452 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.666 HG22 ' H ' ' A' ' 4' ' ' GLU . 8.2 m 60.88 175.22 0.1 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.165 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.666 ' H ' HG22 ' A' ' 3' ' ' THR . 2.0 tp10 -121.69 19.92 11.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.848 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.543 ' H ' ' CD ' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -107.04 -45.8 0.12 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.264 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' A' ' 5' ' ' ASN . 2.8 Cg_endo -77.58 47.23 2.23 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 122.661 2.241 . . . . 0.0 110.865 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.9 p -69.35 179.51 1.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.992 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.442 ' O ' HG13 ' A' ' 12' ' ' VAL . 42.2 mtt -47.36 -51.58 19.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.853 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -40.59 -44.64 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -57.42 -55.66 31.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.565 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.9 tt0 -57.8 -65.7 0.59 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.656 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.617 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.3 m -49.14 -52.97 9.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.617 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.92 -46.87 64.81 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -65.16 -54.41 30.18 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.952 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 11' ' ' GLN . 40.8 t -57.53 -49.21 81.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.996 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.2 mt -53.61 -61.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -54.35 -35.73 63.07 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.656 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.4 tpt85 -65.76 -50.9 63.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.668 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tp -78.14 -22.1 49.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.798 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.59 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 43.7 ttm180 -36.86 -55.01 1.66 Allowed Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.8 Cg_endo -41.6 -37.42 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.839 2.36 . . . . 0.0 112.477 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -77.59 -48.7 16.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.0 110.133 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.2 mt -60.08 -43.48 95.44 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.946 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.6 tp -56.13 -56.41 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.991 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -58.11 -32.82 68.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -100.64 -57.78 2.04 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.148 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -96.47 -75.49 1.26 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 170.53 -148.71 11.75 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -105.5 132.33 51.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.876 0.37 . . . . 0.0 110.318 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.594 ' SG ' HD22 ' A' ' 42' ' ' LEU . 33.0 t -119.26 153.97 34.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.317 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.5 m -149.87 124.02 9.46 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.897 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -74.65 122.03 22.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.926 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.02 -29.04 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.732 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -163.58 128.11 2.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.813 0.339 . . . . 0.0 110.583 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 35' ' ' VAL . 11.5 p -92.93 122.2 44.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.038 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.65 165.42 27.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.315 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -47.6 -55.18 9.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.58 -22.2 0.62 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 39' ' ' ILE . 2.1 mp -87.77 59.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.906 0.384 . . . . 0.0 110.35 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.74 123.04 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.112 0.482 . . . . 0.0 111.349 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -87.91 143.41 27.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.75 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.594 HD22 ' SG ' ' A' ' 30' ' ' CYS . 3.7 mt -136.14 162.55 32.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.867 0.365 . . . . 0.0 110.688 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -147.58 116.44 6.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.953 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.97 171.31 13.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -158.3 84.27 0.85 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.836 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.51 -3.65 64.59 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 53.93 23.87 4.23 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.839 0.352 . . . . 0.0 110.814 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 50' ' ' THR . 7.5 t -139.58 39.23 2.04 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.74 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.71 74.1 0.11 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 48' ' ' CYS . 20.4 p -137.69 -54.88 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.969 0.414 . . . . 0.0 110.164 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.55 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 19.4 p -156.46 47.38 0.29 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.358 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 51' ' ' CYS . 2.5 Cg_endo -46.32 105.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 123.175 2.583 . . . . 0.0 112.207 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -97.28 -28.43 14.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.188 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -89.64 -32.65 16.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.984 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.6 m -59.94 -30.11 68.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.58 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.76 -57.56 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.7 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.3 m -62.77 -45.68 91.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.555 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 58' ' ' LEU . 2.9 mm? -58.16 -57.51 12.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.332 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -46.26 -56.86 5.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -27.24 67.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.493 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.71 -48.09 51.81 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -63.5 -53.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -43.84 -59.92 2.04 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.727 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -38.01 71.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.29 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 62' ' ' ILE . . . -59.18 -50.0 75.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.561 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.644 ' O ' HG12 ' A' ' 70' ' ' VAL . 9.1 mp -56.67 -50.13 73.02 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.503 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -54.75 -52.95 60.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.07 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.9 -25.2 67.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.571 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -84.11 -10.47 57.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.83 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.701 ' O ' HG13 ' A' ' 70' ' ' VAL . 7.8 p -156.14 55.67 1.13 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 120.92 0.391 . . . . 0.0 110.965 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.72 124.66 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 123.058 2.506 . . . . 0.0 111.925 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.78 16.61 3.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.9 m -65.13 155.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.326 0.584 . . . . 0.0 111.225 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mm -102.73 -60.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.268 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -165.7 104.19 0.7 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.597 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 77' ' ' GLU . 7.9 p -87.88 161.39 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.52 ' N ' HG22 ' A' ' 76' ' ' VAL . 32.2 mt-10 -145.42 124.07 12.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.0 110.857 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -127.57 88.13 2.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.746 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 m -86.35 173.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.895 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -95.54 -179.5 4.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.698 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.683 ' C ' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -65.85 1.0 1.5 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.644 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' N ' HD13 ' A' ' 81' ' ' LEU . 36.8 mm-40 -63.5 139.06 58.73 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.87 14.72 2.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.806 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -139.32 80.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.192 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 86' ' ' HIS . 0.8 OUTLIER -89.46 -140.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.969 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.605 ' H ' ' CG ' ' A' ' 85' ' ' HIS . 27.7 t-80 48.85 -130.79 1.81 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.526 ' H ' ' CG ' ' A' ' 86' ' ' HIS . 0.4 OUTLIER -153.83 -66.79 0.14 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.969 0.414 . . . . 0.0 109.906 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.3 t60 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.095 179.783 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.28 -170.6 0.83 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.849 2.366 . . . . 0.0 111.87 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 4' ' ' GLU . 71.2 p -67.62 -108.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.172 0.511 . . . . 0.0 110.548 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' N ' ' OG1' ' A' ' 3' ' ' THR . 1.8 tp10 63.31 6.37 2.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.286 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.497 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -63.5 -47.81 82.54 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.6 Cg_endo -79.41 94.79 1.05 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.728 2.285 . . . . 0.0 110.885 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 p -73.79 -175.7 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.745 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -48.95 60.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.082 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -40.15 -41.92 1.36 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.736 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.83 -58.02 9.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.162 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.872 ' O ' HG22 ' A' ' 15' ' ' VAL . 1.5 mp0 -61.02 -60.54 3.62 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.52 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.776 HG23 ' N ' ' A' ' 13' ' ' ALA . 10.0 m -46.0 -61.33 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.791 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.776 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.28 -42.53 63.79 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.175 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.43 -61.87 1.95 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.133 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 11' ' ' GLN . 11.8 m -61.59 -44.83 99.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.665 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' ARG . 52.4 mt -55.41 -52.62 44.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.333 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.23 -37.32 67.02 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.812 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -67.07 -52.48 41.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.588 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 19' ' ' LEU . 10.4 mp -75.65 -20.78 58.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.106 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' ILE . 28.2 ttm-85 -33.63 -59.16 0.5 Allowed Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.807 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.0 Cg_exo -42.42 -35.13 3.52 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.606 2.204 . . . . 0.0 111.953 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -77.73 -50.68 11.9 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.225 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 28' ' ' GLY . 4.4 mm? -58.56 -45.55 88.75 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.87 -43.23 69.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.918 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -56.44 -62.02 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.322 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -101.77 -54.84 2.64 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -71.53 5.23 11.26 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.583 -0.341 . . . . 0.0 112.465 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 60.65 -162.9 19.93 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.49 142.81 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.865 0.364 . . . . 0.0 110.799 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.5 p -128.65 156.18 43.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.887 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.2 m -149.79 120.21 7.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.974 0.416 . . . . 0.0 111.227 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.87 119.89 21.98 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.366 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.91 -31.04 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.53 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -164.86 142.98 6.46 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.644 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 40' ' ' VAL . 10.8 p -109.73 142.84 21.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.873 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 38' ' ' GLY . 24.0 tt0 -162.34 99.06 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.027 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 49.37 -86.76 0.01 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.099 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -129.09 -13.42 2.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.768 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.7 mp -86.99 63.22 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.157 0.503 . . . . 0.0 110.276 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -78.68 125.91 38.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.845 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -87.57 148.7 24.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.594 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' GLU . 3.9 mt -143.87 167.88 21.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.915 0.388 . . . . 0.0 110.915 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.426 HE21 ' CG2' ' A' ' 79' ' ' VAL . 9.8 mp0 -142.01 120.81 12.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.923 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 44' ' ' LEU . 6.9 tp -85.67 168.42 14.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.075 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -161.29 74.98 0.49 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.958 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.18 31.23 0.18 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.08 2.27 18.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.552 0.215 . . . . 0.0 110.892 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.2 t -69.25 73.64 0.32 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.973 0.416 . . . . 0.0 110.57 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.73 36.49 0.16 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.5 p 44.29 70.43 0.33 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.926 0.393 . . . . 0.0 110.92 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.1 m 56.35 81.39 0.26 Allowed Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.641 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.8 116.98 4.92 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.853 2.369 . . . . 0.0 112.113 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.1 p -82.56 -19.46 38.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.336 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -77.24 -42.31 37.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.626 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.7 m -52.61 -42.74 64.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.361 . . . . 0.0 110.246 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 56' ' ' ILE . 2.9 mm -60.01 -45.57 95.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.041 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.7 m -64.85 -46.01 83.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.511 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.0 tp -57.6 -51.35 69.85 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.052 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -50.74 -49.91 56.83 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.138 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.66 -29.32 69.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.578 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.07 -58.06 8.65 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 pt -61.71 -44.27 98.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.428 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 24.8 tt0 -45.29 -65.12 0.58 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.614 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -54.97 -47.38 74.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.963 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.77 82.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.715 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 70' ' ' VAL . 9.3 mt -56.0 -45.31 79.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.63 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.483 ' ND1' HG21 ' A' ' 73' ' ' VAL . 1.4 m-70 -54.35 -55.88 24.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.428 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -68.57 -29.07 67.54 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -85.71 -11.49 53.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.022 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' LEU . 1.9 t -151.97 57.13 2.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.15 142.32 4.13 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 123.369 2.713 . . . . 0.0 112.38 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 136.93 -31.96 2.49 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.483 HG21 ' ND1' ' A' ' 67' ' ' HIS . 5.2 m -65.6 145.18 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.007 0.432 . . . . 0.0 110.409 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.28 -28.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.282 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -165.02 171.11 14.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.719 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.31 158.62 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.442 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' LEU . 67.5 mt-10 -142.65 116.72 9.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.393 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -125.3 86.61 2.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.812 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.426 ' CG2' HE21 ' A' ' 43' ' ' GLN . 12.9 m -89.59 178.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.043 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -110.28 144.74 38.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.09 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tp -70.05 75.79 0.49 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.887 0.375 . . . . 0.0 110.645 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 49.1 63.62 2.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -94.94 70.01 3.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -154.42 -57.27 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.963 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -92.34 -156.3 0.46 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.855 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -142.1 -166.07 2.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.384 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -87.15 -7.14 58.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.429 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 . . . . . 0 C--O 1.222 -0.381 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.771 179.88 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.0 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -75.49 -88.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.75 2.3 . . . . 0.0 111.567 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.8 m -161.59 -36.41 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.436 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.85 15.4 7.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.34 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -57.63 -50.32 88.81 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.172 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.9 Cg_endo -77.08 91.19 1.19 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.653 2.235 . . . . 0.0 110.815 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 p -75.19 -170.84 1.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.854 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.482 ' N ' ' SD ' ' A' ' 8' ' ' MET . 1.2 mpp? -51.74 -46.21 63.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.634 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.415 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 13.0 t80 -41.0 -36.44 0.67 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.36 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -60.76 -62.56 1.77 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -52.85 63.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.123 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.755 HG23 ' N ' ' A' ' 13' ' ' ALA . 19.2 m -51.22 -60.34 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.989 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.755 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.24 -37.9 56.54 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.102 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.82 -60.48 3.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.609 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 m -55.68 -43.64 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.76 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 12' ' ' VAL . 14.9 mm -53.58 -48.79 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.034 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -53.47 -45.9 69.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.642 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -68.49 -37.58 80.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.338 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.63 -32.72 64.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.56 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.435 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 14.3 mtt180 -42.64 -63.21 0.99 Allowed Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.9 Cg_endo -46.15 -36.76 17.12 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.821 2.347 . . . . 0.0 112.986 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -75.46 -60.31 2.36 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.542 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 26.9 mt -58.52 -45.05 89.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.936 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.2 tp -51.39 -41.52 60.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.104 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.6 mtt85 -58.92 -54.28 48.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.407 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -100.91 -59.35 1.71 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -80.33 -77.73 0.95 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.911 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 170.71 -142.79 7.34 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -109.27 165.25 11.77 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 111.159 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.668 ' SG ' HD22 ' A' ' 42' ' ' LEU . 38.4 t -126.93 158.02 37.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.833 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.448 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 64.0 m -150.29 122.27 8.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.884 0.373 . . . . 0.0 111.204 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 33' ' ' VAL . 1.1 tt -69.14 128.22 35.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.864 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 32' ' ' LEU . 49.1 t -97.58 -39.79 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.199 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -155.48 118.54 4.33 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.677 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.9 p -81.85 142.14 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.814 ' CG ' ' H ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -158.93 -158.49 0.69 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.843 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.535 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -88.94 -46.27 9.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.406 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.567 ' H ' HD12 ' A' ' 39' ' ' ILE . . . -157.0 27.2 0.51 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.916 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.814 ' H ' ' CG ' ' A' ' 36' ' ' GLU . 1.1 mp -145.34 59.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.435 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -78.96 128.01 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.254 -178.176 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -91.06 145.16 24.92 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.668 HD22 ' SG ' ' A' ' 30' ' ' CYS . 2.9 mt -139.66 174.13 10.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.293 0.568 . . . . 0.0 111.47 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 1.2 mt-30 -146.31 126.72 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.021 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.689 ' H ' ' HB2' ' A' ' 80' ' ' PHE . 5.2 mt -86.88 -179.24 6.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.915 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.467 ' HA ' ' CE2' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -162.82 63.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.403 ' H ' ' HG2' ' A' ' 82' ' ' GLU . . . -54.03 -89.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.78 39.33 0.27 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.865 0.364 . . . . 0.0 110.42 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 67.4 m 57.18 62.59 2.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.688 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.34 -175.88 10.4 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.3 p -115.97 -38.54 3.63 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.764 0.316 . . . . 0.0 110.618 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.5 p -128.49 89.44 49.56 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.163 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 54' ' ' SER . 3.3 Cg_exo -73.2 28.33 0.3 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.673 2.248 . . . . 0.0 113.154 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -63.01 -9.93 12.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.425 ' N ' ' C ' ' A' ' 52' ' ' PRO . 8.4 m -90.73 -31.89 16.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.334 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.46 -42.79 54.85 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.17 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.528 HD13 ' N ' ' A' ' 56' ' ' ILE . 2.1 mm -56.02 -50.86 67.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.875 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 m -65.41 -54.91 21.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.721 HD11 ' O ' ' A' ' 85' ' ' HIS . 1.2 tt -57.05 -53.12 61.7 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.712 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -48.99 -47.24 44.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.4 69.69 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.188 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.63 -45.17 95.23 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.431 HG13 ' H ' ' A' ' 62' ' ' ILE . 0.9 OUTLIER -64.7 -60.67 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -43.72 -51.61 7.07 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.832 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -53.56 -50.86 64.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.696 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.62 -48.84 79.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.767 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 8.7 mp -58.62 -54.57 45.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.089 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.434 ' NE2' HG21 ' A' ' 73' ' ' VAL . 10.8 m170 -53.06 -44.07 67.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.349 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -64.61 -45.33 87.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.198 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.64 -9.58 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.102 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 66' ' ' LEU . 47.7 t -153.39 72.46 6.85 Favored Pre-proline 0 N--CA 1.463 0.184 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.79 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.96 37.32 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 123.153 2.569 . . . . 0.0 112.163 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -102.68 -21.14 10.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.434 HG21 ' NE2' ' A' ' 67' ' ' HIS . 3.7 m -64.07 160.72 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.11 -41.66 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.786 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HB3' HG23 ' A' ' 39' ' ' ILE . 3.2 mm-40 -164.54 157.03 16.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.993 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -149.94 156.18 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -143.8 78.17 1.58 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.111 0.481 . . . . 0.0 110.583 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.407 ' OE1' HD12 ' A' ' 44' ' ' LEU . 5.4 tm0? -102.33 96.39 6.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.36 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 2.9 m -111.18 161.58 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.689 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 6.5 t80 179.79 -179.4 0.45 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.605 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' N ' ' CG ' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -114.18 52.43 0.83 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.728 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' OE2' HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -142.47 -147.97 0.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.286 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.659 ' O ' HD13 ' A' ' 58' ' ' LEU . 2.6 m-70 -136.69 -47.78 0.62 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.707 ' HB3' HD22 ' A' ' 58' ' ' LEU . 2.9 t-80 89.66 -158.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.531 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.721 ' O ' HD11 ' A' ' 58' ' ' LEU . 6.0 t60 -121.22 -96.02 0.48 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.791 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.556 ' N ' ' CG ' ' A' ' 85' ' ' HIS . 16.2 m-70 -168.04 -170.52 1.34 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.829 0.347 . . . . 0.0 110.459 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 87' ' ' HIS . 82.1 t60 -84.97 13.98 5.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.545 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.833 -179.87 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.8 mtt . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.35 169.86 21.54 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.849 2.366 . . . . 0.0 111.405 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 5' ' ' ASN . 2.9 m -90.91 150.81 21.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.661 0.267 . . . . 0.0 110.47 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' CD ' ' N ' ' A' ' 4' ' ' GLU . 17.7 mp0 -99.82 5.57 45.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.525 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -69.0 -46.04 30.66 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.186 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.5 Cg_endo -78.51 87.95 1.49 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.507 2.138 . . . . 0.0 110.726 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -74.64 165.52 25.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 44.3 mtm -51.13 -45.04 61.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.81 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -42.79 -34.16 0.88 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.437 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.62 -63.69 1.21 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.036 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.3 tt0 -58.04 -58.87 6.51 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.029 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.766 HG23 ' N ' ' A' ' 13' ' ' ALA . 10.4 m -48.27 -60.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.528 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.766 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -50.07 -42.7 50.5 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.632 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.81 -51.68 63.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.77 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 11' ' ' GLN . 98.7 t -57.56 -61.64 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.312 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 12' ' ' VAL . 20.4 mm -48.54 -46.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.706 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -53.06 -43.26 66.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.347 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -66.55 -47.07 74.02 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.203 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 19' ' ' LEU . 7.4 mp -73.93 -33.53 63.98 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -34.84 -63.35 0.36 Allowed Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.2 Cg_exo -42.88 -39.04 7.34 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 123.119 2.546 . . . . 0.0 113.219 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -77.51 -50.34 12.82 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.516 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 27' ' ' GLY . 8.0 mp -55.93 -37.55 69.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.25 -60.94 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.475 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -54.57 -34.01 61.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.666 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.64 -57.63 2.07 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.263 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -100.41 -76.04 1.2 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.782 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 179.63 -150.75 9.52 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -111.05 137.11 49.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.815 0.34 . . . . 0.0 110.726 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.6 t -111.78 148.57 33.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.937 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.7 m -150.57 124.81 9.44 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.371 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.75 129.23 38.58 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.696 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.65 -35.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.763 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -160.27 134.16 7.15 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.318 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 40' ' ' VAL . 9.9 p -101.69 123.62 54.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.915 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.6 tp10 -148.9 80.32 1.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.764 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 t0 54.79 -81.29 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.122 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -124.87 -22.36 1.99 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.02 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.65 65.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.193 0.52 . . . . 0.0 110.296 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 35' ' ' VAL . 32.3 t -87.32 120.23 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.225 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -90.03 139.97 30.09 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.596 HD21 HG22 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -149.33 148.27 29.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 0.0 111.21 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -96.49 166.28 11.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.882 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 44' ' ' LEU . 23.5 tp -148.56 94.76 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.237 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -75.9 77.68 2.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.025 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.66 -88.19 0.19 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.23 12.93 4.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.74 0.305 . . . . 0.0 110.681 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.4 t -55.49 -13.26 1.42 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.634 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.37 165.7 12.58 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.6 t -58.92 134.66 57.13 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.4 t 48.97 72.88 1.12 Allowed Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.441 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -70.3 106.2 1.71 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.587 2.191 . . . . 0.0 112.311 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.8 t -81.18 -11.06 59.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.394 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.6 t -86.66 -49.9 7.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.115 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -47.45 -35.16 8.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.998 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 90.0 mt -58.18 -46.68 88.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.1 m -64.48 -46.22 83.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.127 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.3 tp -57.5 -57.62 11.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.807 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -46.36 -54.87 8.2 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.21 68.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.613 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.97 -45.0 90.55 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -64.82 -62.23 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.519 0.2 . . . . 0.0 110.918 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -43.84 -51.94 7.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.9 0.381 . . . . 0.0 110.517 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.2 ttm-85 -55.4 -39.85 70.69 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.202 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -57.16 -42.92 81.99 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.342 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.44 -53.31 59.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -59.14 -59.88 4.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.387 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.69 -10.26 34.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.229 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 mt-10 -157.15 99.12 1.78 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.849 0.357 . . . . 0.0 110.376 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 69' ' ' GLU . 62.1 t 77.05 72.77 0.19 Allowed Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.175 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.84 -149.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 123.03 2.487 . . . . 0.0 111.35 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.19 -20.72 44.36 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 73' ' ' VAL . 3.3 m -64.54 151.02 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.023 0.439 . . . . 0.0 110.684 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.56 -30.55 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.411 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -159.91 154.31 23.8 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.463 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.596 HG22 HD21 ' A' ' 42' ' ' LEU . 8.2 p -149.15 119.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -96.53 124.72 40.61 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.468 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -118.48 83.2 1.97 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.103 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 79' ' ' VAL . 1.6 m -94.03 157.22 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 111.694 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -99.55 177.35 5.19 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.192 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.4 tp -94.59 81.01 3.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.99 0.424 . . . . 0.0 109.877 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -39.02 -88.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.231 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.57 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -51.35 94.64 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.462 ' ND1' ' O ' ' A' ' 85' ' ' HIS . 57.0 t-80 -62.73 130.21 43.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.228 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.462 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -84.74 -170.18 2.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.277 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.423 ' O ' ' CG ' ' A' ' 86' ' ' HIS . 1.0 OUTLIER -119.78 59.24 0.87 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.074 0.464 . . . . 0.0 110.246 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.6 m80 43.8 25.28 0.09 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.007 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.408 ' OXT' ' CG ' ' A' ' 88' ' ' HIS . 9.8 t60 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.49 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.418 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 1' ' ' MET . 2.7 Cg_endo -45.5 136.68 11.87 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.881 2.388 . . . . 0.0 112.015 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.94 162.63 3.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.896 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -152.82 36.98 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.164 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.529 ' H ' ' CD ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -105.4 -46.62 0.13 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.332 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.529 ' CD ' ' H ' ' A' ' 5' ' ' ASN . 2.8 Cg_endo -77.88 54.94 5.06 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.779 2.319 . . . . 0.0 111.15 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -70.21 178.25 2.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.849 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 8' ' ' MET . 5.3 mpp? -49.08 -51.96 28.55 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.784 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -41.57 -39.36 1.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.066 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -59.36 -62.06 2.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -60.54 -57.93 10.66 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.051 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.746 HG23 ' N ' ' A' ' 13' ' ' ALA . 8.5 m -51.03 -59.84 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.442 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.746 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.28 -42.03 63.38 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.13 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.4 -57.22 12.07 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.945 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.13 -48.86 86.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.203 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.6 mt -54.39 -53.37 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.593 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -50.87 -47.13 60.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.62 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -65.78 -38.31 88.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.054 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tp -76.85 -26.37 54.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.994 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 6.2 mtt180 -40.14 -60.92 1.27 Allowed Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.8 Cg_endo -43.83 -36.01 7.46 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.078 2.518 . . . . 0.0 113.184 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -75.53 -46.07 34.34 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' GLY . 4.6 mp -58.42 -38.5 77.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.669 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 24' ' ' LEU . 2.0 tt -54.5 -58.79 6.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -56.74 -34.65 67.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.567 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -100.4 -58.65 1.86 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.469 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -97.86 -76.2 1.27 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.76 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 178.15 -141.48 5.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -114.65 125.44 53.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.676 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 31' ' ' THR . 7.8 t -84.48 158.03 21.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.472 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.524 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 18.5 m -146.99 114.9 6.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.818 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tp -73.6 125.17 27.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.126 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.76 -47.59 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.814 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -165.37 143.51 6.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.95 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 35' ' ' VAL . 12.9 p -107.23 122.33 61.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.572 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.4 tp10 -141.0 88.48 2.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.734 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.7 t0 55.02 -79.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -131.0 -17.35 1.48 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.783 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.9 mp -84.88 60.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.051 0.453 . . . . 0.0 109.979 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 35' ' ' VAL . 2.1 t -74.62 115.96 16.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.763 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -88.98 140.5 29.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.146 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 42' ' ' LEU . 2.2 pt? -159.79 -178.76 7.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.294 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -140.88 170.72 15.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.165 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tt -150.51 138.64 20.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.595 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -162.34 130.79 4.1 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.91 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -106.21 -26.51 5.96 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 46' ' ' GLY . . . 172.25 -79.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.2 p -173.13 -50.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.974 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 43.46 -134.88 5.22 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.81 -42.39 0.06 Allowed 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.0 m -154.18 77.04 5.62 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.554 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.53 121.42 7.42 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.709 2.272 . . . . 0.0 112.089 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t -86.94 -28.93 22.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.046 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.9 t -68.32 -41.95 80.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.621 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 m -65.97 -47.35 74.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.679 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.31 -48.86 85.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.685 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -64.5 -45.44 87.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.246 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.4 tp -57.94 -56.99 14.85 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.545 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -47.37 -54.29 11.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 110.156 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 64' ' ' ARG . . . -59.07 -21.24 58.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.31 -44.93 26.5 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.645 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -65.63 -61.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -43.89 -47.42 8.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.524 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.411 ' CG ' ' O ' ' A' ' 60' ' ' ALA . 14.4 mmt180 -54.38 -47.3 72.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.63 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.39 -54.74 43.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.521 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.088 ' O ' HG13 ' A' ' 70' ' ' VAL . 7.3 mp -55.48 -64.1 0.96 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.203 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -42.55 -50.87 5.28 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.951 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.98 -14.57 62.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.755 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 66' ' ' LEU . 32.0 mt-10 -155.76 98.44 1.92 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.088 HG13 ' O ' ' A' ' 66' ' ' LEU . 2.0 m -135.06 66.15 66.87 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.627 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 70' ' ' VAL . 3.2 Cg_exo -79.4 29.43 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.884 2.389 . . . . 0.0 111.301 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.45 -48.97 0.05 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.946 HG13 HG12 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -69.16 145.91 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.096 0.474 . . . . 0.0 110.659 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.604 HD12 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -122.02 -49.84 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.802 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -166.27 108.8 0.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.037 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -83.4 174.81 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -145.94 87.47 1.76 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.765 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.96 94.88 7.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.843 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 79' ' ' VAL . 17.0 m -87.0 168.39 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.959 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -112.52 121.13 43.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.336 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 tp -65.24 82.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.049 0.452 . . . . 0.0 110.513 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -60.23 179.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.438 ' H ' ' H ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -176.8 0.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.738 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.438 ' H ' ' H ' ' A' ' 83' ' ' HIS . 20.1 p-80 -72.78 -172.73 1.05 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.701 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -113.26 -88.22 0.55 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.089 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -111.25 63.17 0.61 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.008 0.433 . . . . 0.0 110.562 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -75.64 168.19 20.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.54 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 35.2 m80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.703 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -45.45 148.02 2.37 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.8 2.333 . . . . 0.0 111.938 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.79 130.49 2.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.617 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -92.2 26.45 2.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.379 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -101.39 -47.28 0.2 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.261 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.5 Cg_endo -81.45 77.03 4.11 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.567 2.178 . . . . 0.0 110.702 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -73.68 -174.93 1.89 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.854 0.359 . . . . 0.0 111.006 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.447 ' O ' HG22 ' A' ' 12' ' ' VAL . 19.1 mmt -49.78 -59.8 3.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.292 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -44.23 -36.64 2.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.239 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -61.07 2.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -57.67 -55.77 30.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.978 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 13' ' ' ALA . 18.6 m -51.66 -63.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.171 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.777 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -47.29 -38.99 13.62 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 120.086 -0.645 . . . . 0.0 109.565 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.9 -63.99 1.01 Allowed 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.073 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 16' ' ' ILE . 4.8 m -62.32 -45.26 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.483 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 12' ' ' VAL . 23.4 mm -53.87 -62.17 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.801 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -53.78 -31.37 48.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 55.1 ttt180 -66.97 -50.64 61.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 19' ' ' LEU . 11.0 mp -79.03 -21.49 46.83 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.536 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 12.9 ttm180 -37.3 -43.28 1.18 Allowed Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 20' ' ' ARG . 3.4 Cg_exo -77.5 -28.31 5.59 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.292 1.995 . . . . 0.0 112.506 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -77.08 -46.9 22.04 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.633 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 27' ' ' GLY . 12.4 mt -55.78 -37.8 69.06 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 24' ' ' LEU . 1.3 tt -57.45 -56.06 26.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -54.07 -35.19 61.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.988 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -100.99 -60.94 1.43 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -102.03 -76.31 1.17 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.816 -0.513 . . . . 0.0 111.816 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 24' ' ' LEU . . . -173.0 -138.31 2.57 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -130.94 123.7 29.45 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.421 -0.458 . . . . 0.0 110.602 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.1 p -94.93 159.53 14.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.54 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.7 m -150.75 124.75 9.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.136 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 41' ' ' LYS . 25.6 tp -77.25 123.08 25.96 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.847 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.11 -34.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.066 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -167.98 139.49 2.91 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.885 0.374 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 35' ' ' VAL . 14.8 p -104.04 126.8 58.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.761 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -149.64 77.76 1.34 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.662 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.9 t70 55.38 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.021 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.73 -21.6 5.34 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 39' ' ' ILE . 3.2 mp -84.05 63.79 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.374 0.607 . . . . 0.0 109.883 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.18 118.97 33.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.125 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.414 ' O ' HD12 ' A' ' 32' ' ' LEU . 46.9 mttp -85.26 139.66 31.45 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -139.72 169.6 17.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 0.0 111.176 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -145.41 112.86 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.108 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' CD2' HG23 ' A' ' 55' ' ' THR . 9.7 tp -91.02 105.53 17.89 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.343 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -78.35 86.25 4.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.503 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 48' ' ' CYS . . . -86.96 91.63 1.75 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.52 1.03 0.88 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.823 0.344 . . . . 0.0 111.022 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 36.9 t -96.32 58.94 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.883 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 50' ' ' THR . . . -63.44 111.84 4.47 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER 175.48 -100.98 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.607 ' H ' HG23 ' A' ' 50' ' ' THR . 21.7 t -149.23 65.62 8.09 Favored Pre-proline 0 C--O 1.233 0.216 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 51' ' ' CYS . 3.0 Cg_exo -76.96 114.95 3.92 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.993 2.462 . . . . 0.0 111.895 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.3 p -83.36 -17.81 41.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.029 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -78.6 -49.58 13.0 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.948 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.496 HG23 ' CD2' ' A' ' 44' ' ' LEU . 53.9 m -41.67 -39.88 1.79 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.899 0.38 . . . . 0.0 110.179 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.2 mt -61.24 -53.35 50.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.591 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 94.2 m -62.88 -36.11 82.23 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.718 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 tp -57.17 -57.23 13.5 Favored 'General case' 0 CA--C 1.523 -0.063 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.524 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -48.35 -54.81 12.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.176 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.14 -21.57 61.76 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.036 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.56 -44.23 41.32 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 5.9 mt -60.62 -58.86 5.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -45.07 -52.96 8.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.93 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -53.45 -41.27 65.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.481 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 62' ' ' ILE . . . -58.34 -47.43 83.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.172 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.4 mt -59.36 -59.62 5.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.024 0.44 . . . . 0.0 110.496 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -53.59 -56.88 13.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.508 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -68.76 -12.02 60.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.637 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' C ' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -152.78 98.99 2.4 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.514 HG23 ' C ' ' A' ' 69' ' ' GLU . 11.2 t 86.28 78.52 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.533 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.9 -151.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.451 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.22 -21.78 22.76 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.78 142.24 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.065 0.459 . . . . 0.0 110.3 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.75 -39.02 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.326 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -164.74 108.97 0.92 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.084 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 77' ' ' GLU . 8.8 p -84.16 176.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.379 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.725 ' H ' HG22 ' A' ' 76' ' ' VAL . 15.7 mt-10 -147.33 85.65 1.6 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.995 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.85 91.04 3.98 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.181 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.2 m -93.63 174.77 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.121 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -97.94 164.86 12.19 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.8 tp -76.26 -72.42 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.297 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -177.02 144.77 0.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.52 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.529 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 1.0 OUTLIER -86.79 -68.39 0.75 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -154.72 97.34 1.96 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.248 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -157.35 88.15 1.0 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.218 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -91.01 -47.97 7.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.848 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -124.73 164.94 18.86 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.482 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.593 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.7 p . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.818 0.342 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.623 ' O ' HG13 ' A' ' 12' ' ' VAL . 20.3 mtt -50.23 -53.75 25.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.624 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -39.92 -51.88 2.45 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.964 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.53 -51.16 69.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.717 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.487 ' O ' HG22 ' A' ' 15' ' ' VAL . 4.4 mt-30 -61.29 -60.02 4.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.642 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 8' ' ' MET . 1.1 m -54.47 -54.22 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.72 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.603 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.28 -43.92 64.68 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.177 0.513 . . . . 0.0 109.743 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -61.6 -61.8 2.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.458 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 11' ' ' GLN . 34.1 m -60.51 -40.22 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.337 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 12' ' ' VAL . 26.8 mt -54.72 -64.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.841 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -30.59 32.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.717 0.294 . . . . 0.0 111.051 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -68.06 -51.41 46.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.602 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.2 -22.52 55.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.569 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 9.8 mtp180 -36.84 -60.58 0.76 Allowed Pre-proline 0 N--CA 1.469 0.494 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.9 Cg_endo -45.9 -39.26 19.13 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.809 2.339 . . . . 0.0 112.406 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -75.15 -43.7 51.03 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.403 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.3 mt -59.48 -48.73 80.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.285 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.1 tp -53.08 -43.67 66.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.8 mmm-85 -58.04 -48.04 81.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.037 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.75 -57.5 2.06 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -90.73 -76.41 1.32 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.462 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.5 -136.83 3.66 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.406 ' HB2' ' CE1' ' A' ' 45' ' ' HIS . 4.1 m-20 -130.77 131.15 44.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.48 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.1 t -95.33 156.19 16.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 85.2 m -149.93 114.07 5.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.375 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 tp -69.6 126.77 30.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.258 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.98 -39.07 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.955 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -157.82 133.78 9.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.023 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 35' ' ' VAL . 7.7 p -104.05 117.98 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.971 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -120.32 -179.18 3.88 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.964 0.411 . . . . 0.0 110.76 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -13.93 62.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.33 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.43 -32.69 0.03 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.801 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.6 mp -84.7 59.98 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.019 0.437 . . . . 0.0 110.602 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 41' ' ' LYS . 1.2 t -69.51 163.75 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.153 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.493 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -151.19 121.08 7.09 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.378 -179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.454 ' N ' HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -129.72 -179.66 5.32 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.205 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -144.08 117.91 9.33 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.022 0.439 . . . . 0.0 111.103 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tp -92.12 148.01 22.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.087 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.435 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 16.1 p80 -164.27 120.08 1.55 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 0.0 110.711 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.11 -25.53 6.7 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.753 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.74 118.34 5.27 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.932 2.421 . . . . 0.0 112.391 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -91.04 -24.15 20.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.235 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -84.43 -41.99 16.09 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.89 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -56.85 -35.6 69.05 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.463 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.7 mt -59.19 -47.51 90.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.143 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 m -63.98 -50.4 68.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.191 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.68 -45.69 88.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.409 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -46.1 -58.72 3.38 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.558 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.1 68.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.443 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.34 -56.62 14.56 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -53.62 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -43.93 -56.2 4.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.71 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -54.79 -47.81 73.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.643 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.06 84.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.73 -56.07 26.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.373 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -54.61 -43.26 72.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.02 -45.8 80.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -81.84 -2.15 50.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.132 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.5 t -152.47 70.11 7.4 Favored Pre-proline 0 C--N 1.332 -0.179 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.01 125.36 9.79 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.893 2.396 . . . . 0.0 111.986 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.72 -13.38 1.75 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 m -65.17 165.75 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.105 0.479 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.19 -34.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.575 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -163.6 156.44 18.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.103 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -152.39 124.91 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.382 . . . . 0.0 110.706 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -99.64 98.96 9.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.619 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -103.93 94.89 5.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.802 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 79' ' ' VAL . 17.5 m -87.62 121.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.35 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.254 179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 8' ' ' MET . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.639 0.257 . . . . 0.0 110.496 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.531 ' H ' HG22 ' A' ' 7' ' ' THR . 46.6 mtt -49.86 -45.13 50.14 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.79 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -41.64 -35.3 0.73 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.55 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.39 -61.84 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.21 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.55 -54.41 47.31 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.754 HG23 ' N ' ' A' ' 13' ' ' ALA . 15.3 m -52.34 -60.3 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.635 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.754 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -51.23 -41.73 60.52 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -65.21 -55.55 17.87 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.797 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.56 -51.75 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.033 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 20' ' ' ARG . 49.2 mt -52.68 -49.42 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.712 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -50.49 -47.23 57.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.907 0.384 . . . . 0.0 110.179 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -69.7 -42.21 74.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.37 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tp -74.92 -22.85 58.36 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' CB ' ' CD ' ' A' ' 21' ' ' PRO . 14.4 mtt180 -43.14 -63.25 1.03 Allowed Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.619 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 20' ' ' ARG . 2.4 Cg_endo -44.78 -28.36 2.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.975 2.45 . . . . 0.0 112.509 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -77.42 -51.46 10.76 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.865 0.364 . . . . 0.0 110.321 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.522 HD13 ' SG ' ' A' ' 30' ' ' CYS . 11.3 mt -57.62 -41.87 82.17 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.76 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.2 tt -54.5 -54.07 45.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.552 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -56.42 -34.68 67.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.366 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -101.34 -58.96 1.78 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -101.08 -75.72 1.16 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -178.11 -147.6 6.99 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -106.99 133.68 51.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 110.389 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 23' ' ' LEU . 55.0 m -97.86 150.88 20.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.102 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.9 m -148.71 111.97 4.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 110.531 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.67 129.89 40.86 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.054 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.56 -39.46 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.395 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -163.09 143.53 9.24 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.498 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 40' ' ' VAL . 69.9 t -108.78 103.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.904 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 18.1 tt0 -104.89 176.89 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.981 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.469 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.5 m-20 -55.45 -9.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.88 -24.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.649 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.2 mp -83.23 62.08 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.247 0.546 . . . . 0.0 110.225 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 35' ' ' VAL . 2.3 t -74.73 117.54 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -84.39 150.14 25.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.409 HD23 ' HG3' ' A' ' 78' ' ' GLN . 38.7 tp -144.63 160.24 41.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.18 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -144.4 109.16 4.94 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.856 0.36 . . . . 0.0 111.095 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.91 143.42 26.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.303 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 10.5 p80 -162.21 112.7 1.56 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.145 0.497 . . . . 0.0 110.603 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.62 -84.41 1.78 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 120.657 0.265 . . . . 0.0 110.357 179.826 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.777 0.322 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.07 134.14 19.08 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 112.452 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t -93.54 -25.9 17.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.424 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 p -83.98 -44.72 13.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.547 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -50.88 -32.19 19.73 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.823 0.344 . . . . 0.0 110.397 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.8 mt -57.54 -42.84 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.178 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -64.73 -53.45 47.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.346 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 tp -57.06 -46.9 82.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.303 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -48.97 -52.61 23.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.03 -23.12 66.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.632 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.68 -59.73 4.29 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.31 -49.14 84.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.242 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -45.49 -60.74 2.01 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.428 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -53.17 -45.9 68.68 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.623 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.56 -57.89 10.7 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.676 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.47 -49.39 74.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.105 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -51.11 -40.35 58.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.362 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.4 -55.63 29.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.761 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.87 -120.39 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.409 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 10.9 t 36.53 53.24 2.37 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.579 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 70' ' ' VAL . 2.7 Cg_endo -42.46 99.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.074 2.516 . . . . 0.0 112.003 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 130.84 -9.11 5.77 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.94 141.5 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.029 0.442 . . . . 0.0 110.499 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.72 -50.5 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.507 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -164.86 109.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.998 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.08 179.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.622 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -148.67 86.63 1.53 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.159 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.409 ' HG3' HD23 ' A' ' 42' ' ' LEU . 7.0 tt0 -101.75 90.39 4.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.304 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 m -89.55 176.05 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.456 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.236 179.894 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.5 p . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.853 0.358 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' PHE . 21.1 mtp -51.68 -53.42 39.19 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.321 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 8' ' ' MET . 28.4 t80 -36.25 -48.07 0.61 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.638 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.0 -52.17 66.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.485 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -68.95 0.25 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.811 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.606 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.3 m -46.55 -52.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.986 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.606 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.27 -49.31 61.46 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -63.48 -53.96 43.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.163 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.84 -54.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.247 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.2 mt -51.9 -56.04 7.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.739 0.304 . . . . 0.0 110.612 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -50.58 -33.21 21.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -66.15 -56.66 10.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.287 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mt -75.27 -24.46 57.56 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.542 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 4.3 ttp180 -35.7 -59.84 0.7 Allowed Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.734 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.0 Cg_endo -44.62 -36.54 10.32 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.877 2.385 . . . . 0.0 112.254 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -76.87 -45.09 29.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.459 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 27' ' ' GLY . 11.1 mp -60.84 -47.33 86.85 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.554 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -54.27 45.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 111.199 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -56.62 -39.42 73.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.574 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -98.88 -57.25 2.22 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -98.32 -77.19 1.32 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.219 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -176.22 -158.83 20.71 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -108.69 139.99 42.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.711 0.291 . . . . 0.0 110.668 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 31' ' ' THR . 4.4 t -108.45 156.56 19.32 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 5.9 m -149.89 119.36 6.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.761 0.315 . . . . 0.0 110.772 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -69.48 112.81 6.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.761 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.3 t -78.98 -45.31 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.988 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -166.73 142.93 4.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.946 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.438 ' HA ' HG22 ' A' ' 40' ' ' VAL . 9.7 p -110.68 127.44 67.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.97 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 38' ' ' GLY . 17.3 tt0 -152.75 99.17 2.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.282 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 52.69 -85.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.721 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -129.1 -12.09 2.68 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.0 mp -83.83 60.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.08 0.467 . . . . 0.0 110.023 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.3 t -81.99 111.49 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.689 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -88.11 129.01 35.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.494 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.68 144.62 37.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.98 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -99.97 165.03 11.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.189 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.438 ' HB3' HE21 ' A' ' 78' ' ' GLN . 4.5 tp -150.1 100.96 2.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.758 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -78.97 97.38 6.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.289 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -70.93 69.44 0.78 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 46' ' ' GLY . . . . . . . . 0 CA--C 1.53 0.188 0 C-N-CA 122.054 0.142 . . . . 0.0 111.229 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.455 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.13 0.048 . . . . 0.0 111.13 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 51' ' ' CYS . 3.2 Cg_exo -45.02 124.28 5.78 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.7 2.266 . . . . 0.0 112.238 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -82.13 -20.37 38.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.862 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 94.3 p -85.29 -30.43 23.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.391 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -45.62 -33.66 2.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 110.19 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.7 mt -58.72 -43.77 88.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.496 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.6 m -63.25 -50.82 68.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.381 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.44 -46.98 88.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.649 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -45.58 -61.8 1.55 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.74 -24.79 64.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.53 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.58 -59.36 7.27 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -51.2 72.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.189 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -43.72 -53.66 5.68 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.419 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -53.7 -56.79 14.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.676 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.9 -51.35 66.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.417 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 70' ' ' VAL . 97.4 mt -59.38 -56.03 27.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.327 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -50.72 -40.88 55.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.639 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -63.08 -57.03 12.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.868 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -84.02 -118.93 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.241 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 66' ' ' LEU . 9.0 t 35.91 53.89 2.23 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.642 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 70' ' ' VAL . 3.0 Cg_endo -42.15 109.38 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 123.253 2.635 . . . . 0.0 112.34 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.21 -8.32 12.38 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.01 147.71 12.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 121.053 0.454 . . . . 0.0 111.021 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.01 -32.62 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.896 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.01 107.33 0.62 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.88 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.583 HG22 ' H ' ' A' ' 77' ' ' GLU . 7.0 p -88.38 171.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.583 ' H ' HG22 ' A' ' 76' ' ' VAL . 3.6 mm-40 -142.78 117.28 9.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.898 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 44' ' ' LEU . 14.3 tm0? -112.87 88.71 2.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.615 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.9 m -92.31 153.64 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.82 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.031 179.632 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 8' ' ' MET . 1.1 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.764 0.316 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.458 ' O ' HG22 ' A' ' 12' ' ' VAL . 13.1 mmt -46.99 -54.46 10.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.21 -40.77 1.67 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.996 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.32 -60.04 4.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.874 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -57.06 14.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.886 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.754 HG23 ' N ' ' A' ' 13' ' ' ALA . 13.2 m -51.57 -59.21 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.38 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.754 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.47 -41.28 63.2 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.986 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -63.29 -58.84 5.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.048 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.8 t -58.98 -52.7 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.041 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.5 mt -55.58 -51.63 56.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.921 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -51.35 -40.5 59.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.009 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.7 mtt-85 -66.17 -45.88 79.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.7 mt -74.69 -24.56 58.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.159 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 18.3 mtt-85 -36.9 -62.07 0.59 Allowed Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.6 Cg_endo -45.53 -48.34 12.03 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.639 2.226 . . . . 0.0 112.277 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -76.52 -45.12 32.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.654 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.9 tp -58.55 -53.48 57.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.032 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 24' ' ' LEU . 4.4 tt -47.25 -45.21 23.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -55.39 -62.03 1.95 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.353 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -102.95 -52.67 3.0 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -82.17 5.46 71.92 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-O 119.992 -0.338 . . . . 0.0 113.901 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 66.75 -159.38 48.87 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -122.71 145.42 48.41 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.901 0.382 . . . . 0.0 111.38 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.9 m -116.9 170.21 8.79 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.92 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 96.6 m -151.33 123.68 8.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.436 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.5 tp -74.02 109.8 7.81 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.08 -31.35 6.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.616 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -165.01 139.62 5.09 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.484 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.621 ' HA ' HG22 ' A' ' 40' ' ' VAL . 7.3 p -107.57 137.96 36.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.797 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -154.2 85.34 1.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.705 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 56.52 -86.12 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.94 -15.49 2.86 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.6 mp -86.99 62.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 0.0 109.96 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.621 HG22 ' HA ' ' A' ' 35' ' ' VAL . 1.4 t -81.33 121.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.888 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -84.98 151.79 23.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.415 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mt -140.91 171.28 14.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 110.997 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -146.5 121.72 10.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.554 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.428 HD13 ' CG2' ' A' ' 55' ' ' THR . 1.2 mt -84.11 162.44 20.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.843 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -155.87 78.55 0.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.025 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -145.13 50.95 0.62 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 46' ' ' GLY . . . . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 121.018 0.437 . . . . 0.0 110.606 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 29.5 p . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.68 0.276 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 51' ' ' CYS . 2.8 Cg_endo -46.21 112.85 0.5 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.9 2.4 . . . . 0.0 111.967 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.7 t -89.33 -21.15 23.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.564 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.1 p -80.35 -41.28 25.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.994 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.428 ' CG2' HD13 ' A' ' 44' ' ' LEU . 3.8 m -57.71 -42.79 84.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.929 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -59.44 -45.83 93.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.536 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.3 m -64.52 -44.96 89.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.484 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -57.56 -55.99 27.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.398 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -46.19 -55.48 7.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.55 -27.34 66.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.23 -52.24 37.79 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -53.13 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -43.72 -59.05 2.38 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.16 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.75 -50.64 65.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.936 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.32 -45.08 88.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.573 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 70' ' ' VAL . 27.9 mt -58.53 -53.85 53.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -54.55 -41.14 69.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.786 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.74 -48.49 74.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -81.77 -7.94 59.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.538 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 70' ' ' VAL . 97.7 t -153.76 71.26 6.61 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 120.966 0.412 . . . . 0.0 110.088 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.91 125.68 8.22 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.993 2.462 . . . . 0.0 111.742 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.59 -0.3 1.91 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.551 -0.619 . . . . 0.0 111.551 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.4 m -62.79 153.62 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.157 0.504 . . . . 0.0 110.484 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.14 -63.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.428 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -164.76 107.33 0.86 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 77' ' ' GLU . 11.3 p -84.12 166.73 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.922 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.564 ' N ' HG22 ' A' ' 76' ' ' VAL . 14.0 mt-10 -143.59 128.33 18.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.029 0.443 . . . . 0.0 110.591 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.413 HE22 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -133.43 87.94 2.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.655 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.6 m -85.23 168.81 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.949 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.884 -179.715 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.779 0.323 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.442 ' O ' HG13 ' A' ' 12' ' ' VAL . 42.2 mtt -47.36 -51.58 19.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.853 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -40.59 -44.64 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -57.42 -55.66 31.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.565 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -57.8 -65.7 0.59 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.656 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.617 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.3 m -49.14 -52.97 9.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.617 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.92 -46.87 64.81 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -65.16 -54.41 30.18 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.952 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 11' ' ' GLN . 40.8 t -57.53 -49.21 81.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.996 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.2 mt -53.61 -61.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -54.35 -35.73 63.07 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.656 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.4 tpt85 -65.76 -50.9 63.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.668 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tp -78.14 -22.1 49.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.798 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.59 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 43.7 ttm180 -36.86 -55.01 1.66 Allowed Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.8 Cg_endo -41.6 -37.42 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.839 2.36 . . . . 0.0 112.477 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -77.59 -48.7 16.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.0 110.133 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.2 mt -60.08 -43.48 95.44 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.946 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.6 tp -56.13 -56.41 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.991 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -58.11 -32.82 68.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -100.64 -57.78 2.04 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.148 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -96.47 -75.49 1.26 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 170.53 -148.71 11.75 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -105.5 132.33 51.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.876 0.37 . . . . 0.0 110.318 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.594 ' SG ' HD22 ' A' ' 42' ' ' LEU . 33.0 t -119.26 153.97 34.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.317 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.5 m -149.87 124.02 9.46 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.897 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -74.65 122.03 22.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.926 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.02 -29.04 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.732 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -163.58 128.11 2.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.813 0.339 . . . . 0.0 110.583 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 35' ' ' VAL . 11.5 p -92.93 122.2 44.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.038 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.65 165.42 27.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.315 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -47.6 -55.18 9.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.58 -22.2 0.62 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 39' ' ' ILE . 2.1 mp -87.77 59.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.906 0.384 . . . . 0.0 110.35 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.74 123.04 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.112 0.482 . . . . 0.0 111.349 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -87.91 143.41 27.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.75 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.594 HD22 ' SG ' ' A' ' 30' ' ' CYS . 3.7 mt -136.14 162.55 32.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.867 0.365 . . . . 0.0 110.688 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -147.58 116.44 6.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.953 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.97 171.31 13.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -158.3 84.27 0.85 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.836 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.51 -3.65 64.59 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.839 0.352 . . . . 0.0 110.814 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.55 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 19.4 p . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 51' ' ' CYS . 2.5 Cg_endo -46.32 105.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 123.175 2.583 . . . . 0.0 112.207 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -97.28 -28.43 14.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.188 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -89.64 -32.65 16.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.984 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.6 m -59.94 -30.11 68.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.58 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.76 -57.56 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.7 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.3 m -62.77 -45.68 91.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.555 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 58' ' ' LEU . 2.9 mm? -58.16 -57.51 12.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.332 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -46.26 -56.86 5.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -27.24 67.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.493 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.71 -48.09 51.81 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -63.5 -53.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -43.84 -59.92 2.04 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.727 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -38.01 71.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.29 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 62' ' ' ILE . . . -59.18 -50.0 75.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.561 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.644 ' O ' HG12 ' A' ' 70' ' ' VAL . 9.1 mp -56.67 -50.13 73.02 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.503 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -54.75 -52.95 60.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.07 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.9 -25.2 67.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.571 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -84.11 -10.47 57.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.83 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 70' ' ' VAL . 7.8 p -156.14 55.67 1.13 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 120.92 0.391 . . . . 0.0 110.965 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.72 124.66 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 123.058 2.506 . . . . 0.0 111.925 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.78 16.61 3.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.9 m -65.13 155.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.326 0.584 . . . . 0.0 111.225 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mm -102.73 -60.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.268 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -165.7 104.19 0.7 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.597 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 77' ' ' GLU . 7.9 p -87.88 161.39 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.52 ' N ' HG22 ' A' ' 76' ' ' VAL . 32.2 mt-10 -145.42 124.07 12.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.0 110.857 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.57 88.13 2.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.746 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 m -86.35 173.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.895 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.698 -179.678 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.461 0.092 0 CA-C-O 120.808 0.337 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -48.95 60.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.082 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -40.15 -41.92 1.36 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.736 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.83 -58.02 9.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.162 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.872 ' O ' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -61.02 -60.54 3.62 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.52 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.776 HG23 ' N ' ' A' ' 13' ' ' ALA . 10.0 m -46.0 -61.33 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.791 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.776 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.28 -42.53 63.79 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.175 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.43 -61.87 1.95 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.133 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 11' ' ' GLN . 11.8 m -61.59 -44.83 99.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.665 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' ARG . 52.4 mt -55.41 -52.62 44.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.333 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.23 -37.32 67.02 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.812 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -67.07 -52.48 41.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.588 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 19' ' ' LEU . 10.4 mp -75.65 -20.78 58.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.106 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' ILE . 28.2 ttm-85 -33.63 -59.16 0.5 Allowed Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.807 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.0 Cg_exo -42.42 -35.13 3.52 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.606 2.204 . . . . 0.0 111.953 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -77.73 -50.68 11.9 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.225 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 28' ' ' GLY . 4.4 mm? -58.56 -45.55 88.75 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.87 -43.23 69.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.918 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -56.44 -62.02 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.322 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -101.77 -54.84 2.64 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -71.53 5.23 11.26 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.583 -0.341 . . . . 0.0 112.465 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 60.65 -162.9 19.93 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.49 142.81 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.865 0.364 . . . . 0.0 110.799 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.5 p -128.65 156.18 43.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.887 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.2 m -149.79 120.21 7.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.974 0.416 . . . . 0.0 111.227 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.87 119.89 21.98 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.366 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.91 -31.04 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.53 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -164.86 142.98 6.46 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.644 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 40' ' ' VAL . 10.8 p -109.73 142.84 21.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.873 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 38' ' ' GLY . 24.0 tt0 -162.34 99.06 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.027 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 49.37 -86.76 0.01 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.099 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -129.09 -13.42 2.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.768 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.7 mp -86.99 63.22 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.157 0.503 . . . . 0.0 110.276 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -78.68 125.91 38.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.845 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -87.57 148.7 24.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.594 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' GLU . 3.9 mt -143.87 167.88 21.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.915 0.388 . . . . 0.0 110.915 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.426 HE21 ' CG2' ' A' ' 79' ' ' VAL . 9.8 mp0 -142.01 120.81 12.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.923 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.445 HD13 ' NE2' ' A' ' 78' ' ' GLN . 6.9 tp -85.67 168.42 14.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.075 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -161.29 74.98 0.49 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.958 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.18 31.23 0.18 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.213 0 CA-C-O 120.552 0.215 . . . . 0.0 110.892 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.789 0.328 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.8 116.98 4.92 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.853 2.369 . . . . 0.0 112.113 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.1 p -82.56 -19.46 38.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.336 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -77.24 -42.31 37.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.626 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.7 m -52.61 -42.74 64.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.361 . . . . 0.0 110.246 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 56' ' ' ILE . 2.9 mm -60.01 -45.57 95.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.041 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.7 m -64.85 -46.01 83.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.511 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.0 tp -57.6 -51.35 69.85 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.052 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -50.74 -49.91 56.83 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.138 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.66 -29.32 69.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.578 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.07 -58.06 8.65 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 pt -61.71 -44.27 98.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -45.29 -65.12 0.58 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.614 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -54.97 -47.38 74.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.963 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.77 82.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.715 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 70' ' ' VAL . 9.3 mt -56.0 -45.31 79.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.63 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.694 ' CD2' HG21 ' A' ' 73' ' ' VAL . 27.9 m170 -54.35 -55.88 24.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.428 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -68.57 -29.07 67.54 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -85.71 -11.49 53.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.022 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' LEU . 1.9 t -151.97 57.13 2.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.15 142.32 4.13 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 123.369 2.713 . . . . 0.0 112.38 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 136.93 -31.96 2.49 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.694 HG21 ' CD2' ' A' ' 67' ' ' HIS . 5.2 m -65.6 145.18 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.007 0.432 . . . . 0.0 110.409 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.28 -28.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.282 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -165.02 171.11 14.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.719 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.31 158.62 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.442 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' LEU . 67.5 mt-10 -142.65 116.72 9.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.393 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.445 ' NE2' HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -125.3 86.61 2.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.812 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.426 ' CG2' HE21 ' A' ' 43' ' ' GLN . 12.9 m -89.59 178.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.043 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.09 179.575 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.482 ' N ' ' SD ' ' A' ' 8' ' ' MET . 1.2 mpp? -51.74 -46.21 63.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.634 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.415 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 13.0 t80 -41.0 -36.44 0.67 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.36 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -60.76 -62.56 1.77 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -52.85 63.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.123 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.755 HG23 ' N ' ' A' ' 13' ' ' ALA . 19.2 m -51.22 -60.34 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.989 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.755 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.24 -37.9 56.54 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.102 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.82 -60.48 3.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.609 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 m -55.68 -43.64 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.76 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 12' ' ' VAL . 14.9 mm -53.58 -48.79 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.034 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -53.47 -45.9 69.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.642 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -68.49 -37.58 80.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.338 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.63 -32.72 64.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.56 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.435 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 14.3 mtt180 -42.64 -63.21 0.99 Allowed Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.9 Cg_endo -46.15 -36.76 17.12 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.821 2.347 . . . . 0.0 112.986 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -75.46 -60.31 2.36 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.542 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 26.9 mt -58.52 -45.05 89.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.936 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.2 tp -51.39 -41.52 60.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.104 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.6 mtt85 -58.92 -54.28 48.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.407 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -100.91 -59.35 1.71 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -80.33 -77.73 0.95 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.911 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 170.71 -142.79 7.34 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -109.27 165.25 11.77 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 111.159 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.668 ' SG ' HD22 ' A' ' 42' ' ' LEU . 38.4 t -126.93 158.02 37.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.833 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.448 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 64.0 m -150.29 122.27 8.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.884 0.373 . . . . 0.0 111.204 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 33' ' ' VAL . 1.1 tt -69.14 128.22 35.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.864 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 32' ' ' LEU . 49.1 t -97.58 -39.79 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.199 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -155.48 118.54 4.33 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.677 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.9 p -81.85 142.14 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.814 ' CG ' ' H ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -158.93 -158.49 0.69 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.843 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.535 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -88.94 -46.27 9.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.406 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.567 ' H ' HD12 ' A' ' 39' ' ' ILE . . . -157.0 27.2 0.51 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.916 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.814 ' H ' ' CG ' ' A' ' 36' ' ' GLU . 1.1 mp -145.34 59.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.435 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -78.96 128.01 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.254 -178.176 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -91.06 145.16 24.92 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.668 HD22 ' SG ' ' A' ' 30' ' ' CYS . 2.9 mt -139.66 174.13 10.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.293 0.568 . . . . 0.0 111.47 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -146.31 126.72 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.021 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.689 ' H ' ' HB2' ' A' ' 80' ' ' PHE . 5.2 mt -86.88 -179.24 6.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.915 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.467 ' HA ' ' CE2' ' A' ' 80' ' ' PHE . 1.4 m-70 -162.82 63.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.03 -89.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.865 0.364 . . . . 0.0 110.42 -179.839 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 54' ' ' SER . 3.3 Cg_exo -73.2 28.33 0.3 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.673 2.248 . . . . 0.0 113.154 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -63.01 -9.93 12.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.425 ' N ' ' C ' ' A' ' 52' ' ' PRO . 8.4 m -90.73 -31.89 16.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.334 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.46 -42.79 54.85 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.17 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.528 HD13 ' N ' ' A' ' 56' ' ' ILE . 2.1 mm -56.02 -50.86 67.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.875 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 m -65.41 -54.91 21.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.05 -53.12 61.7 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.712 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -48.99 -47.24 44.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.4 69.69 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.188 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.63 -45.17 95.23 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.431 HG13 ' H ' ' A' ' 62' ' ' ILE . 0.9 OUTLIER -64.7 -60.67 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -43.72 -51.61 7.07 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.832 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -53.56 -50.86 64.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.696 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.62 -48.84 79.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.767 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 8.7 mp -58.62 -54.57 45.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.089 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.434 ' NE2' HG21 ' A' ' 73' ' ' VAL . 10.8 m170 -53.06 -44.07 67.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.349 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -64.61 -45.33 87.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.198 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.64 -9.58 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.102 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 66' ' ' LEU . 47.7 t -153.39 72.46 6.85 Favored Pre-proline 0 N--CA 1.463 0.184 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.79 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.96 37.32 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 123.153 2.569 . . . . 0.0 112.163 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -102.68 -21.14 10.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.434 HG21 ' NE2' ' A' ' 67' ' ' HIS . 3.7 m -64.07 160.72 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.11 -41.66 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.786 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HB3' HG23 ' A' ' 39' ' ' ILE . 3.2 mm-40 -164.54 157.03 16.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.993 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -149.94 156.18 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -143.8 78.17 1.58 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.111 0.481 . . . . 0.0 110.583 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.407 ' OE1' HD12 ' A' ' 44' ' ' LEU . 5.4 tm0? -102.33 96.39 6.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.36 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 2.9 m -111.18 161.58 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.689 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 6.5 t80 . . . . . 0 C--O 1.233 0.211 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.605 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.8 0.333 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 44.3 mtm -51.13 -45.04 61.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.81 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -42.79 -34.16 0.88 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.437 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.62 -63.69 1.21 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.036 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.3 tt0 -58.04 -58.87 6.51 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.029 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.766 HG23 ' N ' ' A' ' 13' ' ' ALA . 10.4 m -48.27 -60.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.528 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.766 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -50.07 -42.7 50.5 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.632 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.81 -51.68 63.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.77 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 11' ' ' GLN . 98.7 t -57.56 -61.64 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.312 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 12' ' ' VAL . 20.4 mm -48.54 -46.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.706 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -53.06 -43.26 66.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.347 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -66.55 -47.07 74.02 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.203 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 19' ' ' LEU . 7.4 mp -73.93 -33.53 63.98 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -34.84 -63.35 0.36 Allowed Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.2 Cg_exo -42.88 -39.04 7.34 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 123.119 2.546 . . . . 0.0 113.219 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -77.51 -50.34 12.82 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.516 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 27' ' ' GLY . 8.0 mp -55.93 -37.55 69.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.25 -60.94 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.475 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -54.57 -34.01 61.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.666 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.64 -57.63 2.07 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.263 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -100.41 -76.04 1.2 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.782 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 179.63 -150.75 9.52 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -111.05 137.11 49.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.815 0.34 . . . . 0.0 110.726 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.6 t -111.78 148.57 33.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.937 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.7 m -150.57 124.81 9.44 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.371 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.75 129.23 38.58 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.696 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.65 -35.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.763 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -160.27 134.16 7.15 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.318 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 40' ' ' VAL . 9.9 p -101.69 123.62 54.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.915 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.6 tp10 -148.9 80.32 1.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.764 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 t0 54.79 -81.29 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.122 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -124.87 -22.36 1.99 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.02 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.65 65.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.193 0.52 . . . . 0.0 110.296 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 35' ' ' VAL . 32.3 t -87.32 120.23 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.225 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -90.03 139.97 30.09 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.596 HD21 HG22 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -149.33 148.27 29.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 0.0 111.21 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -96.49 166.28 11.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.882 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 44' ' ' LEU . 23.5 tp -148.56 94.76 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.237 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -75.9 77.68 2.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.025 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.66 -88.19 0.19 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.74 0.305 . . . . 0.0 110.681 -179.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.4 t . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.803 0.335 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -70.3 106.2 1.71 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.587 2.191 . . . . 0.0 112.311 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.8 t -81.18 -11.06 59.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.394 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.6 t -86.66 -49.9 7.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.115 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -47.45 -35.16 8.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.998 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 90.0 mt -58.18 -46.68 88.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.1 m -64.48 -46.22 83.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.127 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.3 tp -57.5 -57.62 11.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.807 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -46.36 -54.87 8.2 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.21 68.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.613 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.97 -45.0 90.55 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -64.82 -62.23 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.519 0.2 . . . . 0.0 110.918 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -43.84 -51.94 7.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.9 0.381 . . . . 0.0 110.517 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.2 ttm-85 -55.4 -39.85 70.69 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.202 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -57.16 -42.92 81.99 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.342 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.44 -53.31 59.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -59.14 -59.88 4.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.387 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.69 -10.26 34.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.229 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.494 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 mt-10 -157.15 99.12 1.78 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.849 0.357 . . . . 0.0 110.376 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 69' ' ' GLU . 62.1 t 77.05 72.77 0.19 Allowed Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.175 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.84 -149.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 123.03 2.487 . . . . 0.0 111.35 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.19 -20.72 44.36 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 73' ' ' VAL . 3.3 m -64.54 151.02 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.023 0.439 . . . . 0.0 110.684 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.56 -30.55 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.411 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -159.91 154.31 23.8 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.463 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.596 HG22 HD21 ' A' ' 42' ' ' LEU . 8.2 p -149.15 119.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -96.53 124.72 40.61 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.468 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.48 83.2 1.97 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.103 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 79' ' ' VAL . 1.6 m -94.03 157.22 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 111.694 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--O 1.232 0.162 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.192 179.552 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.894 0.378 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 8' ' ' MET . 5.3 mpp? -49.08 -51.96 28.55 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.784 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -41.57 -39.36 1.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.066 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -59.36 -62.06 2.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -57.93 10.66 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.051 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.746 HG23 ' N ' ' A' ' 13' ' ' ALA . 8.5 m -51.03 -59.84 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.442 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.746 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.28 -42.03 63.38 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.13 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.4 -57.22 12.07 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.945 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.13 -48.86 86.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.203 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.6 mt -54.39 -53.37 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.593 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -50.87 -47.13 60.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.62 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -65.78 -38.31 88.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.054 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tp -76.85 -26.37 54.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.994 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 6.2 mtt180 -40.14 -60.92 1.27 Allowed Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.8 Cg_endo -43.83 -36.01 7.46 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.078 2.518 . . . . 0.0 113.184 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -75.53 -46.07 34.34 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' GLY . 4.6 mp -58.42 -38.5 77.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.669 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 24' ' ' LEU . 2.0 tt -54.5 -58.79 6.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -56.74 -34.65 67.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.567 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -100.4 -58.65 1.86 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.469 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -97.86 -76.2 1.27 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.76 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 178.15 -141.48 5.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -114.65 125.44 53.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.676 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 31' ' ' THR . 7.8 t -84.48 158.03 21.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.472 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.524 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 18.5 m -146.99 114.9 6.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.818 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tp -73.6 125.17 27.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.126 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.76 -47.59 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.814 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -165.37 143.51 6.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.95 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 35' ' ' VAL . 12.9 p -107.23 122.33 61.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.572 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.4 tp10 -141.0 88.48 2.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.734 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.7 t0 55.02 -79.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -131.0 -17.35 1.48 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.783 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.9 mp -84.88 60.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.051 0.453 . . . . 0.0 109.979 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 35' ' ' VAL . 2.1 t -74.62 115.96 16.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.763 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -88.98 140.5 29.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.146 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 42' ' ' LEU . 2.2 pt? -159.79 -178.76 7.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.294 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.88 170.72 15.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.165 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tt -150.51 138.64 20.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.595 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -162.34 130.79 4.1 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.91 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -106.21 -26.51 5.96 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 46' ' ' GLY . . . . . . . . 0 C--N 1.331 -0.208 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.793 0.33 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.53 121.42 7.42 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.709 2.272 . . . . 0.0 112.089 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t -86.94 -28.93 22.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.046 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.9 t -68.32 -41.95 80.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.621 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 m -65.97 -47.35 74.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.679 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.31 -48.86 85.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.685 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -64.5 -45.44 87.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.246 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.4 tp -57.94 -56.99 14.85 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.545 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -47.37 -54.29 11.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 110.156 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 64' ' ' ARG . . . -59.07 -21.24 58.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.31 -44.93 26.5 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.645 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -65.63 -61.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -43.89 -47.42 8.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.524 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.411 ' CG ' ' O ' ' A' ' 60' ' ' ALA . 14.4 mmt180 -54.38 -47.3 72.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.63 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.39 -54.74 43.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.521 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.088 ' O ' HG13 ' A' ' 70' ' ' VAL . 7.3 mp -55.48 -64.1 0.96 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.203 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -42.55 -50.87 5.28 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.951 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.98 -14.57 62.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.755 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 66' ' ' LEU . 32.0 mt-10 -155.76 98.44 1.92 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.088 HG13 ' O ' ' A' ' 66' ' ' LEU . 2.0 m -135.06 66.15 66.87 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.627 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 70' ' ' VAL . 3.2 Cg_exo -79.4 29.43 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.884 2.389 . . . . 0.0 111.301 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.45 -48.97 0.05 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.946 HG13 HG12 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -69.16 145.91 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.096 0.474 . . . . 0.0 110.659 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.604 HD12 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -122.02 -49.84 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.802 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -166.27 108.8 0.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.037 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -83.4 174.81 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -145.94 87.47 1.76 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.765 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.96 94.88 7.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.843 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 79' ' ' VAL . 17.0 m -87.0 168.39 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.959 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.336 179.686 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.854 0.359 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.447 ' O ' HG22 ' A' ' 12' ' ' VAL . 19.1 mmt -49.78 -59.8 3.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.292 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -44.23 -36.64 2.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.239 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -61.07 2.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -57.67 -55.77 30.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.978 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 13' ' ' ALA . 18.6 m -51.66 -63.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.171 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.777 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -47.29 -38.99 13.62 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 120.086 -0.645 . . . . 0.0 109.565 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.9 -63.99 1.01 Allowed 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.073 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 16' ' ' ILE . 4.8 m -62.32 -45.26 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.483 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 12' ' ' VAL . 23.4 mm -53.87 -62.17 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.801 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -53.78 -31.37 48.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 55.1 ttt180 -66.97 -50.64 61.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 19' ' ' LEU . 11.0 mp -79.03 -21.49 46.83 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.536 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 12.9 ttm180 -37.3 -43.28 1.18 Allowed Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 20' ' ' ARG . 3.4 Cg_exo -77.5 -28.31 5.59 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.292 1.995 . . . . 0.0 112.506 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -77.08 -46.9 22.04 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.633 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 27' ' ' GLY . 12.4 mt -55.78 -37.8 69.06 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 24' ' ' LEU . 1.3 tt -57.45 -56.06 26.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -54.07 -35.19 61.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.988 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -100.99 -60.94 1.43 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -102.03 -76.31 1.17 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.816 -0.513 . . . . 0.0 111.816 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 24' ' ' LEU . . . -173.0 -138.31 2.57 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -130.94 123.7 29.45 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.421 -0.458 . . . . 0.0 110.602 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.1 p -94.93 159.53 14.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.54 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.7 m -150.75 124.75 9.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.136 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 41' ' ' LYS . 25.6 tp -77.25 123.08 25.96 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.847 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.11 -34.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.066 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -167.98 139.49 2.91 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.885 0.374 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 35' ' ' VAL . 14.8 p -104.04 126.8 58.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.761 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -149.64 77.76 1.34 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.662 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.9 t70 55.38 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.021 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.73 -21.6 5.34 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 39' ' ' ILE . 3.2 mp -84.05 63.79 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.374 0.607 . . . . 0.0 109.883 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.18 118.97 33.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.125 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.414 ' O ' HD12 ' A' ' 32' ' ' LEU . 46.9 mttp -85.26 139.66 31.45 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -139.72 169.6 17.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 0.0 111.176 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -145.41 112.86 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.108 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' CD2' HG23 ' A' ' 55' ' ' THR . 9.7 tp -91.02 105.53 17.89 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.343 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -78.35 86.25 4.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.503 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.96 91.63 1.75 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.823 0.344 . . . . 0.0 111.022 -179.807 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 51' ' ' CYS . 21.7 t . . . . . 0 C--O 1.233 0.216 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 51' ' ' CYS . 3.0 Cg_exo -76.96 114.95 3.92 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.993 2.462 . . . . 0.0 111.895 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.3 p -83.36 -17.81 41.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.029 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -78.6 -49.58 13.0 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.948 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.496 HG23 ' CD2' ' A' ' 44' ' ' LEU . 53.9 m -41.67 -39.88 1.79 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.899 0.38 . . . . 0.0 110.179 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.2 mt -61.24 -53.35 50.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.591 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 94.2 m -62.88 -36.11 82.23 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.718 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 tp -57.17 -57.23 13.5 Favored 'General case' 0 CA--C 1.523 -0.063 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.524 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -48.35 -54.81 12.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.176 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.14 -21.57 61.76 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.036 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.56 -44.23 41.32 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 5.9 mt -60.62 -58.86 5.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -45.07 -52.96 8.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.93 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -53.45 -41.27 65.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.481 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 62' ' ' ILE . . . -58.34 -47.43 83.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.172 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.4 mt -59.36 -59.62 5.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.024 0.44 . . . . 0.0 110.496 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -53.59 -56.88 13.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.508 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -68.76 -12.02 60.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.637 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' C ' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -152.78 98.99 2.4 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.514 HG23 ' C ' ' A' ' 69' ' ' GLU . 11.2 t 86.28 78.52 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.533 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.9 -151.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.451 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.22 -21.78 22.76 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.78 142.24 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.065 0.459 . . . . 0.0 110.3 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.75 -39.02 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.326 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -164.74 108.97 0.92 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.084 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 77' ' ' GLU . 8.8 p -84.16 176.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.379 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.725 ' H ' HG22 ' A' ' 76' ' ' VAL . 15.7 mt-10 -147.33 85.65 1.6 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.995 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.85 91.04 3.98 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.181 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.2 m -93.63 174.77 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.121 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.773 -179.851 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.444 ' C ' ' HG1' ' A' ' 3' ' ' THR . 2.9 Cg_endo -75.05 -81.06 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.814 2.343 . . . . 0.0 111.801 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.444 ' HG1' ' C ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER -172.99 158.66 3.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.147 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -81.36 37.64 0.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -53.68 175.41 0.14 Allowed Pre-proline 0 N--CA 1.456 -0.133 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 5' ' ' ASN . 3.7 Cg_exo -39.83 91.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.821 1.681 . . . . 0.0 110.469 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 5' ' ' ASN . 75.7 p -66.76 -175.27 0.39 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.95 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.623 ' O ' HG13 ' A' ' 12' ' ' VAL . 20.3 mtt -50.23 -53.75 25.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.624 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -39.92 -51.88 2.45 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.964 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -56.53 -51.16 69.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.717 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.487 ' O ' HG22 ' A' ' 15' ' ' VAL . 4.4 mt-30 -61.29 -60.02 4.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.642 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 8' ' ' MET . 1.1 m -54.47 -54.22 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.72 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.603 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -52.28 -43.92 64.68 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.177 0.513 . . . . 0.0 109.743 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -61.6 -61.8 2.26 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.458 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 11' ' ' GLN . 34.1 m -60.51 -40.22 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.337 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 12' ' ' VAL . 26.8 mt -54.72 -64.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.841 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -30.59 32.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.717 0.294 . . . . 0.0 111.051 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -68.06 -51.41 46.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.602 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.2 -22.52 55.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.569 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 9.8 mtp180 -36.84 -60.58 0.76 Allowed Pre-proline 0 N--CA 1.469 0.494 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.9 Cg_endo -45.9 -39.26 19.13 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.809 2.339 . . . . 0.0 112.406 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -75.15 -43.7 51.03 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.403 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.3 mt -59.48 -48.73 80.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.285 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.1 tp -53.08 -43.67 66.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.8 mmm-85 -58.04 -48.04 81.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.037 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.75 -57.5 2.06 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -90.73 -76.41 1.32 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.462 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.5 -136.83 3.66 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.406 ' HB2' ' CE1' ' A' ' 45' ' ' HIS . 4.1 m-20 -130.77 131.15 44.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.48 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.1 t -95.33 156.19 16.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 85.2 m -149.93 114.07 5.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.375 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 tp -69.6 126.77 30.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.258 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.98 -39.07 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.955 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -157.82 133.78 9.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.023 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 35' ' ' VAL . 7.7 p -104.05 117.98 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.971 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -120.32 -179.18 3.88 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.964 0.411 . . . . 0.0 110.76 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -13.93 62.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.33 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.43 -32.69 0.03 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.801 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.6 mp -84.7 59.98 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.019 0.437 . . . . 0.0 110.602 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 41' ' ' LYS . 1.2 t -69.51 163.75 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.153 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.493 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -151.19 121.08 7.09 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.378 -179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -129.72 -179.66 5.32 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.205 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -144.08 117.91 9.33 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.022 0.439 . . . . 0.0 111.103 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tp -92.12 148.01 22.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.087 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.435 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 16.1 p80 -164.27 120.08 1.55 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 0.0 110.711 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.11 -25.53 6.7 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -173.75 -103.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.8 t -175.84 98.82 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.619 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' H ' ' CB ' ' A' ' 82' ' ' GLU . . . -119.06 -148.4 8.33 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 52.2 p -140.25 -44.4 0.42 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.737 0.304 . . . . 0.0 110.415 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 97.1 m -135.99 79.57 44.41 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.065 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HG3' ' H ' ' A' ' 83' ' ' HIS . 3.3 Cg_exo -74.74 118.34 5.27 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.932 2.421 . . . . 0.0 112.391 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.8 t -91.04 -24.15 20.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.235 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -84.43 -41.99 16.09 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.89 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -56.85 -35.6 69.05 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.463 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.7 mt -59.19 -47.51 90.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.143 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 m -63.98 -50.4 68.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.191 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.68 -45.69 88.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.409 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -46.1 -58.72 3.38 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.558 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.1 68.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.443 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.34 -56.62 14.56 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -53.62 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -43.93 -56.2 4.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.71 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -54.79 -47.81 73.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.643 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.06 84.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.73 -56.07 26.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.373 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -54.61 -43.26 72.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.02 -45.8 80.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -81.84 -2.15 50.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.132 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.5 t -152.47 70.11 7.4 Favored Pre-proline 0 C--N 1.332 -0.179 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.01 125.36 9.79 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.893 2.396 . . . . 0.0 111.986 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.72 -13.38 1.75 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 m -65.17 165.75 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.105 0.479 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.19 -34.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.575 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -163.6 156.44 18.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.103 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -152.39 124.91 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.901 0.382 . . . . 0.0 110.706 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -99.64 98.96 9.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.619 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -103.93 94.89 5.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.802 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 79' ' ' VAL . 17.5 m -87.62 121.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.35 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -94.79 139.93 30.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.254 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 tp -95.95 44.66 1.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.695 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' CB ' ' H ' ' A' ' 49' ' ' GLY . 2.6 mp0 64.05 154.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.327 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.496 ' H ' ' HG3' ' A' ' 52' ' ' PRO . 12.5 t-160 -178.85 76.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.587 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -59.51 179.21 0.12 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.907 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -134.35 156.66 48.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.715 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -57.02 11.65 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.56 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.408 ' CG ' ' N ' ' A' ' 88' ' ' HIS . 28.3 t-80 -164.66 162.59 21.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.364 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.408 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 8.0 t60 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.459 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.581 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 2.8 ttm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 1' ' ' MET . 3.4 Cg_exo -73.36 -176.17 2.35 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.444 2.096 . . . . 0.0 112.23 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.02 170.06 0.7 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.009 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -136.56 29.26 2.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.37 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.473 ' H ' ' CD ' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -103.12 -49.26 0.16 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.872 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.473 ' CD ' ' H ' ' A' ' 5' ' ' ASN . 2.8 Cg_endo -76.84 40.87 0.84 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.756 2.304 . . . . 0.0 111.413 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 8' ' ' MET . 0.2 OUTLIER -71.72 -161.11 0.06 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.496 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.531 ' H ' HG22 ' A' ' 7' ' ' THR . 46.6 mtt -49.86 -45.13 50.14 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.79 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -41.64 -35.3 0.73 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.55 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.39 -61.84 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.21 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.55 -54.41 47.31 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.754 HG23 ' N ' ' A' ' 13' ' ' ALA . 15.3 m -52.34 -60.3 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.635 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.754 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -51.23 -41.73 60.52 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -65.21 -55.55 17.87 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.797 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.56 -51.75 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.033 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 20' ' ' ARG . 49.2 mt -52.68 -49.42 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.712 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -50.49 -47.23 57.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.907 0.384 . . . . 0.0 110.179 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -69.7 -42.21 74.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.37 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tp -74.92 -22.85 58.36 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' CB ' ' CD ' ' A' ' 21' ' ' PRO . 14.4 mtt180 -43.14 -63.25 1.03 Allowed Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.619 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 20' ' ' ARG . 2.4 Cg_endo -44.78 -28.36 2.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.975 2.45 . . . . 0.0 112.509 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -77.42 -51.46 10.76 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.865 0.364 . . . . 0.0 110.321 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.522 HD13 ' SG ' ' A' ' 30' ' ' CYS . 11.3 mt -57.62 -41.87 82.17 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.76 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 24' ' ' LEU . 1.2 tt -54.5 -54.07 45.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.552 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -56.42 -34.68 67.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.366 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -101.34 -58.96 1.78 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -101.08 -75.72 1.16 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -178.11 -147.6 6.99 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -106.99 133.68 51.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.889 0.376 . . . . 0.0 110.389 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 23' ' ' LEU . 55.0 m -97.86 150.88 20.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.102 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.9 m -148.71 111.97 4.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 110.531 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.67 129.89 40.86 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.054 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.56 -39.46 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.395 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -163.09 143.53 9.24 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.498 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 40' ' ' VAL . 69.9 t -108.78 103.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.904 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 18.1 tt0 -104.89 176.89 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.981 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.469 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.5 m-20 -55.45 -9.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.88 -24.85 0.06 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.649 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.2 mp -83.23 62.08 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.247 0.546 . . . . 0.0 110.225 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 35' ' ' VAL . 2.3 t -74.73 117.54 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -84.39 150.14 25.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.409 HD23 ' HG3' ' A' ' 78' ' ' GLN . 38.7 tp -144.63 160.24 41.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.18 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -144.4 109.16 4.94 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.856 0.36 . . . . 0.0 111.095 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.91 143.42 26.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.303 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 10.5 p80 -162.21 112.7 1.56 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.145 0.497 . . . . 0.0 110.603 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.62 -84.41 1.78 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.57 -90.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.657 0.265 . . . . 0.0 110.357 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.5 p -143.63 7.33 1.48 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.37 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.48 28.16 22.9 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -72.18 61.94 0.47 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.087 0.47 . . . . 0.0 110.419 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.405 ' C ' ' O ' ' A' ' 50' ' ' THR . 7.6 p 32.64 76.82 0.37 Allowed Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.562 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.07 134.14 19.08 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 112.452 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t -93.54 -25.9 17.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.424 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 p -83.98 -44.72 13.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.547 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 m -50.88 -32.19 19.73 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.823 0.344 . . . . 0.0 110.397 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.8 mt -57.54 -42.84 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.178 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -64.73 -53.45 47.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.346 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 tp -57.06 -46.9 82.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.303 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -48.97 -52.61 23.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.03 -23.12 66.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.632 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.68 -59.73 4.29 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.31 -49.14 84.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.242 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -45.49 -60.74 2.01 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.428 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -53.17 -45.9 68.68 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.623 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.56 -57.89 10.7 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.676 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.47 -49.39 74.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.105 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -51.11 -40.35 58.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.362 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.4 -55.63 29.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.761 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.87 -120.39 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.409 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' ' CD ' ' A' ' 71' ' ' PRO . 10.9 t 36.53 53.24 2.37 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.579 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 70' ' ' VAL . 2.7 Cg_endo -42.46 99.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.074 2.516 . . . . 0.0 112.003 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 130.84 -9.11 5.77 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.94 141.5 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.029 0.442 . . . . 0.0 110.499 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.72 -50.5 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.507 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -164.86 109.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.998 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.08 179.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.622 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -148.67 86.63 1.53 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.159 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.409 ' HG3' HD23 ' A' ' 42' ' ' LEU . 7.0 tt0 -101.75 90.39 4.0 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.304 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 m -89.55 176.05 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.456 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -109.97 108.63 18.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.236 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 tp -89.73 91.88 8.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.488 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -71.77 0.09 9.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.394 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -92.29 94.05 8.96 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.992 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.472 ' CG ' ' N ' ' A' ' 85' ' ' HIS . 37.2 t-80 -59.18 -104.65 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.356 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.472 ' N ' ' CG ' ' A' ' 84' ' ' HIS . 15.9 t-80 58.13 164.89 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 111.065 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -131.31 153.96 49.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.266 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -87.21 -48.93 7.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.372 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.036 179.743 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -74.66 134.04 17.91 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.775 2.317 . . . . 0.0 111.511 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.542 HG22 ' N ' ' A' ' 4' ' ' GLU . 25.8 m -77.72 164.77 24.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.132 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.542 ' N ' HG22 ' A' ' 3' ' ' THR . 85.2 mt-10 -93.17 32.35 1.32 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.932 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.452 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.5 OUTLIER -100.66 -51.37 0.18 Allowed Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.452 ' HD3' ' CB ' ' A' ' 5' ' ' ASN . 2.5 Cg_endo -81.35 98.22 1.01 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.682 2.255 . . . . 0.0 110.116 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.5 p -71.2 176.8 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.358 . . . . 0.0 110.973 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' PHE . 21.1 mtp -51.68 -53.42 39.19 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.321 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 8' ' ' MET . 28.4 t80 -36.25 -48.07 0.61 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.638 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.0 -52.17 66.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.485 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.43 -68.95 0.25 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.811 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.606 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.3 m -46.55 -52.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.986 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.606 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.27 -49.31 61.46 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -63.48 -53.96 43.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.163 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.84 -54.36 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.247 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.2 mt -51.9 -56.04 7.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.739 0.304 . . . . 0.0 110.612 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -50.58 -33.21 21.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -66.15 -56.66 10.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.287 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mt -75.27 -24.46 57.56 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.542 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 4.3 ttp180 -35.7 -59.84 0.7 Allowed Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.734 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.0 Cg_endo -44.62 -36.54 10.32 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.877 2.385 . . . . 0.0 112.254 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -76.87 -45.09 29.56 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.459 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 27' ' ' GLY . 11.1 mp -60.84 -47.33 86.85 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.554 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -54.27 45.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 0.0 111.199 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -56.62 -39.42 73.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.574 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -98.88 -57.25 2.22 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -98.32 -77.19 1.32 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.219 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -176.22 -158.83 20.71 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -108.69 139.99 42.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.711 0.291 . . . . 0.0 110.668 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 31' ' ' THR . 4.4 t -108.45 156.56 19.32 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 5.9 m -149.89 119.36 6.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.761 0.315 . . . . 0.0 110.772 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -69.48 112.81 6.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.761 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.3 t -78.98 -45.31 24.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.988 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -166.73 142.93 4.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.946 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.438 ' HA ' HG22 ' A' ' 40' ' ' VAL . 9.7 p -110.68 127.44 67.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.97 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 38' ' ' GLY . 17.3 tt0 -152.75 99.17 2.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.282 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 52.69 -85.55 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.721 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -129.1 -12.09 2.68 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.0 mp -83.83 60.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.08 0.467 . . . . 0.0 110.023 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.3 t -81.99 111.49 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.689 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -88.11 129.01 35.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.494 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.68 144.62 37.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 110.98 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -99.97 165.03 11.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.189 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.438 ' HB3' HE21 ' A' ' 78' ' ' GLN . 4.5 tp -150.1 100.96 2.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.758 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -78.97 97.38 6.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.289 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -70.93 69.44 0.78 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' O ' ' SG ' ' A' ' 48' ' ' CYS . . . 70.25 -46.35 0.61 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.054 0.142 . . . . 0.0 111.229 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 47' ' ' ALA . 2.1 m -166.18 31.5 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.72 0.295 . . . . 0.0 110.817 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.16 179.84 28.66 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 50' ' ' THR . 5.2 t -41.46 114.98 0.57 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.566 0.222 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.455 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -178.28 -63.92 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.13 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 51' ' ' CYS . 3.2 Cg_exo -45.02 124.28 5.78 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.7 2.266 . . . . 0.0 112.238 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -82.13 -20.37 38.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.862 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 94.3 p -85.29 -30.43 23.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.391 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -45.62 -33.66 2.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 110.19 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.7 mt -58.72 -43.77 88.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.496 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.6 m -63.25 -50.82 68.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.381 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mp -60.44 -46.98 88.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.649 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -45.58 -61.8 1.55 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.74 -24.79 64.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.53 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.58 -59.36 7.27 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -51.2 72.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.189 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -43.72 -53.66 5.68 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.419 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -53.7 -56.79 14.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.676 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.9 -51.35 66.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.417 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 70' ' ' VAL . 97.4 mt -59.38 -56.03 27.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.327 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -50.72 -40.88 55.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.639 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -63.08 -57.03 12.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.868 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -84.02 -118.93 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.241 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 66' ' ' LEU . 9.0 t 35.91 53.89 2.23 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.642 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 70' ' ' VAL . 3.0 Cg_endo -42.15 109.38 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 123.253 2.635 . . . . 0.0 112.34 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.21 -8.32 12.38 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.01 147.71 12.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 121.053 0.454 . . . . 0.0 111.021 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.01 -32.62 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.896 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.01 107.33 0.62 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.88 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.583 HG22 ' H ' ' A' ' 77' ' ' GLU . 7.0 p -88.38 171.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.583 ' H ' HG22 ' A' ' 76' ' ' VAL . 3.6 mm-40 -142.78 117.28 9.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.898 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 44' ' ' LEU . 14.3 tm0? -112.87 88.71 2.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.615 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.9 m -92.31 153.64 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.82 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -95.99 -179.57 4.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.031 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 tp -71.48 75.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 110.085 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -53.67 161.08 1.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.585 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -73.56 -58.28 3.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.651 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 61.99 139.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.57 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -164.14 136.15 4.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.523 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -114.0 84.05 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.937 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -66.72 -163.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.467 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t60 . . . . . 0 C--O 1.223 -0.34 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.068 179.49 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -74.53 -83.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.689 2.26 . . . . 0.0 111.882 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.83 147.35 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.623 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -48.29 -42.46 30.94 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.609 ' HB2' ' CD ' ' A' ' 6' ' ' PRO . 7.5 p30 43.7 -165.87 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.486 0 O-C-N 123.534 0.521 . . . . 0.0 110.006 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.609 ' CD ' ' HB2' ' A' ' 5' ' ' ASN . 3.9 Cg_exo -68.97 84.69 0.52 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 N-CA-C 108.874 -1.241 . . . . 0.0 108.874 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 8' ' ' MET . 1.1 m -63.01 168.08 4.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.767 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.458 ' O ' HG22 ' A' ' 12' ' ' VAL . 13.1 mmt -46.99 -54.46 10.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.21 -40.77 1.67 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.996 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.32 -60.04 4.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.874 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -57.06 14.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.886 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.754 HG23 ' N ' ' A' ' 13' ' ' ALA . 13.2 m -51.57 -59.21 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.38 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.754 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.47 -41.28 63.2 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.986 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -63.29 -58.84 5.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.048 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.8 t -58.98 -52.7 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.041 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.5 mt -55.58 -51.63 56.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.921 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -51.35 -40.5 59.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.009 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.7 mtt-85 -66.17 -45.88 79.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.7 mt -74.69 -24.56 58.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.159 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 18.3 mtt-85 -36.9 -62.07 0.59 Allowed Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.6 Cg_endo -45.53 -48.34 12.03 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.639 2.226 . . . . 0.0 112.277 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -76.52 -45.12 32.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.654 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.9 tp -58.55 -53.48 57.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.032 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 24' ' ' LEU . 4.4 tt -47.25 -45.21 23.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.858 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -55.39 -62.03 1.95 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.353 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -102.95 -52.67 3.0 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -82.17 5.46 71.92 Favored Glycine 0 N--CA 1.47 0.916 0 CA-C-O 119.992 -0.338 . . . . 0.0 113.901 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 66.75 -159.38 48.87 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -122.71 145.42 48.41 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.901 0.382 . . . . 0.0 111.38 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.9 m -116.9 170.21 8.79 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.92 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 96.6 m -151.33 123.68 8.33 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.436 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.5 tp -74.02 109.8 7.81 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.08 -31.35 6.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.616 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -165.01 139.62 5.09 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.484 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.621 ' HA ' HG22 ' A' ' 40' ' ' VAL . 7.3 p -107.57 137.96 36.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.797 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -154.2 85.34 1.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.705 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 56.52 -86.12 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.94 -15.49 2.86 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.6 mp -86.99 62.23 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 0.0 109.96 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.621 HG22 ' HA ' ' A' ' 35' ' ' VAL . 1.4 t -81.33 121.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.888 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -84.98 151.79 23.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.415 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mt -140.91 171.28 14.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 110.997 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -146.5 121.72 10.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.554 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.428 HD13 ' CG2' ' A' ' 55' ' ' THR . 1.2 mt -84.11 162.44 20.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.843 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -155.87 78.55 0.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.025 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -145.13 50.95 0.62 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 46' ' ' GLY . . . 67.84 98.94 0.05 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.018 0.437 . . . . 0.0 110.606 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.4 m -52.48 -35.32 52.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.809 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 57.82 -119.85 18.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.4 t -152.76 -36.77 0.11 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.787 0.327 . . . . 0.0 110.398 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 29.5 p -151.95 48.88 0.5 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.847 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 51' ' ' CYS . 2.8 Cg_endo -46.21 112.85 0.5 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.9 2.4 . . . . 0.0 111.967 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.7 t -89.33 -21.15 23.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.564 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.1 p -80.35 -41.28 25.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.994 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.428 ' CG2' HD13 ' A' ' 44' ' ' LEU . 3.8 m -57.71 -42.79 84.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.929 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -59.44 -45.83 93.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.536 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.3 m -64.52 -44.96 89.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.484 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -57.56 -55.99 27.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.398 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -46.19 -55.48 7.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.55 -27.34 66.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.23 -52.24 37.79 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -53.13 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -43.72 -59.05 2.38 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.16 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.75 -50.64 65.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.936 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.32 -45.08 88.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.573 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 70' ' ' VAL . 27.9 mt -58.53 -53.85 53.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -54.55 -41.14 69.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.786 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.74 -48.49 74.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -81.77 -7.94 59.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.538 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 70' ' ' VAL . 97.7 t -153.76 71.26 6.61 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 120.966 0.412 . . . . 0.0 110.088 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.91 125.68 8.22 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.993 2.462 . . . . 0.0 111.742 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.59 -0.3 1.91 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.551 -0.619 . . . . 0.0 111.551 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.4 m -62.79 153.62 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.157 0.504 . . . . 0.0 110.484 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.14 -63.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.428 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -164.76 107.33 0.86 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 77' ' ' GLU . 11.3 p -84.12 166.73 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.922 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.564 ' N ' HG22 ' A' ' 76' ' ' VAL . 14.0 mt-10 -143.59 128.33 18.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.029 0.443 . . . . 0.0 110.591 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.413 HE22 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -133.43 87.94 2.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.655 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.6 m -85.23 168.81 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.949 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -93.35 -179.32 5.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.884 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.1 tp -88.04 -9.57 52.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.915 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -96.32 -10.6 27.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.099 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -103.36 77.07 1.48 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.174 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -58.45 156.89 9.63 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.041 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -122.19 -24.96 4.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.99 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 52.4 -92.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.472 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 51.34 -118.59 1.29 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.872 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' ND1' ' N ' ' A' ' 88' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.785 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -45.74 148.95 2.21 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.346 2.697 . . . . 0.0 112.452 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.666 HG22 ' H ' ' A' ' 4' ' ' GLU . 8.2 m 60.88 175.22 0.1 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.165 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.666 ' H ' HG22 ' A' ' 3' ' ' THR . 2.0 tp10 -121.69 19.92 11.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.848 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.543 ' H ' ' CD ' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -107.04 -45.8 0.12 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.264 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' A' ' 5' ' ' ASN . 2.8 Cg_endo -77.58 47.23 2.23 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 122.661 2.241 . . . . 0.0 110.865 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.9 p -69.35 179.51 1.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.992 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.442 ' O ' HG13 ' A' ' 12' ' ' VAL . 42.2 mtt -47.36 -51.58 19.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.853 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -40.59 -44.64 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -57.42 -55.66 31.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.565 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -57.8 -65.7 0.59 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.656 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.617 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 1.3 m -49.14 -52.97 9.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.617 ' N ' ' CG2' ' A' ' 12' ' ' VAL . . . -51.92 -46.87 64.81 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -65.16 -54.41 30.18 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.952 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 11' ' ' GLN . 40.8 t -57.53 -49.21 81.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.996 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.2 mt -53.61 -61.14 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -54.35 -35.73 63.07 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.656 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.4 tpt85 -65.76 -50.9 63.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.668 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tp -78.14 -22.1 49.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.798 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.59 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 43.7 ttm180 -36.86 -55.01 1.66 Allowed Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.8 Cg_endo -41.6 -37.42 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.839 2.36 . . . . 0.0 112.477 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -77.59 -48.7 16.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.0 110.133 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.2 mt -60.08 -43.48 95.44 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.946 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.6 tp -56.13 -56.41 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.991 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -58.11 -32.82 68.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -100.64 -57.78 2.04 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.148 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -96.47 -75.49 1.26 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 170.53 -148.71 11.75 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -105.5 132.33 51.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.876 0.37 . . . . 0.0 110.318 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.594 ' SG ' HD22 ' A' ' 42' ' ' LEU . 33.0 t -119.26 153.97 34.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.317 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.5 m -149.87 124.02 9.46 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.897 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -74.65 122.03 22.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.926 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.02 -29.04 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.732 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -163.58 128.11 2.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.813 0.339 . . . . 0.0 110.583 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 35' ' ' VAL . 11.5 p -92.93 122.2 44.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.038 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.65 165.42 27.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.315 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -47.6 -55.18 9.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.58 -22.2 0.62 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 39' ' ' ILE . 2.1 mp -87.77 59.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.906 0.384 . . . . 0.0 110.35 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.74 123.04 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.112 0.482 . . . . 0.0 111.349 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -87.91 143.41 27.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.75 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.594 HD22 ' SG ' ' A' ' 30' ' ' CYS . 3.7 mt -136.14 162.55 32.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.867 0.365 . . . . 0.0 110.688 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -147.58 116.44 6.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.953 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.97 171.31 13.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -158.3 84.27 0.85 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.836 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.51 -3.65 64.59 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 53.93 23.87 4.23 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.839 0.352 . . . . 0.0 110.814 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 50' ' ' THR . 7.5 t -139.58 39.23 2.04 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.74 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.71 74.1 0.11 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.511 -1.035 . . . . 0.0 110.511 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 48' ' ' CYS . 20.4 p -137.69 -54.88 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.969 0.414 . . . . 0.0 110.164 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.55 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 19.4 p -156.46 47.38 0.29 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.358 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 51' ' ' CYS . 2.5 Cg_endo -46.32 105.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 123.175 2.583 . . . . 0.0 112.207 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -97.28 -28.43 14.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.188 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -89.64 -32.65 16.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.984 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.6 m -59.94 -30.11 68.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.58 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.76 -57.56 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.7 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.3 m -62.77 -45.68 91.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.555 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 58' ' ' LEU . 2.9 mm? -58.16 -57.51 12.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.332 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -46.26 -56.86 5.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -27.24 67.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.493 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.71 -48.09 51.81 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -63.5 -53.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -43.84 -59.92 2.04 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.727 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -38.01 71.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.29 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 62' ' ' ILE . . . -59.18 -50.0 75.7 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.561 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.644 ' O ' HG12 ' A' ' 70' ' ' VAL . 9.1 mp -56.67 -50.13 73.02 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.503 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -54.75 -52.95 60.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.07 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.9 -25.2 67.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.571 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -84.11 -10.47 57.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.83 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.701 ' O ' HG13 ' A' ' 70' ' ' VAL . 7.8 p -156.14 55.67 1.13 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 120.92 0.391 . . . . 0.0 110.965 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.72 124.66 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 123.058 2.506 . . . . 0.0 111.925 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.78 16.61 3.64 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.9 m -65.13 155.49 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.326 0.584 . . . . 0.0 111.225 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mm -102.73 -60.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.268 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -165.7 104.19 0.7 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.597 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 77' ' ' GLU . 7.9 p -87.88 161.39 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.52 ' N ' HG22 ' A' ' 76' ' ' VAL . 32.2 mt-10 -145.42 124.07 12.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.0 110.857 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.57 88.13 2.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.746 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.9 m -86.35 173.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.895 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -95.54 -179.5 4.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.698 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.683 ' C ' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -65.85 1.0 1.5 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.644 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' N ' HD13 ' A' ' 81' ' ' LEU . 36.8 mm-40 -63.5 139.06 58.73 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.87 14.72 2.68 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.806 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -139.32 80.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.192 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 86' ' ' HIS . 12.1 t-160 -89.46 -140.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.969 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.605 ' H ' ' CG ' ' A' ' 85' ' ' HIS . 27.7 t-80 48.85 -130.79 1.81 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.526 ' H ' ' CG ' ' A' ' 86' ' ' HIS . 0.4 OUTLIER -153.83 -66.79 0.14 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.969 0.414 . . . . 0.0 109.906 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.3 t60 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.095 179.783 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.28 -170.6 0.83 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.849 2.366 . . . . 0.0 111.87 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 4' ' ' GLU . 71.2 p -67.62 -108.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.172 0.511 . . . . 0.0 110.548 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' N ' ' OG1' ' A' ' 3' ' ' THR . 1.8 tp10 63.31 6.37 2.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.286 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.497 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -63.5 -47.81 82.54 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.6 Cg_endo -79.41 94.79 1.05 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.728 2.285 . . . . 0.0 110.885 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.3 p -73.79 -175.7 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.745 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -48.95 60.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.082 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -40.15 -41.92 1.36 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.736 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.83 -58.02 9.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.162 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.872 ' O ' HG22 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -61.02 -60.54 3.62 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.52 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.776 HG23 ' N ' ' A' ' 13' ' ' ALA . 10.0 m -46.0 -61.33 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.791 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.776 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.28 -42.53 63.79 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.175 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -64.43 -61.87 1.95 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.133 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 11' ' ' GLN . 11.8 m -61.59 -44.83 99.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.665 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' ARG . 52.4 mt -55.41 -52.62 44.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.333 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.23 -37.32 67.02 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.812 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -67.07 -52.48 41.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.588 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 19' ' ' LEU . 10.4 mp -75.65 -20.78 58.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.106 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' ILE . 28.2 ttm-85 -33.63 -59.16 0.5 Allowed Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.807 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.0 Cg_exo -42.42 -35.13 3.52 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.606 2.204 . . . . 0.0 111.953 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -77.73 -50.68 11.9 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.225 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 28' ' ' GLY . 4.4 mm? -58.56 -45.55 88.75 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.87 -43.23 69.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.918 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -56.44 -62.02 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.322 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -101.77 -54.84 2.64 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -71.53 5.23 11.26 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.583 -0.341 . . . . 0.0 112.465 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 60.65 -162.9 19.93 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.49 142.81 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.865 0.364 . . . . 0.0 110.799 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.5 p -128.65 156.18 43.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.887 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.2 m -149.79 120.21 7.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.974 0.416 . . . . 0.0 111.227 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 tt -77.87 119.89 21.98 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.366 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.91 -31.04 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.53 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -164.86 142.98 6.46 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.644 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 40' ' ' VAL . 10.8 p -109.73 142.84 21.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.873 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 38' ' ' GLY . 24.0 tt0 -162.34 99.06 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.027 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 49.37 -86.76 0.01 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.099 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -129.09 -13.42 2.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.768 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.7 mp -86.99 63.22 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.157 0.503 . . . . 0.0 110.276 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -78.68 125.91 38.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.845 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -87.57 148.7 24.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.594 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' GLU . 3.9 mt -143.87 167.88 21.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.915 0.388 . . . . 0.0 110.915 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.426 HE21 ' CG2' ' A' ' 79' ' ' VAL . 9.8 mp0 -142.01 120.81 12.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.923 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.445 HD13 ' NE2' ' A' ' 78' ' ' GLN . 6.9 tp -85.67 168.42 14.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.075 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -161.29 74.98 0.49 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.958 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.18 31.23 0.18 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.08 2.27 18.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.552 0.215 . . . . 0.0 110.892 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.2 t -69.25 73.64 0.32 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.973 0.416 . . . . 0.0 110.57 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.73 36.49 0.16 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.5 p 44.29 70.43 0.33 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.926 0.393 . . . . 0.0 110.92 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.1 m 56.35 81.39 0.26 Allowed Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.641 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.8 116.98 4.92 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.853 2.369 . . . . 0.0 112.113 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.1 p -82.56 -19.46 38.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.336 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -77.24 -42.31 37.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.626 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.7 m -52.61 -42.74 64.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.361 . . . . 0.0 110.246 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 56' ' ' ILE . 2.9 mm -60.01 -45.57 95.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.041 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.7 m -64.85 -46.01 83.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.511 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.0 tp -57.6 -51.35 69.85 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.052 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -50.74 -49.91 56.83 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.138 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.66 -29.32 69.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.578 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.07 -58.06 8.65 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.7 pt -61.71 -44.27 98.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -45.29 -65.12 0.58 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.614 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -54.97 -47.38 74.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.963 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.77 82.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.715 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 70' ' ' VAL . 9.3 mt -56.0 -45.31 79.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.63 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.694 ' CD2' HG21 ' A' ' 73' ' ' VAL . 27.9 m170 -54.35 -55.88 24.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.428 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -68.57 -29.07 67.54 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -85.71 -11.49 53.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.022 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' LEU . 1.9 t -151.97 57.13 2.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.15 142.32 4.13 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 123.369 2.713 . . . . 0.0 112.38 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 136.93 -31.96 2.49 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.694 HG21 ' CD2' ' A' ' 67' ' ' HIS . 5.2 m -65.6 145.18 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.007 0.432 . . . . 0.0 110.409 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.28 -28.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.282 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -165.02 171.11 14.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.719 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.31 158.62 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.442 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' LEU . 67.5 mt-10 -142.65 116.72 9.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.393 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.445 ' NE2' HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -125.3 86.61 2.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.812 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.426 ' CG2' HE21 ' A' ' 43' ' ' GLN . 12.9 m -89.59 178.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.043 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -110.28 144.74 38.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.09 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tp -70.05 75.79 0.49 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.887 0.375 . . . . 0.0 110.645 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 49.1 63.62 2.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -94.94 70.01 3.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -154.42 -57.27 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.963 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -92.34 -156.3 0.46 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.855 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -142.1 -166.07 2.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.384 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -87.15 -7.14 58.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.429 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 . . . . . 0 C--O 1.222 -0.381 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.771 179.88 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.0 ttp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -75.49 -88.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.75 2.3 . . . . 0.0 111.567 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.8 m -161.59 -36.41 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.436 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.85 15.4 7.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.34 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -57.63 -50.32 88.81 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.172 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.9 Cg_endo -77.08 91.19 1.19 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.653 2.235 . . . . 0.0 110.815 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 p -75.19 -170.84 1.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.854 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.482 ' N ' ' SD ' ' A' ' 8' ' ' MET . 1.2 mpp? -51.74 -46.21 63.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.634 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.415 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 13.0 t80 -41.0 -36.44 0.67 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.36 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -60.76 -62.56 1.77 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -52.85 63.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.123 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.755 HG23 ' N ' ' A' ' 13' ' ' ALA . 19.2 m -51.22 -60.34 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.989 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.755 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.24 -37.9 56.54 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.102 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.82 -60.48 3.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.609 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 m -55.68 -43.64 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.76 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 12' ' ' VAL . 14.9 mm -53.58 -48.79 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.034 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -53.47 -45.9 69.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.642 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -68.49 -37.58 80.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.338 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.63 -32.72 64.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.56 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.435 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 14.3 mtt180 -42.64 -63.21 0.99 Allowed Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.9 Cg_endo -46.15 -36.76 17.12 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.821 2.347 . . . . 0.0 112.986 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -75.46 -60.31 2.36 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.542 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 26.9 mt -58.52 -45.05 89.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.936 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.2 tp -51.39 -41.52 60.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.104 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.6 mtt85 -58.92 -54.28 48.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.407 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -100.91 -59.35 1.71 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -80.33 -77.73 0.95 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.911 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 170.71 -142.79 7.34 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -109.27 165.25 11.77 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 111.159 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.668 ' SG ' HD22 ' A' ' 42' ' ' LEU . 38.4 t -126.93 158.02 37.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.833 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.448 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 64.0 m -150.29 122.27 8.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.884 0.373 . . . . 0.0 111.204 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 33' ' ' VAL . 1.1 tt -69.14 128.22 35.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.864 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 32' ' ' LEU . 49.1 t -97.58 -39.79 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.199 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -155.48 118.54 4.33 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.677 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.9 p -81.85 142.14 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.814 ' CG ' ' H ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -158.93 -158.49 0.69 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.843 -178.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.535 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -88.94 -46.27 9.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.406 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.567 ' H ' HD12 ' A' ' 39' ' ' ILE . . . -157.0 27.2 0.51 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.916 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.814 ' H ' ' CG ' ' A' ' 36' ' ' GLU . 1.1 mp -145.34 59.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.435 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -78.96 128.01 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.254 -178.176 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -91.06 145.16 24.92 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.668 HD22 ' SG ' ' A' ' 30' ' ' CYS . 2.9 mt -139.66 174.13 10.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.293 0.568 . . . . 0.0 111.47 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -146.31 126.72 14.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.021 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.689 ' H ' ' HB2' ' A' ' 80' ' ' PHE . 5.2 mt -86.88 -179.24 6.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.915 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.467 ' HA ' ' CE2' ' A' ' 80' ' ' PHE . 1.4 m-70 -162.82 63.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.403 ' H ' ' HG2' ' A' ' 82' ' ' GLU . . . -54.03 -89.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.78 39.33 0.27 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.865 0.364 . . . . 0.0 110.42 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 67.4 m 57.18 62.59 2.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.688 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.34 -175.88 10.4 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.3 p -115.97 -38.54 3.63 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.764 0.316 . . . . 0.0 110.618 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.5 p -128.49 89.44 49.56 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.163 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 54' ' ' SER . 3.3 Cg_exo -73.2 28.33 0.3 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.673 2.248 . . . . 0.0 113.154 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -63.01 -9.93 12.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.425 ' N ' ' C ' ' A' ' 52' ' ' PRO . 8.4 m -90.73 -31.89 16.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.334 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.46 -42.79 54.85 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.17 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.528 HD13 ' N ' ' A' ' 56' ' ' ILE . 2.1 mm -56.02 -50.86 67.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.875 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 m -65.41 -54.91 21.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.721 HD11 ' O ' ' A' ' 85' ' ' HIS . 1.2 tt -57.05 -53.12 61.7 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.712 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -48.99 -47.24 44.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.4 69.69 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.188 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.63 -45.17 95.23 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.431 HG13 ' H ' ' A' ' 62' ' ' ILE . 0.9 OUTLIER -64.7 -60.67 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -43.72 -51.61 7.07 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.832 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -53.56 -50.86 64.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.696 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.62 -48.84 79.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.767 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 8.7 mp -58.62 -54.57 45.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.089 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.434 ' NE2' HG21 ' A' ' 73' ' ' VAL . 10.8 m170 -53.06 -44.07 67.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.349 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -64.61 -45.33 87.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.198 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.64 -9.58 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.102 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 66' ' ' LEU . 47.7 t -153.39 72.46 6.85 Favored Pre-proline 0 N--CA 1.463 0.184 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.79 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.96 37.32 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 123.153 2.569 . . . . 0.0 112.163 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -102.68 -21.14 10.68 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.434 HG21 ' NE2' ' A' ' 67' ' ' HIS . 3.7 m -64.07 160.72 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.11 -41.66 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.786 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HB3' HG23 ' A' ' 39' ' ' ILE . 3.2 mm-40 -164.54 157.03 16.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.993 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -149.94 156.18 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -143.8 78.17 1.58 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.111 0.481 . . . . 0.0 110.583 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.407 ' OE1' HD12 ' A' ' 44' ' ' LEU . 5.4 tm0? -102.33 96.39 6.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.36 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 2.9 m -111.18 161.58 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.689 ' HB2' ' H ' ' A' ' 44' ' ' LEU . 6.5 t80 179.79 -179.4 0.45 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.605 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' N ' ' CG ' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -114.18 52.43 0.83 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.728 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' OE2' HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -142.47 -147.97 0.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.286 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.659 ' O ' HD13 ' A' ' 58' ' ' LEU . 2.6 m-70 -136.69 -47.78 0.62 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.707 ' HB3' HD22 ' A' ' 58' ' ' LEU . 2.9 t-80 89.66 -158.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.531 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.721 ' O ' HD11 ' A' ' 58' ' ' LEU . 6.0 t60 -121.22 -96.02 0.48 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.791 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.556 ' N ' ' CG ' ' A' ' 85' ' ' HIS . 16.2 m-70 -168.04 -170.52 1.34 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.829 0.347 . . . . 0.0 110.459 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 87' ' ' HIS . 82.1 t60 -84.97 13.98 5.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.545 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.833 -179.87 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.8 mtt . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.35 169.86 21.54 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.849 2.366 . . . . 0.0 111.405 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 5' ' ' ASN . 2.9 m -90.91 150.81 21.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.661 0.267 . . . . 0.0 110.47 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' CD ' ' N ' ' A' ' 4' ' ' GLU . 17.7 mp0 -99.82 5.57 45.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.525 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -69.0 -46.04 30.66 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.186 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.5 Cg_endo -78.51 87.95 1.49 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.507 2.138 . . . . 0.0 110.726 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -74.64 165.52 25.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 44.3 mtm -51.13 -45.04 61.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.81 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -42.79 -34.16 0.88 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.437 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.62 -63.69 1.21 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.036 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.491 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.3 tt0 -58.04 -58.87 6.51 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.029 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.766 HG23 ' N ' ' A' ' 13' ' ' ALA . 10.4 m -48.27 -60.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.528 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.766 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -50.07 -42.7 50.5 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.632 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.81 -51.68 63.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.77 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 11' ' ' GLN . 98.7 t -57.56 -61.64 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.312 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 12' ' ' VAL . 20.4 mm -48.54 -46.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.706 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -53.06 -43.26 66.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.347 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -66.55 -47.07 74.02 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.203 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 19' ' ' LEU . 7.4 mp -73.93 -33.53 63.98 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -34.84 -63.35 0.36 Allowed Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 3.2 Cg_exo -42.88 -39.04 7.34 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 123.119 2.546 . . . . 0.0 113.219 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -77.51 -50.34 12.82 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.516 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 27' ' ' GLY . 8.0 mp -55.93 -37.55 69.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.25 -60.94 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.475 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -54.57 -34.01 61.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.666 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.64 -57.63 2.07 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.263 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -100.41 -76.04 1.2 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.782 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 179.63 -150.75 9.52 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -111.05 137.11 49.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.815 0.34 . . . . 0.0 110.726 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.6 t -111.78 148.57 33.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.937 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.7 m -150.57 124.81 9.44 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.371 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.75 129.23 38.58 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.696 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.65 -35.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.763 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -160.27 134.16 7.15 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.318 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 40' ' ' VAL . 9.9 p -101.69 123.62 54.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.915 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 38' ' ' GLY . 6.6 tp10 -148.9 80.32 1.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.764 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 t0 54.79 -81.29 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.122 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -124.87 -22.36 1.99 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.02 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.65 65.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.193 0.52 . . . . 0.0 110.296 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 35' ' ' VAL . 32.3 t -87.32 120.23 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.225 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -90.03 139.97 30.09 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.596 HD21 HG22 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -149.33 148.27 29.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 0.0 111.21 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -96.49 166.28 11.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.882 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 44' ' ' LEU . 23.5 tp -148.56 94.76 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.237 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -75.9 77.68 2.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.025 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.66 -88.19 0.19 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.23 12.93 4.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.74 0.305 . . . . 0.0 110.681 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.4 t -55.49 -13.26 1.42 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.634 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.37 165.7 12.58 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.6 t -58.92 134.66 57.13 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.4 t 48.97 72.88 1.12 Allowed Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.441 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -70.3 106.2 1.71 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.587 2.191 . . . . 0.0 112.311 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.8 t -81.18 -11.06 59.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.394 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.6 t -86.66 -49.9 7.17 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.115 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -47.45 -35.16 8.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.998 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 90.0 mt -58.18 -46.68 88.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.1 m -64.48 -46.22 83.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.127 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.3 tp -57.5 -57.62 11.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.807 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -46.36 -54.87 8.2 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.21 68.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.613 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.97 -45.0 90.55 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -64.82 -62.23 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.519 0.2 . . . . 0.0 110.918 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -43.84 -51.94 7.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.9 0.381 . . . . 0.0 110.517 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.2 ttm-85 -55.4 -39.85 70.69 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.202 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -57.16 -42.92 81.99 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.342 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.44 -53.31 59.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -59.14 -59.88 4.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.387 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.69 -10.26 34.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.229 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 mt-10 -157.15 99.12 1.78 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.849 0.357 . . . . 0.0 110.376 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 69' ' ' GLU . 62.1 t 77.05 72.77 0.19 Allowed Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.175 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.84 -149.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 123.03 2.487 . . . . 0.0 111.35 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.19 -20.72 44.36 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 73' ' ' VAL . 3.3 m -64.54 151.02 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.023 0.439 . . . . 0.0 110.684 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.56 -30.55 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.411 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -159.91 154.31 23.8 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.463 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.596 HG22 HD21 ' A' ' 42' ' ' LEU . 8.2 p -149.15 119.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -96.53 124.72 40.61 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.468 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.48 83.2 1.97 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.103 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 79' ' ' VAL . 1.6 m -94.03 157.22 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.1 0.476 . . . . 0.0 111.694 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -99.55 177.35 5.19 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.192 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.4 tp -94.59 81.01 3.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.99 0.424 . . . . 0.0 109.877 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -39.02 -88.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.231 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.57 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -51.35 94.64 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.462 ' ND1' ' O ' ' A' ' 85' ' ' HIS . 57.0 t-80 -62.73 130.21 43.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.228 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.462 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -84.74 -170.18 2.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.277 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.423 ' O ' ' CG ' ' A' ' 86' ' ' HIS . 20.3 t-160 -119.78 59.24 0.87 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.074 0.464 . . . . 0.0 110.246 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.6 m80 43.8 25.28 0.09 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.007 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.408 ' OXT' ' CG ' ' A' ' 88' ' ' HIS . 9.8 t60 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.49 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.418 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 1' ' ' MET . 2.7 Cg_endo -45.5 136.68 11.87 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.881 2.388 . . . . 0.0 112.015 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.94 162.63 3.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.896 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -152.82 36.98 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.164 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.529 ' H ' ' CD ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -105.4 -46.62 0.13 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.332 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.529 ' CD ' ' H ' ' A' ' 5' ' ' ASN . 2.8 Cg_endo -77.88 54.94 5.06 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.779 2.319 . . . . 0.0 111.15 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -70.21 178.25 2.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.849 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 8' ' ' MET . 5.3 mpp? -49.08 -51.96 28.55 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.784 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -41.57 -39.36 1.57 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.066 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -59.36 -62.06 2.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -57.93 10.66 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.051 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.746 HG23 ' N ' ' A' ' 13' ' ' ALA . 8.5 m -51.03 -59.84 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.442 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.746 ' N ' HG23 ' A' ' 12' ' ' VAL . . . -52.28 -42.03 63.38 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.13 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.4 -57.22 12.07 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.945 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.13 -48.86 86.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.203 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.6 mt -54.39 -53.37 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.593 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -50.87 -47.13 60.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.62 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -65.78 -38.31 88.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.054 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tp -76.85 -26.37 54.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.994 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 6.2 mtt180 -40.14 -60.92 1.27 Allowed Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 2.8 Cg_endo -43.83 -36.01 7.46 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.078 2.518 . . . . 0.0 113.184 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -75.53 -46.07 34.34 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' GLY . 4.6 mp -58.42 -38.5 77.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.669 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 24' ' ' LEU . 2.0 tt -54.5 -58.79 6.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.119 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -56.74 -34.65 67.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.567 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -100.4 -58.65 1.86 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.469 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -97.86 -76.2 1.27 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.76 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 178.15 -141.48 5.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -114.65 125.44 53.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.676 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 31' ' ' THR . 7.8 t -84.48 158.03 21.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.472 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.524 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 18.5 m -146.99 114.9 6.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.818 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tp -73.6 125.17 27.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.126 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.76 -47.59 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.814 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -165.37 143.51 6.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.95 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 35' ' ' VAL . 12.9 p -107.23 122.33 61.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.572 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.4 tp10 -141.0 88.48 2.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.734 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.7 t0 55.02 -79.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.142 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 36' ' ' GLU . . . -131.0 -17.35 1.48 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.783 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.9 mp -84.88 60.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.051 0.453 . . . . 0.0 109.979 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 35' ' ' VAL . 2.1 t -74.62 115.96 16.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.763 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -88.98 140.5 29.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.146 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 42' ' ' LEU . 2.2 pt? -159.79 -178.76 7.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.294 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.88 170.72 15.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.165 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tt -150.51 138.64 20.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.595 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -162.34 130.79 4.1 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.91 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -106.21 -26.51 5.96 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 46' ' ' GLY . . . 172.25 -79.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.2 p -173.13 -50.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.974 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 43.46 -134.88 5.22 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.81 -42.39 0.06 Allowed 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.0 m -154.18 77.04 5.62 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.554 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.53 121.42 7.42 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.709 2.272 . . . . 0.0 112.089 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t -86.94 -28.93 22.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.046 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.9 t -68.32 -41.95 80.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.621 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 m -65.97 -47.35 74.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.679 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.31 -48.86 85.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.685 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.0 m -64.5 -45.44 87.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.246 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.4 tp -57.94 -56.99 14.85 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.545 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -47.37 -54.29 11.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 110.156 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 64' ' ' ARG . . . -59.07 -21.24 58.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.31 -44.93 26.5 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.645 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -65.63 -61.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -43.89 -47.42 8.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.524 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.411 ' CG ' ' O ' ' A' ' 60' ' ' ALA . 14.4 mmt180 -54.38 -47.3 72.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.63 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.39 -54.74 43.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.521 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.088 ' O ' HG13 ' A' ' 70' ' ' VAL . 7.3 mp -55.48 -64.1 0.96 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.203 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -42.55 -50.87 5.28 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.951 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.98 -14.57 62.76 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.755 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 66' ' ' LEU . 32.0 mt-10 -155.76 98.44 1.92 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.088 HG13 ' O ' ' A' ' 66' ' ' LEU . 2.0 m -135.06 66.15 66.87 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.627 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 70' ' ' VAL . 3.2 Cg_exo -79.4 29.43 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.884 2.389 . . . . 0.0 111.301 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.45 -48.97 0.05 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.946 HG13 HG12 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -69.16 145.91 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.096 0.474 . . . . 0.0 110.659 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.604 HD12 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -122.02 -49.84 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.802 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -166.27 108.8 0.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.037 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -83.4 174.81 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -145.94 87.47 1.76 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.765 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.96 94.88 7.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.843 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 79' ' ' VAL . 17.0 m -87.0 168.39 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.959 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -112.52 121.13 43.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.336 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 tp -65.24 82.88 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.049 0.452 . . . . 0.0 110.513 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -60.23 179.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -176.8 0.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.738 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.438 ' H ' ' H ' ' A' ' 83' ' ' HIS . 20.1 p-80 -72.78 -172.73 1.05 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.701 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -113.26 -88.22 0.55 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.089 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -111.25 63.17 0.61 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.008 0.433 . . . . 0.0 110.562 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.414 ' CD2' ' H ' ' A' ' 88' ' ' HIS . 32.4 t60 -75.64 168.19 20.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.54 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.414 ' H ' ' CD2' ' A' ' 87' ' ' HIS . 35.2 m80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.703 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -45.45 148.02 2.37 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.8 2.333 . . . . 0.0 111.938 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.79 130.49 2.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.617 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -92.2 26.45 2.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.379 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -101.39 -47.28 0.2 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.261 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 5' ' ' ASN . 2.5 Cg_endo -81.45 77.03 4.11 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.567 2.178 . . . . 0.0 110.702 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -73.68 -174.93 1.89 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.854 0.359 . . . . 0.0 111.006 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.447 ' O ' HG22 ' A' ' 12' ' ' VAL . 19.1 mmt -49.78 -59.8 3.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.292 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -44.23 -36.64 2.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.239 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -61.07 2.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -57.67 -55.77 30.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.978 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 13' ' ' ALA . 18.6 m -51.66 -63.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.171 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.777 ' H ' HG23 ' A' ' 12' ' ' VAL . . . -47.29 -38.99 13.62 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 120.086 -0.645 . . . . 0.0 109.565 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.9 -63.99 1.01 Allowed 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.073 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 16' ' ' ILE . 4.8 m -62.32 -45.26 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.483 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 12' ' ' VAL . 23.4 mm -53.87 -62.17 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.801 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -53.78 -31.37 48.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 55.1 ttt180 -66.97 -50.64 61.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 19' ' ' LEU . 11.0 mp -79.03 -21.49 46.83 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.536 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.456 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 12.9 ttm180 -37.3 -43.28 1.18 Allowed Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 20' ' ' ARG . 3.4 Cg_exo -77.5 -28.31 5.59 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.292 1.995 . . . . 0.0 112.506 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -77.08 -46.9 22.04 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.633 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 27' ' ' GLY . 12.4 mt -55.78 -37.8 69.06 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 24' ' ' LEU . 1.3 tt -57.45 -56.06 26.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -54.07 -35.19 61.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.988 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -100.99 -60.94 1.43 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -102.03 -76.31 1.17 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.816 -0.513 . . . . 0.0 111.816 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 24' ' ' LEU . . . -173.0 -138.31 2.57 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -130.94 123.7 29.45 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.421 -0.458 . . . . 0.0 110.602 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.1 p -94.93 159.53 14.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.54 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.7 m -150.75 124.75 9.28 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.136 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 41' ' ' LYS . 25.6 tp -77.25 123.08 25.96 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.847 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.11 -34.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.066 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -167.98 139.49 2.91 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.885 0.374 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 35' ' ' VAL . 14.8 p -104.04 126.8 58.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.761 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -149.64 77.76 1.34 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.662 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.9 t70 55.38 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.021 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.73 -21.6 5.34 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 39' ' ' ILE . 3.2 mp -84.05 63.79 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.374 0.607 . . . . 0.0 109.883 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.18 118.97 33.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.125 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.414 ' O ' HD12 ' A' ' 32' ' ' LEU . 46.9 mttp -85.26 139.66 31.45 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -139.72 169.6 17.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 0.0 111.176 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -145.41 112.86 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.108 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' CD2' HG23 ' A' ' 55' ' ' THR . 9.7 tp -91.02 105.53 17.89 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.343 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -78.35 86.25 4.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.503 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 48' ' ' CYS . . . -86.96 91.63 1.75 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.52 1.03 0.88 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.823 0.344 . . . . 0.0 111.022 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 36.9 t -96.32 58.94 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.883 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 50' ' ' THR . . . -63.44 111.84 4.47 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 51' ' ' CYS . 0.1 OUTLIER 175.48 -100.98 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.607 ' H ' HG23 ' A' ' 50' ' ' THR . 21.7 t -149.23 65.62 8.09 Favored Pre-proline 0 C--O 1.233 0.216 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 51' ' ' CYS . 3.0 Cg_exo -76.96 114.95 3.92 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.993 2.462 . . . . 0.0 111.895 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.3 p -83.36 -17.81 41.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.029 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -78.6 -49.58 13.0 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.948 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.496 HG23 ' CD2' ' A' ' 44' ' ' LEU . 53.9 m -41.67 -39.88 1.79 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.899 0.38 . . . . 0.0 110.179 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.2 mt -61.24 -53.35 50.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.591 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 94.2 m -62.88 -36.11 82.23 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.718 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 tp -57.17 -57.23 13.5 Favored 'General case' 0 CA--C 1.523 -0.063 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.524 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -48.35 -54.81 12.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.176 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.14 -21.57 61.76 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.036 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.56 -44.23 41.32 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 5.9 mt -60.62 -58.86 5.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -45.07 -52.96 8.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.93 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -53.45 -41.27 65.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.481 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 62' ' ' ILE . . . -58.34 -47.43 83.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.172 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.4 mt -59.36 -59.62 5.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.024 0.44 . . . . 0.0 110.496 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -53.59 -56.88 13.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.508 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -68.76 -12.02 60.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.637 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' C ' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -152.78 98.99 2.4 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.514 HG23 ' C ' ' A' ' 69' ' ' GLU . 11.2 t 86.28 78.52 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.533 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.9 -151.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 123.069 2.513 . . . . 0.0 112.451 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.22 -21.78 22.76 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.8 t -65.78 142.24 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.065 0.459 . . . . 0.0 110.3 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.75 -39.02 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.326 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -164.74 108.97 0.92 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.084 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 77' ' ' GLU . 8.8 p -84.16 176.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.379 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.725 ' H ' HG22 ' A' ' 76' ' ' VAL . 15.7 mt-10 -147.33 85.65 1.6 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.995 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.85 91.04 3.98 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.181 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.2 m -93.63 174.77 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.121 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -97.94 164.86 12.19 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.8 tp -76.26 -72.42 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.297 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -177.02 144.77 0.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.52 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.529 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 1.0 OUTLIER -86.79 -68.39 0.75 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -154.72 97.34 1.96 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.248 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -157.35 88.15 1.0 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.218 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -91.01 -47.97 7.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.848 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -124.73 164.94 18.86 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.482 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.7 p80 . . . . . 0 C--O 1.218 -0.556 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.593 179.964 . . . . . . . . 0 0 . 1 stop_ save_